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ABSTRACT IN ENGLISH 
The present thesis is focused on genomic epidemiology of bacterial hospital infections. The 
hospital environment is unique, as it concentrates a high number of bacterial agents, 
frequent antibiotic use, and patients with weak immune systems. This combination favours 
the development and selection of antibiotic resistant strains and the spread of opportunistic 
infections: in general the thriving of nosocomial pathogens. Genomics and evolutionary 
approaches have emerged as the cutting edge tools for studying this kind of infections, 
allowing to study the genomic features of bacterial strains and their evolution. Thanks to the 
possibility to sequence DNA at a constantly cheaper price, research projects are supported 
by a growing number of genomes and a considerable amount of genomic data is available in 
the databases, expanding the amount of possible investigations that can be performed. 
The first work presented here describes the evolution of the Clonal Complex 258 (CC258) of 
Klebsiella pneumoniae. Single nucleotide polymorphisms (SNPs) allowed to reconstruct the 
global phylogeny of the entire species and to collocate the CC258 in its evolutionary context. 
Furthermore, it was possible to detect the presence of a 1.3 Mb recombination in the 
genomes of the clade in analysis. A molecular clock approach allowed to date this and other 
previously discovered recombination events. These findings were used to complete the 
picture of the evolutionary history of CC258, which is characterized by frequent macro-
recombination events. A quick evolutive strategy characterized by exchange of high amount 
of information is a common feature to other nosocomial pathogens, which develop 
“superbug” phenotypes. 
Although common, the macro-recombination evolution model is not shared by all nosocomial 
infection bacteria. One exception is the SMAL strain of Acinetobacter baumannii, presented 
in another subproject of this thesis. In this work, the genomes of Sequence Type (ST) 78 of 
A. baumannii were analyzed. Phylogeny and comparative genomics revealed the presence 
of two different clades within the ST, presenting different evolutive “lifestyles”. One group 
(containing the SMAL genomes) was characterized by a lower gene content variability and 
by the presence of a higher copy number of insertion sequences (ISs). One IS interrupts the 
comEC/rec2 gene in all the SMAL genomes. This gene codes for a protein involved in the 
exogenous DNA importation, thus its inactivation limits the gene exchange, suggesting an 
explanation for the low genomic plasticity. 
In another work presented in this document, genomic epidemiology was applied to 
reconstruct the spreading routes of a K. pneumoniae epidemic event in an hospital intensive 
care unit. At first, a phylogenetic approach was used to separate the isolates that belonged 
to the outbreak from the sporadic ones. Then the isolation dates and genomic SNPs allowed 
to build a genomic network, which modelled the chain of infection events in the ward. The 
reconstruction suggested a star-like diffusion of the pathogen from patient zero to the other 
infected ones, thus revealing a systematic error in the biosafety procedures of the hospital. 
This almost-forensic application of genomic epidemiology was also used in two other works 
presented, both of them concerning the reconstruction of food-borne infections. In one of the 
works, focused on Salmonella enterica, only synonymous SNPs were used as input to a 
phylogenetic based investigation, in order to filter out pathoadaptative mutations. In the other 
article, epidemiological data, molecular typing and SNP-based phylogeny were used to 
investigate the infection of nine Listeria monocytogenes isolates, which were believed to be 
part of the same outbreak and in the end proved to be genomically unrelated. 
Lastly, a review paper on genomic epidemiology is also presented. The article is focused on 
the latest high impact publications analyzing the genome evolution of bacterial pathogens as 
well as the propagation dynamics of epidemic outbreaks in very short periods of time. The 
article also describes the latest historical epidemiological studies, which are possible thanks 
to modern DNA isolation and sequencing technologies. 
ABSTRACT IN ITALIANO 
La presente tesi è incentrata sull'epidemiologia genomica delle infezioni batteriche 
ospedaliere. L'ambiente ospedaliero è peculiare, in quanto al suo interno si concentrano un 
elevato numero di agenti batterici, pazienti con un sistema immunitario debole e un uso 
massiccio di sostanze antimicrobiche. Questa combinazione favorisce lo sviluppo e la 
selezione di ceppi resistenti agli antibiotici e la diffusione di infezioni opportunistiche: in 
generale il prosperare dei patogeni nosocomiali. Alcune tecniche all'avanguardia per lo 
studio di questo tipo di infezioni sono basate sull’uso della genomica e di approcci 
evoluzionistici: esse permettono di conoscere le caratteristiche genomiche dei ceppi batterici 
e di ricostruire la loro storia evolutiva. Grazie alla possibilità di sequenziare il DNA ad un 
prezzo sempre più economico, i progetti di ricerca sono supportati da un numero sempre 
crescente di genomi e i dati genomici depositati nelle banche dati sono in crescita 
esponenziale: questo rende possibile eseguire una varietà sempre maggiore di analisi. 
Il primo lavoro qui riportato descrive l'evoluzione del Clonal Complex 258 (CC258) di 
Klebsiella pneumoniae. Le mutazioni puntiformi (single nucleotide polymorphism, SNP) 
hanno permesso di ricostruire la filogenesi globale di tutta la specie e di collocare il CC258 
nel suo contesto evolutivo. Successivamente, è stato possibile rilevare la presenza di una 
ricombinazione di 1,3 Mb nei genomi del clade in analisi. Un’analisi del molecular clock ha 
poi consentito di datare sia questo che gli altri eventi di ricombinazione scoperti in lavori 
precedenti. Questi risultati sono stati usati per completare il quadro della storia evolutiva del 
CC258, caratterizzata da frequenti eventi di macro-ricombinazione. Un’evoluzione rapida e 
caratterizzata da scambi di elevate quantità di informazioni genomiche è una caratteristica 
comune ad altri patogeni nosocomiali che sviluppano fenotipi da "superbatteri". 
Sebbene frequente, il modello di evoluzione per macro-ricombinazioni non è comune a tutti i 
batteri responsabili di infezioni nosocomiali. Un’eccezione è il ceppo SMAL di Acinetobacter 
baumannii, presentato in un altro sottoprogetto di questa tesi. In questo lavoro sono stati 
analizzati i genomi del sequence type (ST) 78 di A. baumannii. La filogenesi e la genomica 
comparativa hanno rivelato la presenza di due differenti cladi all'interno del ST che 
presentano differenti "stili" evolutivi. Un gruppo (contenente i genomi SMAL) è caratterizzato 
da una minore variabilità del contenuto genico e dalla presenza di un numero più elevato di 
copie di insertion sequence (IS). Una IS interrompe il gene comEC/rec2 in tutti i genomi 
SMAL. Questo gene codifica per una proteina coinvolta nell’acquisizione del DNA esogeno, 
quindi la sua inattivazione limita lo scambio di geni. Questo suggerisce una spiegazione per 
la bassa plasticità genomica. 
In un altro lavoro presentato in questa tesi, l'epidemiologia genomica è stata applicata per 
ricostruire la diffusione di un focolaio epidemico di K. pneumoniae in un’unità di terapia 
intensiva ospedaliera. In un primo momento, è stato utilizzato un approccio filogenetico per 
separare gli isolati appartenenti all'epidemia da quelli sporadici. Poi le date di isolamento e 
gli SNP genomici hanno permesso di costruire una rete genomica che modellasse la 
propagazione delle infezioni nel reparto. La ricostruzione ha indicato una diffusione radiale 
del patogeno dal paziente zero a tutti gli altri infetti, rivelando così un errore sistematico nelle 
procedure di biosicurezza dell'ospedale. 
Questa applicazione quasi forense dell'epidemiologia genomica è stata utilizzata anche in 
altri due lavori qui presentati, entrambi riguardanti la ricostruzione di infezioni alimentari. In 
uno degli articoli, incentrato su Salmonella enterica, l’analisi filogenetica è stata eseguita 
solamente con gli SNP sinonimi al fine di filtrare le mutazioni patoadattative. Nell'altro lavoro 
sono stati utilizzati dati epidemiologici, tipizzazione molecolare e filogenesi basata sugli SNP 
per studiare l'infezione di nove isolati di Listeria monocytogenes, che si ritenevano essere 
parte dello stesso focolaio e alla fine sono risultati genomicamente non correlati. 
Infine, viene qui presentato anche un articolo di review riguardante l'epidemiologia 
genomica. L'articolo è focalizzato sulle ultime pubblicazioni ad alto impatto che analizzano 
l'evoluzione genomica degli agenti patogeni batterici e le dinamiche di propagazione delle 
epidemie in brevi periodi di tempo. L'articolo descrive, infine, le ultime ricostruzioni 
epidemiologiche a livello storico, che sono possibili grazie alle moderne tecnologie di 
isolamento e sequenza del DNA. 
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Nosocomial infections. Prokaryotes have appeared on our planet billions of years before 
humans and they have always influenced and shaped our life. Indeed, prokaryotes interact 
with virtually all other life forms, playing multiple important roles, from beneficial symbiosis to 
harmful pathogenesis. They inhabit a big share of the human body, living on the skin, in the 
gut, and in the nasal cavity. Moreover, prokaryotes cover every surface we touch and 
populate every environment we live in. Thus, the interaction with them cannot be avoided, 
but evolution has shaped our immune system in order to restrict the relationship to some 
species and only in certain body compartments. For example, our food is almost completely 
sterilized by the acid environment of the stomach but colonized right afterwards by the gut 
microbiota. Microbial spillover from the gut to other body compartments is a common 
phenomenon but is always controlled and restricted by the immune system. 
Problems occur when the immune system is weakened, i.e. with old age, during recovery 
from surgery or in the presence of pathological states such as AIDS or cancer. By this 
conditions, normally harmless commensals are free to invade and heavily colonize body 
districts in which they are normally not allowed such as the blood stream, the urinary tract or 
even the brain. Such infections occur mostly in the hospital environment (in this case they 
are labelled nosocomial infections). 
The Centers for Disease Control and Prevention (CDC) has classified nosocomial infection 
into 13 types, with 50 infection sites, which are specific on the basis of biological and clinical 
criteria. The most common types are urinary tract infections (UTI), surgical and soft tissue 
infections, gastroenteritis, meningitis and respiratory infections (1). In 2011, the number of 
recorded hospital infections in the USA alone was over 722,000 (2). According to the CDC, 
the total cost for the treatment of healthcare associated infections is around 30 billion US 
Dollars (3). In Italy, the number of infections in one year is between 450,000 and 700,000. 
One percent of these are estimated to be the direct cause of the death of the patient (4). 
Bacteria are responsible for about ninety percent of infections, while protozoans, fungi, 
viruses and mycobacteria take the remaining 10% share. The species that are usually 
involved in hospital-acquired infections include Streptococcus spp., Acinetobacter spp., 
enterococci, Staphylococcus aureus, Bacillus cereus, Pseudomonas aeruginosa, coagulase-
negative staphylococci, Legionella and Enterobacteriaceae family members including 
Proteus mirabilis, Klebsiella pneumoniae, Escherichia coli, Serratia marcescens. Out of 
these, P. aeruginosa, S. aureus, E. coli and Enterococcus spp. have a major role. E. coli is 
common in the UTI, while S. aureus is frequent in other body sites (S. aureus is very 
frequent in blood-borne infections). Enterococcus spp. mostly infect surgical-sites while P. 
aeruginosa infections are evenly distributed among all body districts (1). 
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Resistance to antibiotics. The key factor that turns nosocomial infections in a serious 
threat for health is resistance to antibiotics. Indeed, infections with resistant bacteria are 
difficult to treat because identifying what antibiotic is effective requires time-consuming 
microbiology assays. A delay in the identification of the infective agent and in its 
characterization is often the cause of death for many patients. Moreover, in a growing 
number of cases, physicians have to deal with multiresistant microbes or, in some cases, 
pan-resistant microbes, which are resistant to all known antimicrobial agents. 
There are several mechanisms of antibiotic resistance that bacteria can acquire or develop: 
enzymatic degradation of antibiotics, antibiotic target modification, changes in the bacterial 
cell wall permeability and the use of pathways alternative to that targeted by the 
antimicrobial agent. 
Enzymatic degradation or inactivation of antibiotics is a very common mechanism of 
resistance. The most known examples are the β-lactamases; i.e. enzymes hydrolyzing the β-
lactam ring of antibiotics such as the cephalosporins. These are mainly of concern in Gram-
negative bacteria (5). Additional examples include inactivation of aminoglycosides by 
enzymatic modification by acetyltransferases, nucleotidyltransferases and 
phosphotransferases (6). Each of these enzymes has many variants, each active against 
specific antibiotic molecules (7). 
Resistance by target modification consists in modifying the binding site of the antibiotic on its 
target, thus making the drug ineffective. Examples of this mechanism are mutations in the 
gyrase and topoisomerase genes, which are the targets of the quinolone and 
fluoroquinolone antibiotics (8). Instead, in the case of Methicillin resistant Staphylococcus 
aureus (MRSA), the mecA gene codes for a variant of the penicillin binding protein PBP2A 
that has a very low affinity for β-lactams (9). One curious case is resistance to colistin 
(polimixin E) in Klebsiella pneumoniae. This phenotype is achieved by changing the 
composition and thus the charge of the lipopolysaccharide (LPS), which is the target of the 
antibiotic (10). 
Changing the cell wall or cell envelope permeability implies reducing the entry rate or 
increasing the efflux of antibiotics. Mutations in pores can limit or completely inhibit the influx 
of antibiotics into the cell. On the other side, efflux can be increased by synthesizing specific 
efflux pumps, as in the case of resistance to tetracycline (11), or by over-producing 
physiologically expressed ones. 
Finally, cells can become resistant by deviating from their normal physiological pathway by 
including a step alternative to that targeted by the antibiotic. An example of this mechanism 
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is the production of an alternative dihydrofolate reductase in trimethoprim resistant 
Escherichia coli and Citrobacter sp (12). 
Virulence factors in specialized strains. Very often nosocomial pathogenic species 
comprise strains that evolved specifically to fit into the hospital environment and to invade 
specific body district of patients. This is achieved through the acquisition of virulence factors, 
including mechanisms used to attach to surfaces, to migrate between body districts, to 
defend from the host immune system, to outcompete other microorganism in nutrients 
uptake and to attack and damage the host.  
Bacteria produce a wide variety of surface proteins that allow them to adhere to the host 
tissues, such as fimbriae, lipoteichoic acid and trimeric autotransporter adhesins. Capsules, 
instead, are used to evade the immune system, by inhibiting phagocytosis, and to protect the 
bacteria while outside the host. Another group of virulence factors are destructive enzymes, 
which cause damage to host tissues in order to invade other body districts or gain nutrients. 
Enzymes include hyaluronidase, which breaks down the connective tissue component 
hyaluronic acid, but also a range of proteases, lipases and DNases (13). Other mechanisms 
to provide nutrients include siderophores and other system used for the uptake of metals 
and ions. One example of this category of virulence factor is Yersiniabactin, a siderophore 
used by Yersinia pestis (and frequently horizontally transmitted to other species)(14) to 
monopolize iron in colonized environments (15). 
Lastly, a major category of virulence factors are toxins. The lipid A component of LPS (also 
known as endotoxin) binds to monocytes receptors and stimulates the inflammatory 
response in the host. An excess of such response can lead to septic shock. Exotoxins, on 
the other hand, are actively secreted molecules and cause damage to the host by targeting 
different specific biological processes. The two most potent known exotoxins are 
tetanospasmin (secreted by Clostridium tetani) and the botulinum toxin (Clostridium 
botulinum). Other bacteria that produce exotoxins include: Escherichia coli, Vibrio cholerae, 
Bacillus anthracis, and Clostridium difficile. 
Acquisition of antimicrobial resistance factors and virulence factors is also common in 
bacteria that cause food-borne infections (such as Salmonella spp. and Listeria 
monocytogenes), sex transmitted diseases (Neisseria gonorrhoeae, Treponema pallidum, 
Chlamydia trachomatis, Haemophilus ducreyi, Mycoplasma genitalium) (7, 16). 
Horizontal gene transfer. Antimicrobial resistance and virulence factors can surely evolve 
through random mutations and selection, however they can also be exchanged among 
bacteria using several mechanisms of horizontal gene transfer (HGT). HGT allows such 
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factors to spread quickly in a population and among populations, species and genera, and 
thus represents a set of mechanisms of great importance for increasing a pathogen 
virulence of resistance. 
Transformation is the direct uptake of DNA and depends on the expression of numerous 
genes (17). Transformation happens most frequently with genomic material of the same 
species as the recipient bacterium; Transformed DNA is usually integrated by homologous 
recombination. Competence for transformation is typically induced by stress conditions 
during the stationary phase of growth.  
Bacterial conjugation, instead, involves the presence and contact of the two living individuals 
between whom the DNA exchange happens. This process is mediated by pili and consists in 
the transfer of a conjugative or mobilizable genetic element that is most often a plasmid or 
transposon. Most conjugative plasmids have systems ensuring that the recipient cell does 
not already contain a similar element (18). Conjugation was discovered observing the 
transmission of fertility factor F, an autonomous DNA molecule. F can integrate into the 
bacterial chromosome to produce Hfr derivatives. Both in the autonomous and in the 
integrated state, F allows the bacterium to pair with F− recipient bacteria. This allows a copy 
of the replicating F to be transferred to the partner cell. From in the Hfr state, F can also 
transfer neighboring parts of the donor chromosome. This process allows the transmission of 
new functions to the recipient strain (19). 
Lastly, transduction is a mechanism of HGT based on bacterial viruses that carry part of the 
previous host genome when infecting other individuals. Generalized transduction is operated 
by viral particles that carry a segment of host DNA instead of a replica of the viral genome. 
On the other hand, specialized transduction is based on the transportation of hybrid 
molecule with a part of the phage genes and some bacterial genes (20). 
The role of genomic epidemiology. Nosocomial bacterial infections are mostly transmitted 
by contact. The vectors are often the hands of the medical staff, when they are not carefully 
cleaned in-between the treatment of one patient and another. Other carriers of infections are 
the so-called fomites: i.e. surfaces like diagnostic tools, catheter tubes, ventilators or simply 
door handles that are not sterilized. The control of the spread of pathogens might be difficult, 
due to the many potential sources of contagion and because bacteria can use people with 
healthy immune system as carriers, by colonizing them (e.g. in their intestines). These 
category of people, who do not have any symptom, can include the hospital personnel and 
patients with mild diseases, that are hospitalized in wards where regular checks for 
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pathogens are not run. For this reason, it is fundamental for hospitals to have surveillance 
programs and strict protocols of behaviour for all workers. 
Even the evolution of multidrug resistant pathogens can be contained. This is obtained by 
regulating and limiting the use of antibiotics. Indeed, resistance is acquired when a selective 
pressure is applied on the microbial community, i.e. when antibiotics are used. The best 
environment for the development of resistance is one with a sublethal antimicrobial dose. 
Thus, low dosages or short treatments must be avoided. 
The two provisions above are fundamental in order to solve this problem, but on the other 
hand, much can be done to improve diagnostic and surveillance systems and to design new 
strategies and protocols to prevent the development and spread of resistance mechanisms. 
This can be achieved through the use of genomic approaches and genomic epidemiology. 
Indeed, sequencing the DNA of an isolate allows to know what genes are present in its 
genome and to predict the associated phenotype. Moreover genomic structures can be 
studied using sequencing: e.g. the presence of plasmids, recombined regions in the 
chromosome, insertions and deletions of entire portions of the genome, such as 
pathogenicity islands, i.e. regions where genes coding for virulence factors or determinants 
for resistance to antimicrobial agents are clustered and usually co-transmitted by HGT. 
Lastly, shuffling of genomic regions can be recognized using genomics, together with the 
promoters of such reorganization, e.g. transposons and insertion sequences. 
Comparative genomics consists in finding common tracts and differences between two or 
more genomes or groups of genomes. This allows to find the determinants for a specific 
phenotype, such as a novel resistance factor. Comparative genomics can be performed by 
grouping strains based on their phenotypic traits or in light of their evolution (although the 
two classifications often coincide). 
Evolutionary classification is performed using molecular phylogenetics. Ordering bacteria 
(and their features) on a phylogenetic tree allows to reconstruct the history of a pathogen. 
Furthermore, using molecular clock approaches it is possible to fit a phylogeny inside a 
timescale and date evolutionary events. Lastly, phylogeography allows to compare 
phylogeny with geographical maps: this can be used to locate the area of origin of a strain of 
interest, as well as to hypothesize the origin of an epidemic event. Performing phylogeny 
with more isolates, can often lead to a better comprehension of a pathogen. Using a 
metaphor, genomic sequencing can be compared to taking a picture of a pathogen in a 
specific moment of its history. The more genomes are sequenced, the more frames can be 
used to reconstruct a movie about the evolution of the pathogen. 
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In the present years, sequencing genomes is not a limiting step when performing genomic 
epidemiology. This is thanks to the high amount of available genomes in the databases, 
which were sequenced at low cost. This situation is the result of the ongoing revolution 
represented by the advent of next generation sequencing. 
Next generation sequencing. Next generation sequencing (NGS) techniques were 
introduced in 2005 (21, 22) and completely changed the way many fields of biomedical 
research were conducted. The new technologies permitted to sequence an extremely high 
(when compared to the previous technology) amount of nucleotides at the same time, thus 
making the price of such precious information drop dramatically and starting a revolution, 
possibly more game-changing than the advent of PCR. 
The first technology introduced in 2005 was Roche 454 (21, 22), which was based on the 
use on a system of beads and wells that permit to separate and simultaneously sequence 
hundreds of thousands of small fragments of DNA. 454 machines use the energy of the 
pyrophosphate released by the attached nucleotides to produce a light signal (for this 
reason, this technology is also known as pyrosequencing). The development of this 
technology was discontinued in 2013 but its place in the market was taken by the Ion Torrent 
machines. These sequencers use a similar approach as 454, but replace the base calling 
system based on pyrophosphate with one based on the positive hydrogen ions released in 
the DNA synthesis process. The increase of H+ ions, changes the pH of the solution in which 
the reaction happens. This difference can be translated into an electric signal (23). This 
approach makes ion-torrent sequencing cheaper than 454. The policy of Ion Torrent is to 
produce easy to use sequencing kits and develop analysis software that require very few 
informatic skills, thus optimizing the technology to perform standard assays. 
Among the market leaders in the NGS field, together with Ion Torrent, is Illumina. Machines 
produced by this company use a technology introduced in 2006 by Solexa, which does not 
use beads and wells to handle DNA fragments but a flat surface, called the flowcell. DNA 
fragments are attached to the flowcell thanks to short single strand DNA probes, which bind 
to the sequencing primers. Each piece of DNA is amplified locally and forms an island of 
identical sequences on the flowcell. When sequencing is performed, each island emits a light 
signal which is detectable by a CDC receptor. The use of the flowcells allows Illumina to 
scale up the throughput of its machines easily. Today the machine with the highest output 
capabilities, Illumina HiSeq 4000, can sequence up to 1.5 terabases per run. The other main 
advantage of Illumina technologies is the accuracy in sequencing homopolymers, i.e. 
repeated stretches of the same base. A system of reversible terminators allows to pause the 
reaction after the incorporation of each nucleotide, regardless of the nitrogenous base 
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attached. This allows to detect the right length of homopolymers. The very high throughput 
and versatility of Illumina machines is what makes it the preferred choice for bacterial 
genomics. In fact, all sequences obtained in the works described in the present thesis were 
obtained using this technology. 
In more recent years, so-called third generation sequencing have been launched on the 
market. These technologies allow to sequence very long fragments of DNA (~10,000bp)  in 
one read. In 2011 Pacific Bioscience released a sequencing machine based on the Single 
Molecule Real Time (SMRT) technology, a parallelized single molecule DNA sequencing 
method. This technology relies on the use of nanoscale wells called zero-mode waveguides 
(ZMW). At the bottom of each ZMW, a single DNA polymerase enzyme sequences a single 
molecule of DNA. The structure of ZMW is small enough to observe the light of only one 
fluorescent dye, released with the incorporation of a single nucleotide (24). SMRT 
sequencing, also called PacBio, is used today to produce high quality genomic assemblies. 
Precision and reliability of called bases is achieved through high coverage sequencing or by 
coupling PacBio and Illumina reads. 
A more recent technology called Nanopore, was introduced in 2012. Nanopore sequencing 
uses electrophoresis to transport DNA through a porin protein of diameter 10−9 m. 
Sequencing is made possible because samples cause specific changes in electric current 
density across nanopore surfaces, which allow the nucleotide to be recognized (25). At the 
beginning of 2017, Nick Loman reported having obtained reads of several hundred thousand 
bases in length (with a maximum of 882 kb) (26). Protocols for the use of this technology are 
still being developed; thus it is still not as widely used as SMRT.  
In the present thesis, all genomes are sequenced with the Illumina technology. In particular, 
the MiSeq machine was used for most of the projects. The MiSeq is a low output benchtop 
machine, that allows to obtain the reads of 12-15 bacterial genomes per run. Libraries were 
prepared using the Nextera XT kit. This technology uses a modified transposases to 
fragment the DNA and attach the sequencing primers at the same time, in a process called 
tagmentation. Nextera allows to avoid the use of ultrasonicators and sensibly lower the price 
of library building. The cost of the reagents for one genome using the approach presented in 
this thesis is around 100€. 
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Preface to manuscripts. In the following sections I have included a collection of papers, 
relative to the research work performed during my period as a doctoral student. Works will 
be presented in the following order: 
a) The first three articles included are works in which I was listed as first author and 
contain the main results of this Ph.D. project. They are focused on genomic 
epidemiology of nosocomial pathogens 
b) The fourth and fifth articles are focused on the reconstruction of the spreading routes 
of food-borne pathogens during epidemic events. My contribution in these works was 
minor 
c) The sixth paper is a review article on genomic epidemiology. 
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ABSTRACT 
Klebsiella pneumoniae is at the forefront of antimicrobial resistance for Gram-negative 
pathogenic bacteria, as strains resistant to third-generation cephalosporins and 
carbapenems are widely reported. The worldwide diffusion of these strains is of great 
concern due to the high morbidity and mortality often associated with K. pneumoniae 
infections in nosocomial environments. We sequenced the genomes of 89 K. pneumoniae 
strains isolated in six Italian hospitals. Strains were selected based on antibiotypes, 
regardless of multilocus sequence type, to obtain a picture of the epidemiology of K. 
pneumoniae in Italy. Thirty-one strains were carbapenem-resistant K. pneumoniae 
carbapenemase producers, 29 were resistant to third-generation cephalosporins, and 29 
were susceptible to the aforementioned antibiotics. The genomes were compared to all of 
the sequences available in the databases, obtaining a data set of 319 genomes spanning 
the known diversity of K. pneumoniae worldwide. Bioinformatic analyses of this global data 
set allowed us to construct a whole-species phylogeny, to detect patterns of antibiotic 
resistance distribution, and to date the differentiation between specific clades of interest. 
Finally, we detected an ∼1.3-Mb recombination that characterizes all of the isolates of clonal 
complex 258, the most widespread carbapenem-resistant group of K. pneumoniae. The 
evolution of this complex was modeled, dating the newly detected and the previously 
reported recombination events. The present study contributes to the understanding of K. 
pneumoniae evolution, providing novel insights into its global genomic characteristics and 
drawing a dated epidemiological scenario for this pathogen in Italy. 
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INTRODUCTION 
Multidrug resistance is currently a matter of concern worldwide. At the end of the 1970s, 
most Escherichia coli and Klebsiella pneumoniae strains encoded ampicillin-hydrolyzing β-
lactamases, making it necessary to use third-generation cephalosporins. In the early 1980s, 
the first cases of resistance to these novel antibiotics were reported in Enterobacteriaceae 
(1) and were caused by genes classified as ESBL (extended-spectrum beta-lactamases). In 
1985, the United States Food and Drug Administration approved the commercialization of 
imipenem, a molecule that showed activity against ESBL producers. This drug, and similar 
compounds that quickly followed (i.e., carbapenems), then were introduced into clinical 
practice and widely used. 
In 2001, Yigit and colleagues reported a K. pneumoniae strain isolated in 1996 that exhibited 
resistance to the carbapenems imipenem and meropenem (2). The gene responsible for the 
resistance was identified as a group 2f, class A, carbapenem-hydrolyzing beta-lactamase, 
named Klebsiella pneumoniae carbapenemase 1 (KPC-1). Since its discovery, carbapenem 
resistance caused by the blaKPC gene has been reported increasingly in K. pneumoniae 
isolates, initially moving through the northeastern states (3, 4) and quickly becoming the 
most frequently found carbapenemase in the United States (5). The spread of KPC then 
continued, with reports from different countries appearing ceaselessly, to the point that today 
this is regarded as a worldwide issue (6). 
The blaKPC gene is carried by a plasmid; thus, horizontal transfer between various K. 
pneumoniae strains, as well as other bacterial species, could be expected and was 
extensively reported (7–9). Nevertheless, most of the clinical reports to date have been 
caused by K. pneumoniae isolates belonging to clonal complex 258 (CC258) (10). This 
complex comprises sequence type 258 (ST258) and single-allele mutant STs based on 
multilocus sequence typing (MLST), such as ST11 and ST512. These epidemiological data 
suggest a dissemination starting from a single ancestor and that CC258 presents a genomic 
background that is favorable both to the acquisition of plasmids bearing the blaKPC gene and 
to the clonal spread in nosocomial environments. In 2014, Deleo and colleagues (11) 
presented a phylogenomic study on 85 K. pneumoniae isolates belonging to CC258, 
detecting two subclades and concluding that an ∼215-kb recombination event was at the 
origin of the differentiation between the two. A second comparative genomic analysis, 
presented by Chen and colleagues (12), detected an ∼1.1-Mb recombination between an 
ST11 recipient and an ST442 donor as the event that originated the present ST258 strain. 
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Since the first finding of circulation of ESBL-producing K. pneumoniae in Italy in 1994, a 
rapid and extensive dissemination of different types of ESBLs has been reported (13–15). 
More recently, the first Italian KPC-positive K. pneumoniae strain, belonging to ST258, was 
isolated in a hospital in Florence in 2008 from an inpatient with a complicated intra-
abdominal infection (16). Since then, the diffusion of carbapenemase-producing K. 
pneumoniae in Italy has been extremely rapid and characterized mainly by isolates of 
CC258 (i.e., ST258 and ST512) (17–19). ST512 in particular, first reported in Israel in 2006 
(20), has been spreading in southern Europe and South America (11, 19). The sporadic 
detection of isolates belonging to other STs (e.g., ST101 and ST147) also have 
characterized the epidemiology of KPC K. pneumoniae in Italy (19). 
The aim of this study was to evaluate the geographic and phylogenetic distribution of K. 
pneumoniae isolates of different antibiotypes, both at a national and a global scale. Thus, we 
sequenced and analyzed the genomes from 89 K. pneumoniae strains, collected in six 
Italian hospitals from 2006 to 2013, without any a priori knowledge of the sequence type. We 
compared this national collection to all of the K. pneumoniae genomes available from 
worldwide isolations to obtain insights into both the Italian epidemiology and the global 
structure of the species. 
 
MATERIALS AND METHODS 
Strain sampling. Eighty-nine non-duplicate K. pneumoniae strains, collected from six 
different Italian hospitals, were included in this study without prior knowledge of the 
sequence type. Thirty-one were KPC producers, as demonstrated using phenotypical tests 
(positivity with disk diffusion synergy testing using a meropenem disk alone and in 
combination with aminophenylboronic acid) (21) and/or genotypical analysis (in-house 
methods based on reference 22); 29 were ESBL producers, as demonstrated using the 
procedure recommended by the CLSI (23), while 29 were susceptible to third-generation 
cephalosporins and carbapenems. Throughout this work, we refer to this last group of 
isolates as susceptible. Antimicrobial susceptibility testing was performed using a Vitek2 
automated system (bioMérieux), and MICs were interpreted by following the European 
Committee on Antimicrobial Susceptibility Testing guidelines (24). The list of isolates, year, 
location of isolation, sequence type, and presence of selected antibiotic resistance genes 
are reported in Table S1 in the supplemental material. 
Genome sequences. DNA was extracted using a QIAamp DNA minikit (Qiagen) by 
following the manufacturer's instructions. Whole genomic DNA was sequenced using an 
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Illumina Miseq platform with a 2 by 250 paired-end run after Nextera XT paired-end library 
preparation. On 24 March 2014, sequences of draft and complete genomes of K. 
pneumoniae were retrieved from the NCBI ftp site, while sequencing reads of the isolates 
sequenced by Deleo and coworkers (11) were retrieved from the sequence read archive 
(SRA) database (accession no. SRP036874). 
Genome assembly and retrieval. Sequencing reads from the isolates obtained in this study 
were assembled using MIRA 4.0 software (25) with accurate de novo settings. Assembled 
genomes are now publicly available under Bioproject (EMBL project B6543). Reads 
retrieved from the SRA database were checked and filtered for sequencing quality using an 
in-house script and then assembled using Velvet (26) with a K-mer length of 35 and 
automatic detection of average expected coverage and low coverage threshold. 
Resistance profile and MLST determination. The MLST profile was obtained in silico by 
searching the characterizing gene variants on each genome, using an in-house Python 
script. The antibiotic resistance profile was determined using a BLAST search on a gene 
database comprising all of the most common resistance genes associated with resistance to 
beta-lactams, including ESBL- and KPC-producing phenotypes. 
Core SNP detection and phylogeny. Single-nucleotide polymorphisms (SNPs) were 
detected using an in-house pipeline based on Mauve software (27), using the NJST258_1 
complete genome as a reference. Each genome was individually aligned to the reference, 
and alignments were merged with in-house scripts. Core SNPs were defined as single-
nucleotide mutations flanked by identical bases present in all of the analyzed genomes. The 
core SNP alignment was used to perform a phylogenetic analysis using the software RAxML 
(28) with a generalized time-reversible (GTR) model and 100 bootstraps. The same 
phylogenetic approach was used to perform the analysis on three core SNP sub-data sets 
(i.e., non-recombined regions and two distinct putatively recombined regions). 
Recombination. We divided the genome alignment in 5,264 windows of 1,000 nucleotides 
(nt) each and calculated core SNP frequency in each window for each genome, generating a 
matrix. The software R then was used to generate a heatmap of SNP frequency. The newly 
characterized strain 46AVR was used as a reference for plotting SNPs, being a member of 
the sister group to CC258. In parallel, we created a sub-data set of 174 CC258 genomes 
and 13 closely related K. pneumoniae genomes, removing genomes of isolates distant from 
the CC258 clade (n = 103) and the genomes within CC258 that exhibited extremely limited 
variability (n = 29), such as all but one of those obtained from single outbreaks. The choice 
of using a relatively large number of non-CC258 genomes (n = 13) was made in order to 
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allow the detection of recombination events common to the whole clonal complex. We used 
this sub-data set of core SNPs in 187 genomes to perform a recombination detection 
analysis using the software BRATnextgen (29) with 100-iteration analysis, using 100 
replicates for statistical significance. 
Analysis of the recombined region. A database was created collecting protein sequences 
of factors previously reported to be involved in virulence and antibiotic resistance. We 
collected sequences from the Comprehensive Antibiotic Resistance Database (CARD) (30) 
and from the Antibiotic Resistance Genes Database (ARDB) (31), from proteins involved in 
the biosynthesis of lipopolysaccharides (LPS) and polymyxin resistance, and from the most 
common virulence factors and siderophores found in Gram-negative bacteria (obtained from 
the NCBI site). Finally, we added to our manually designed database all K. pneumoniae 
proteins described as potential virulence or resistance factors in the work by Lery and 
colleagues (32). Gene sequences present in the novel putative recombined region were 
extracted from the genome of strain NJST258_1 using an in-house Python script. 
Correspondence between proteins in our database and genes in the recombined region was 
tested using a TBLASTN search, selecting genes covering at least 75% of the database 
sequence with a minimum of 75% identity. Results then were manually checked (see Table 
S2 in the supplemental material for a complete list). 
Molecular clock. We created a sub-data set of 174 CC258 genomes and 3 closely related 
K. pneumoniae genomes (used as outgroups), removing genomes of isolates distant from 
the CC258 clade (n = 113) and the genomes within CC258 that exhibited extremely limited 
variability (n = 29), such as all but one of those obtained from single outbreaks. We used the 
software BEAST (33) on the core SNP alignment of the 177-genome sub-data set after 
removing SNPs located in the potentially recombined regions. BEAST parameters used 
were the following: uncorrelated log-normal relaxed clock with the GTR model, with no 
correction for site rate heterogeneity according to analyses performed in similar scenarios 
(34). The analysis was run for 1,000,000,000 steps, and at every 10,000 steps samples were 
taken. We discarded 250,000,000 steps as burn-in. The program TRACER 
(http://beast.bio.ed.ac.uk/tracer/) was used to evaluate the convergence of the analysis. 
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RESULTS 
Sampling and genome sequencing. Eighty-nine K. pneumoniae strains were collected in 
six Italian hospitals, chosen based on antibiotypes regardless of sequence type, which was 
determined only afterwards. The data set was composed of 31 KPC producers, 29 ESBL 
producers, and 29 strains susceptible to carbapenems and third-generation cephalosporins, 
here referred to as susceptible. The genome of each of the 89 isolates was sequenced and 
assembled (average genome size, 5,551,959 nt; average N50, 154,414 nt; average 
coverage, 76.46×). All of the available K. pneumoniae genome sequences and reads then 
were retrieved from the databases (n = 230) to create a global data set of 319 K. 
pneumoniae genomes. All genomes in the data set were screened for genes responsible for 
KPC and beta-lactam resistance phenotypes, as well as for all MLST genes. A total of 55 
different MLST profiles were detected, eight of which were novel; thus, they were submitted 
to the curators of the K. pneumoniae MLST database (35). Each of the eight new profiles 
was represented by a single newly sequenced Italian isolate (7 susceptible, 1 ESBL 
producer). Two of these isolates also presented a single novel allele, one for the gene rpoB 
and one for the gene infB. See Table S1 in the supplemental material for a list of all of the 
isolates sequenced in this study and their main characteristics. 
Global SNP phylogeny. We used a maximum likelihood phylogenomic approach based on 
core SNPs to elucidate the relationships within the global genome data set comprising the 
newly sequenced isolates and the K. pneumoniae genome sequences available in the 
database. The presence of antibiotic resistance genes was mapped on the resulting 
phylogenetic tree, obtained from an alignment of 94,812 core SNPs (Fig. 1). This revealed 
that 97% of all KPC K. pneumoniae strains sequenced to date, regardless of the location of 
isolation, belong to a well-supported clade, corresponding to the complex CC258. On the 
other hand, the phylogenomic analysis showed that the isolates encoding common beta-
lactam resistance genes (blaSHV family, blaTEM family, blaOXA family, and blaCTX-Mfamily) are 
widespread along the tree and belong to various STs (both inside and outside CC258), with 
no sign of clustering. In fact, the 141 isolates encoding blaTEM belong to 24 different STs, the 
26 isolates encoding blaOXA belong to 11 different STs, and the 37 isolates encoding blaCTX-M 
belong to 16 different STs. 
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FIG 1. Maximum likelihood phylogeny of Klebsiella pneumoniae, based on 319 genomes. 
The phylogeny was reconstructed starting from an alignment of 94,812 core SNPs, using the 
software RAxML with a generalized time-reversible (GTR) model and 100 bootstraps, which 
are not shown for the sake of figure clarity. (A) Circular representation of the phylogeny, 
obtained using iTOL (itol.embl.de), ignoring branch length. Color circles indicate, from the 
innermost to the outermost, presence/absence of KPC variants, geographic location in terms 
of continents, ST based on multilocus sequence typing, and presence in the genome of 
genes from four beta-lactamase families. The red arrow indicates the origin of the clonal 
complex 258 clade. (B) Unrooted representation of the phylogeny showing the branch 
lengths, highlighting the genetic uniformity of clonal complex 258. 
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Phylogeny excluding potentially recombined regions. In a recent work by Castillo-
Ramirez and coworkers (34), high-density SNPs clusters with a low ratio of nonsynonymous 
to synonymous evolutionary changes (dN/dS) in closely related bacterial genomes were 
suggested to be indicators of recombination events. Thus, we evaluated the distribution of 
SNPs on the genome data set, detecting a highly uneven distribution in the genomes of 
CC258 isolates, as most core SNPs clustered into two main regions. The first region is 
located between positions 1,675,550 and 2,740,033, while the second comprises the origin 
of replication and spans from 4,554,906 to 629,621 in strain NJST258_1 (Fig. 2) (for the 
distribution of core SNPs on the whole data set of 319 genomes, see Fig. S1 in the 
supplemental material). To further analyze the possible presence of recombination events in 
CC258, we used the software BRATnextgen (29), specifically intended for this purpose, on a 
reduced data set of 187 genomes of CC258 and closely related strains. This analysis (see 
Fig. S2) confirmed the presence of the two main recombination events, additionally 
indicating in what position of the phylogeny they could have occurred. The first event was 
placed between the entire CC258 clade and the non-KPC external isolates of different STs, 
while the second was between the outermost strains of ST11 and the inner CC258 clade. 
Details on these recombined regions are presented in the following paragraph. 
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FIG 2. Uneven clustering of core SNPs in the clonal complex 258 clade. The phylogenetic 
reconstruction of the 206 representatives of the clonal complex 258 clade is shown on the 
left, while the core SNP frequency is shown on the right in shades of red, representing the 
number of core SNPs per 1,000-bp window for each genome. Detected recombinations are 
indicated at the top of the figure, and main clades of the clonal complex are indicated on the 
right side of the figure. 
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We removed the two putative recombined regions from the core SNPs data set of 319 K. 
pneumoniae genomes and performed a phylogenetic analysis on the remaining 55,368 core 
SNPs. The resulting tree (see Fig. S3 in the supplemental material) is largely consistent with 
the one generated from the initial data set, confirming the widespread distribution of 
susceptible and ESBL isolates and the presence of the highly supported KPC CC258 clade. 
Indeed, both the analysis on all core SNPs and the one performed by removing recombining 
sites agree in clustering 97% of all KPC K. pneumoniae isolates sequenced in a well-
supported clade (Fig. 1; also see Fig. S3). This monophyletic clade comprises 203 strains 
from Asia, Europe, Oceania, and North and South America, with isolation dates ranging from 
2002 to 2013; 193 of these (95%) present the blaKPC gene. Most isolates of this clade belong 
to ST258 (n = 167), but 4 other sequence types are present (i.e., ST11, SST379, ST418, 
and ST512), all single-nucleotide variants of ST258; thus, they belong to CC258. The 
second most common sequence type in the CC258 clade is 512, represented by 28 isolates 
that form a single monophyletic subgroup, located within the ST258 diversity. Interestingly, 
24 of these 28 have been isolated in Italy, mostly in this study (n = 19) but also in previous 
works (18, 36). Within the CC258 clade, two main highly supported distinct subclades are 
detectable, comprising the vast majority of the genomes. Three additional CC258 genomes 
are located in the tree as sister groups of the two main clades, and all are representatives of 
ST11, again a single-nucleotide variation of ST258. The existence of the two main CC258 
subclades was reported previously, and a single recombination event was proposed to be 
the cause of the differentiation between the two (11), while a subsequent work suggested 
multiple recombination events (37). 
Analysis of recombined regions. As described above, the SNP clustering analysis 
detected high SNP concentrations in two large genomic regions (Fig. 2). The smaller of the 
two is highly congruent with the ∼1.1-Mb recombination found by Chen and colleagues (12), 
which represents the major evolutive change between the members of ST11 and those in 
the 2 main subclades of the CC258 clade. Chen and colleagues found this region to be most 
similar to the corresponding region of isolate Kp13 of ST442 and suggested a recombination 
event, with the donor strain being a close relative of Kp13. Thus, we investigated whether a 
recombination event is at the origin of the second, newly detected, highly mutated genomic 
region, located from positions 4,554,906 to 629,621. We performed a phylogenetic analysis, 
including all of the 319 K. pneumoniae genomes examined in this work, on the core SNPs 
located in this region and in parallel on the core SNPs located in the ∼1.1-Mb region. The 
phylogenetic analysis of the novel ∼1.3-Mb region (see Fig. S4 in the supplemental material) 
confirms the recombination hypothesis, as the topology of the resulting tree clearly shows 
that Italian isolate 67BO, of the newly described ST1628, is the sister taxon to the entire 
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CC258 clade, suggesting that the donor was related to this isolate. The phylogenetic tree 
obtained from the ∼1.1-Mb recombined region (see Fig. S5) confirms the published results, 
clustering the donor Kp13 as a sister taxon of the CC258 clade, with the exclusion of the 
outermost ST11 isolates. Thus, we propose an updated scenario in which a first 
recombination event gave origin to the first CC258 strains (represented by ST11), a second 
recombination subsequently originated ST258, and a third, smaller recombination initiated 
the split between the two main ST258 subclades (Fig. 3). 
 
 
FIG 3. Hypothesis of recombinations occurring in the clonal complex 258 clade. Schematic 
representation based on the results of the analyses presented. Main nodes of interest are 
shown, highlighting the hypothesized pattern of three recombination events leading to the 
current state of clonal complex 258. Dates are inferred based on the molecular clock 
analysis depicted in Fig. 4. 
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In order to investigate the potential effect of the newly discovered recombination on the 
phenotype of the acceptor CC258, the presence of genes possibly related to antibiotic 
resistance and virulence was investigated in the corresponding region of the genome of 
strain NJST258_1, using a specifically designed database (see Materials and Methods). 
Interestingly, 51 genes were detected in the region (see Table S2 in the supplemental 
material), grouped in three main categories: LPS modification (such as the waa operon), 
bacterial efflux transporters (i.e., efflux pumps and permeases), and regulators (e.g., ompR-
envZ operon) (see Discussion for an analysis of the detected genes). 
Molecular clock. In order to date the origin of the CC258 clade and its subclades, we 
performed a molecular clock analysis using the software BEAST (33). We produced a 
reduced data set of 3,615 core SNPs present in a selected subset of taxa (174 CC258 and 
three closely related non-KPC K. pneumoniae genomes used as outgroups), derived from 
the previously filtered data set, in which the potentially recombined regions of the genome 
were excluded (Fig. 4). Compared with the dates indicated in published reports, our 
estimations appear to be fairly accurate. For example, the molecular clock analysis dates the 
appearance of ST512 to 2007, close to the first report in Israel, i.e., 2006 (20). Additionally, 
the molecular clock analysis dates the radiation of American and European ST258 isolates 
to 1997, a time point coherent with the first report of KPC-bearing K. pneumoniae, i.e., 1996 
(2). Thus, our calibration of the evolutionary rate, superimposed on the phylogenetic tree 
(Fig. 4), could be used to infer unavailable dates on the global pandemic of CC258 K. 
pneumoniae. See Discussion for further discussion of the estimated dates. 
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FIG 4 Estimation of divergence times in clonal complex 258. A schematic version of the 
time-scaled phylogeny was obtained using BEAST software with an uncorrelated log-normal 
relaxed clock and GTR model with no correction for site rate heterogeneity. The analysis 
was run for 1,000,000,000 steps, with sampling every 10,000 steps and 25% burn-in. The 
Italian monophyla are highlighted in blue, while the sequence type 11 (ST11) Asian clade is 
highlighted in green. All of the phyla with no indication of ST are comprised mainly of isolates 
of ST258. The dates indicated in the figure, for selected branches and nodes, were inferred 
from the analysis described above; for a comparison with the dates of isolation of strains, 
see Discussion. 
 
Italian strains. The structure of the phylogenomic tree allows us to depict the scenario of 
the epidemiology of K. pneumoniae in Italy (Fig. 1 and 4). While susceptible and ESBL 
Italian strains are homogeneously distributed on the tree and belong to a number of different 
STs (24 and 15, respectively), all of the KPC strains sequenced in Italy belong to CC258, 
indicating a strong epidemiological prevalence of this clonal complex in the Italian hospitals. 
Within CC258, Italian isolates are well clustered in four monophyla, three composed mostly 
of isolates sequenced in this study and one encompassing two isolates from a previous 
study (38). Of the four Italian CC258 monophyla, the one including the most isolates is 
composed solely of ST512 (n = 24), confirming the multiple reports that indicate this ST as 
being of great epidemiological importance, at least in this country. Our phylogenetic analysis 
clearly indicates that this ST512 monophylum is found within the diversity of ST258. 
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DISCUSSION 
Klebsiella pneumoniae in Italy. We sequenced the genomes of 89 K. pneumoniae strains 
isolated in Italy, among them 31 KPC producers, 29 ESBL producers, and 29 strains 
susceptible to beta-lactams and carbapenems. Based on our phylogenomic analysis, the 29 
genomes from susceptible K. pneumoniae strains isolated in Italy are scattered along the 
tree, showing no evident sign of clusterization. The sequencing of these isolates allowed us 
to expand the known diversity of the K. pneumoniae species, detecting seven novel MLST 
profiles and contributing to the overall robustness of current and future phylogenetic 
analyses. The genomes obtained from 29 ESBL isolates also show a considerable diversity, 
as they are distributed on the phylogenetic tree and belong to 15 different STs, among them 
a newly found ST. 
Regarding KPC isolates, all Italian sequenced strains are found in CC258. Since no a priori 
selection of STs was performed, this result indicates a strong prevalence of CC258 among 
KPC K. pneumoniae isolates in Italy, even though isolates from different STs have been 
reported previously by nongenomic studies (e.g., reference 19), and a wider genomic 
sampling surely would allow us to obtain genomes of KPC isolates belonging to other STs. 
The genomes of KPC-producing K. pneumoniae strains isolated in Italy cluster in four 
monophyletic groups. If we consider that the first reported case of KPC in Italy occurred in 
2008, we can use the dates obtained from the molecular clock to conclude that these 
monophyletic groups represent four different entrances of KPC K. pneumoniae in Italy (Fig. 
4). This indicates that KPC strains can move effectively among different countries and 
continents, and that the current Italian scenario of widespread KPC resistance has been 
caused by multiple overlapping outbreaks. Additional sampling from Italian CC258 isolates 
could either confirm these results or detect novel monophyla, possibly discovering additional 
entrance events. 
Among the four Italian CC258 monophyla, one is composed entirely of isolates of ST512. 
This KPC sequence type was first reported in Israel in 2006 (20) but has been spreading 
since then, mostly in Italy and South America (11, 17). In accordance with these reports, the 
four available ST512 genomes from South American isolates cluster in our phylogeny as a 
sister group of the Italian ST512 clade (Fig. 1 and 4). The molecular clock analysis dates the 
common ancestor of all members of ST512 to 2007, in relative agreement with the first 
report of this ST, i.e., 2006 (20). Considering that this ST is known to be a single-nucleotide 
variant of ST258, these results indicate that a mutational event occurred around 2006, giving 
rise to this sequence type, that then spread to Israel, South America, and Italy. Genome 
sequencing of isolates of this ST from Israel, currently unavailable, could allow us to perform 
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phylogenetic analyses aimed at better understanding the geographical and temporal origin of 
the ST512 clade. 
Origin of the CC258 clade. Our phylogenomic analysis, coupled with the detection of 
recombination events and with the molecular clock analysis, allow us to update the 
hypothesis regarding the origin and evolution of CC258, the most widespread bearer of KPC 
resistance worldwide (Fig. 3). We postulate a first recombination event that occurred before 
1985 between a donor similar to ST1628 and a receiver, an ancestor of ST11. This event, 
which transferred a region of ∼1.3 Mb to the current ST11, gave rise to the basal lineage of 
CC258. Since only three genomes of ST11 currently are available, all isolated from Asian 
patients, the current phylogeny suggests that this first recombination event occurred on the 
Asian continent. However, additional genome sequences of ST11 from different geographic 
locations are necessary to support or falsify this hypothesis. Our molecular clock analysis 
also can be useful to date the two subsequent, previously reported (11, 12) recombination 
events. The second recombination event, confirmed by our phylogenies, gave rise to ST258, 
having as a recipient ST11 and a donor similar to ST442 (12). Our molecular clock analysis 
dates this event to between 1985 and 1997. Considering that all of the known genomic 
CC258 diversity from the American and European continents is included within the subclade 
that originated in 1997 (Fig. 4), this second event could have been pivotal in the subsequent 
pandemic of KPC-bearing CC258. Finally, we can date the third smaller recombination 
event, the one that gave origin to the differentiation between the two main CC258 subclades 
(11), to between 1999 and 2001. Thus, we can hypothesize that these three events have 
produced a genomic background apt to bear and diffuse KPC plasmids, contributing to the 
success of the KPC pandemic. 
The proposed scenario suggests that the genomic diversity of the whole K. pneumoniae 
species constitutes a reservoir of genetic variability capable of recombination events of large 
portions of the genome, with subsequent generation of novel variants. In this scenario, we 
hypothesize that large genomic recombinations are at the basis of important 
phenotypic/functional changes that, together with the acquisition and diffusion of plasmids 
bearing antibiotic resistance genes, have led to the current global epidemic. This hypothesis 
is supported by the multiple detected recombination events, as well as by the limited number 
of SNPs identified outside the recombined regions (a total of 1,086 core SNPs in the 206 
analyzed CC258 genomes), and finally by the current impossibility to phenotypically 
differentiate the isolates of subclade ST512 from those of ST258. An alternative hypothesis 
is that the main reason for the diffusion of CC258 is simply the acquisition of the resistance 
to carbapenemic antibiotics, and that the genomic variations, whether they are 
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recombinations or point mutations, do not provide a specific fitness benefit but are merely an 
example of genetic hitchhiking. 
In order to investigate the importance of the recombination event described in this work, the 
gene content of the ∼1.3-Mb region was analyzed. Fifty-one genes in this genomic context 
were found to be potentially related to virulence or antibiotic resistance (see Table S2 in the 
supplemental material). The presence of LPS synthesis genes is worth a mention because 
of the multiple linkages between the outer membrane and virulence (39). Genes of the 
operon waa (also known as rfa) are responsible for the biogenesis of the core LPS, while 
genes of the family arn control the modifications of lipid A. Modifications in membrane 
composition can lead to changes in surface charge and interfere with the activity of 
antibiotics that act on LPS, such as polymyxins and novobiocin (40). Moreover, the presence 
of mla genes in the recombined region is worth being highlighted. These genes are 
presumed to maintain lipid asymmetry in the Gram-negative outer membrane, as they 
transport phospholipids to the inner side of the membrane. mla genes were reported as 
virulence factors in Escherichia coli and in other Gram-negative bacteria, as mutations in 
these genes can lead to a change in the permeability of the outer membrane and to a 
subsequent variation in virulence (41). The presence of fumarate reductase genes of the 
family fmr in the recombined region suggests a link with the variation of virulence of CC258. 
In fact, fumarate reductase is a virulence determinant in Helicobacter pylori, Mycobacterium 
tuberculosis, Actinobacillus pleuropneumoniae, and Salmonella enterica, as mutants of 
these genes show variations in virulence (32). Finally, the ompR-envZ operon, present in the 
recombined region, is a two-component system that acts as a transcription regulator, 
affecting the expression of the genes ompF and ompC (42). Mutations in the ompR and 
envZ genes have been shown to reduce the expression of outer membrane porins OmpF 
and OmpC (43). This in turn can have drastic effects on both the virulence and antibiotic 
resistance of mutant strains. It has been reported in particular that OmpR mutations can lead 
to reduced susceptibility to carbapenemic antibiotics in Enterobacteriaceae (44). 
Further functional investigations aimed at unveiling the reasons for the success of the 
CC258 clade, possibly focusing on the detected recombinant regions, would greatly improve 
our understanding of the K. pneumoniae pandemic and would provide important tools in the 
fight against KPC-producing strains. Finally, our conclusions should lead to additional 
studies focused on the recombination potential of other STs of K. pneumoniae. If this 
capacity were found to be widespread, we should be aware that future recombination events 
could lead to the diffusion of novel epidemic clones. 
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ABSTRACT 
Acinetobacter baumannii is a known opportunistic pathogen. Its genome has been described as 
characterized by a very high plasticity, with high frequency of homologous recombinations and 
proliferation of insertion sequences. The SMAL pulsotype is an A. baumannii strain putatively 
isolated only in Italy, characterized by a low incidence and a high persistence over the years. In the 
present work, we have conducted a comparative genomic analysis on this clone. All genomes 
presented the Sequence Type 78 (ST78) and were analysed in comparison with 11 other 
assemblies of the same ST. The phylogeny highlighted the presence of two different clades, one of 
which (ST78A) encompasses all the SMAL genomes and three others. ST78A resulted to have a 
low rate of homologous recombination and low gene content variability. Surprisingly, genomes 
inside the clade present a high number of Insertion Sequences (IS), mostly absent in the other 
genomes of the ST. Among these IS, one IS66 was found to interrupt the gene comEC/rec2, 
involved in the acquisition of exogenous DNA. This leads to the depiction of an evolutionary 
scenario in which the proliferation of IS is slowing the acquisition of exogenous DNA, thus limiting 
genome plasticity. Such genomic architecture can explain the epidemiological behaviour of high 
persistence and low incidence of the clone, and provides an interesting framework to compare 
ST78 with the highly epidemic international clones, characterized by high genomic plasticity. 
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INTRODUCTION  
The bacterium Acinetobacter baumannii is an opportunistic pathogen diffused worldwide, part of 
the so called ESKAPE group of microbial threats of our age (1). It has emerged in recent decades 
as a clinically relevant pathogen causing a wide range of both nosocomial and community-acquired 
infections, including injured soldiers (2), also thanks to its ability to colonize skin, plastic 
intravascular devices and mucous membranes and to survive in the hospital environment (3). 
Indeed A. baumannii was also known as “Iraqibacter”, when it became a major threat for troops on 
a mission in the Middle East (4). 
The genome of hundreds of A. baumannii isolates have been sequenced, showing a strong level of 
genome plasticity, in the form of a tendency to undergo frequent and substantial rearrangements, 
including recombinations (5, 6) and movement of insertion sequences (IS) (7).  
Generally, proliferation of IS elements in bacteria brings genomic variability, which can lead to 
adaptation in a new niche. Thus, bacterial genomes with higher numbers of IS copies have been 
observed to lead to virulent clones in multiple species (8,9) which often have a successful 
worldwide spread (10,11). Moreover, IS elements act as anchors for homologous recombination 
process, leading to internal genome rearrangements but also very often to the inclusion of 
exogenous DNA in the chromosome. Such homologous recombination events were found to be 
crucial for the evolution and adaptivity of A. baumannii and other pathogens; therefore, this 
genomic feature granted the bacterium a place among the so-called “bacterial hopeful monsters”, a 
set of microorganisms able to rapidly modify their genotype through recombination events, and 
thus capable of quickly adapting to novel environmental conditions (12). The role of ISs in A. 
baumannii has been investigated mainly for what concerns specific classes. For example, the 
presence of the Insertion Sequence ISAba1 upstream the gene encoding for the beta-lactamase 
OXA-51 grants A. baumannii resistance to carbapenemic antibiotics. The gene blaOXA-51 is always 
found in clinical isolates of A. baumannii, but only through the presence of the insertion sequence it 
can confer the bacterium the resistant phenotype (13). 
The most commonly isolated strains of A. baumannii in Europe belong to the two main European 
Clones, i.e. ECI and ECII (also known as International or Global Clones, IC or GC). In the early 
2000s these two clones were the first discovered to carry the plasmid-encoded gene blaOXA-58, 
which confers resistance to carbapenems. More recently, strains of both European Clones have 
been reported to carry another determinant of resistance to carbapenems, the gene blaOXA-23, 
which can be either plasmid or chromosome borne (14). While report of blaOXA-23 strains are 
increasing, the gene blaOXA-58 is being found less commonly in clinical isolates. This has been 
hypothesized to be due to the fitness cost that the gene carries (15, 16). Strong evidence of 
recombination events and movement of IS has been found in the European Clones, not rarely 
related to a change in antimicrobial resistance pattern (7, 17, 18). 
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In the last 15 years, a different clone of A. baumannii, not evolutionary related to the two main 
European Clones, has been isolated multiple times in Italian hospitals. The clone was identified by 
Pulse Field Gel Electrophoresis (PFGE) and named SMAL (based on the hospitals from which it 
was first isolated, San Matteo and Salvatore Maugeri Acute care and Long term care facilities, 
respectively) (19). Concurrently it was characterized by MultiLocus Sequence Typing (MLST) as 
ST78, by multiplex-PCR as Sequence Group 6 (20, 21), by repetitive-sequence-based PCR (rep-
PCR) as type 3 and by Amplification Fragment Length Polymorfism (AFLPTM) analysis as type 21; 
finally termed “Italian Clone” (22). Within a National survey on the spread of carbapenem-resistant 
A. baumannii strains, the majority of the isolates (n=52) belonged to ICII/ST2; however, 3/55 
genotyped strains showed a SMAL pulsotype (15). Despite the low number of isolates reported, 
the SMAL Clone represents an endemic reality in Italy since its first detection, in 2002 
(Migliavacca, personal communication). 
SMAL strains often show resistance to carbapenems in in vitro testing. The mechanisms 
underlying such phenotype are heterogeneous: mainly the overexpression of the chromosomic 
blaOXA-51-like gene or the presence of acquired resistance determinants (e.g. blaOXA-58 and blaOXA-
23). The firstly collected SMAL isolates were characterized by the presence of a blaOXA-58 acquired 
determinant; such resistance gene was then almost completely replaced in 2009 by a blaOXA-23 
gene (19, 22). Therefore, the SMAL Clone seems appears to have followed the same evolutionary 
response (in terms of resistance genes acquisition) of the European Clones I and II (23). 
SMAL isolates showing Minimum Inhibitory Concentration (MIC) values for carbapenems under 
clinical susceptibility breakpoint could be very difficult to treat in case of localized and device 
associated infections. Therapeutic failures can be at least partially due to the SMAL biofilm forming 
ability. This feature has been well demonstrated in previous studies, which showed how the SMAL 
biofilm production was considerably higher in comparison with the ATCC19606 reference strain 
(19, 22). 
The purpose of the present work was to characterize, from the genomic point of view, 15 isolates 
belonging to the SMAL pulsotype, investigating the possible links between the phenotypic and 
genetic features of this Clone. 
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RESULTS 
Genome sequencing and assembly. The total DNA of 15 isolates of A. baumannii previously 
recognized as SMAL was sequenced and assembled resulting in draft genomes with an average of 
193 contigs above 1000bp, an average total length of 4,293,267 bp and an average N50 of 48,860 
bp. Draft genomes are published on EBI-EMBL under the study accession number PRJEB19248. 
One plasmid was detected in each of four genomes (i.e. 14336, 2RED09, 20C15 and 5MO, 
respective accession numbers KY202456, KY202457, KY202458 and KY652669). 
Global phylogeny of the species. All available genomes of the species A. baumannii were 
retrieved from the NCBI database and joined with those of the isolates presented in this work, to 
obtain a database of 1,412 genomes. Genomes were aligned, SNPs were called in order to 
perform a Maximum Likelihood phylogeny. The 15 SMAL isolates were in silico assigned to the 
ST78 and resulted to be clustered on the global tree in a single monophylum, together with 11 
database genomes of the same ST (Supplementary Figure 1). 
Phylogeny of the ST78. The ST78 monophylum was selected to be further investigated. Core 
SNPs were called and used to create a 2,760 core SNP alignment (945 informative sites) to 
perform a phylogeny of the ST78 (Figure 1). The ST78 monophylum was split in two well 
supported monophyletic groups (called ST78A and ST78B) plus a single evolutionary distant 
genome (strain ABBL025). The 15 novel genomes were clustered in a smaller single monophylum, 
together with strain 3909, within ST78A. Analysis of available metadata (see Table 1) revealed that 
strain 3909 was isolated in Italy in 2007 (24). The isolate was obtained from the hospital of origin 
and analyzed with PFGE. The resulting pattern of migration showed that isolate 3909 belongs to 
the pulsotype SMAL as well. For this reason, from now on, the 16 genomes in this monophylum 
will be addressed as the SMAL cluster. Within ST78A, three other genomes isolated in Arizona 
(USA) in 2011 (J. Sahl, personal communication) form a highly supported clade that is positioned 
as a closely evolutionarily related sister group of the SMAL cluster. SNP distribution along the 
genome was plotted in order to spot possible recombinations (See Figure 2). One  ~34 Kbp region 
with higher SNPs density was detected, and identified as common to the genomes of both main 
clades (i.e. ST78A and ST78B), indicating that it could represent a recombination of the common 
ancestor of the two clades, or of the sole genome ABBL025. 
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Strain Year of 
isolation 
Country of 
Isolation 
City/State/Institute of isolation Genome 
length (bp) 
N of predicted 
ORFs 
3909 2007 Italy Napoli, Ospedale Monaldi 3948828 3719 
14336 2010 Italy Firenze, Ospedale Careggi 3961089 3682 
831240 NA USA NA 3970899 3700 
855125 NA USA NA 4401277 4109 
1096934 NA USA NA 4330037 4010 
103SM 2012 Italy Pavia, Policlinico San Matteo 3984084 3705 
20C15 2011 Italy Napoli, Ospedale Cardarelli 4014203 3749 
25C30 2011 Italy Catania, Policlinico di Catania 4002419 3722 
2MG 2012 Italy Pavia, Fondazione Salvatore 
Maugeri 
4028799 3760 
2RED09 2009 Italy Milano, Istituto Geriatrico “P. 
Redaelli” 
3983268 3710 
5MO 2009 Italy Monza, Ospedale San Gerardo 4026195 3760 
61SM01 2006 Italy Pavia, Policlinico San Matteo 4020527 3733 
65SM01 2006 Italy Pavia, Policlinico San Matteo 4002746 3717 
68SM01 2007 Italy Pavia, Policlinico San Matteo 4015623 3738 
72SM01 2007 Italy Pavia, Policlinico San Matteo 4001559 3726 
74SM01 2007 Italy Pavia, Policlinico San Matteo 3969850 3681 
96SM 2012 Italy Pavia, Policlinico San Matteo 4010167 3739 
ABBL025 2006 USA Chicago (IL) 4067524 3765 
ABBL026 2006 USA Chicago (IL) 3934606 3660 
MGTN 2004 Italy Pavia, Fondazione Salvatore 
Maugeri 
4002517 3722 
MONUR 2004 Italy Pavia, Fondazione Salvatore 
Maugeri 
4001892 3721 
TG22142 2011 USA Arizona 4229994 3937 
TG22146 2011 USA Arizona 4240225 3978 
TG22150 2011 USA Arizona 3978141 3708 
UH1752 2007 USA Cleveland (OH) 4007789 3740 
UH5207 2007 USA Cleveland (OH) 4009458 3739 
  
 
Table 1. Microbiologic and genomic information on the strains of the Sequence Type 78. From left 
to right are reported: name of the isolate, year of isolation, country, city and institution (where 
available) of isolation, size of the complete genome (in base pairs), and number of predicted 
ORFs. 
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Figure 1. Phylogeny of the Sequence Type 78 obtained with the software RAxML on a dataset of 
core Single Nucleotide Polymorphisms. Bootstrap values over 40 are reported next to the relative 
node. The main clades are highlighted with colored boxes. 
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Figure 2. Concentration of core Single Nucleotide Polymorphisms, calculated in windows of 
1000bp along the whole genome (using the genome of strain ABBL025 as a reference). Genomes 
are ordered following the phylogenetic tree of Sequence Type 78, which is reported on the left. 
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Phenotypic characterization.  SMAL clade susceptibility profiles were determined using routine 
diagnostic automated systems; MIC values were assessed by E-test. Six out of 16 strains (3909, 
2RED09, 14336, 5MO, 20C15 and 25C30) showed an intermediate/resistant phenotype to both 
Meropenem (MER) and Imipenem (IPM), with MIC values ranging from 6 to >32 mg/L (MIC50= 
>32 mg/L). Susceptibility was retained in 7/16 and 9/16 strains for MER and IPM, respectively. Full 
results of resistance profiles are reported in Supplementary Table 1. 
Biofilm formation was tested for all SMAL cluster strains and no significant difference was 
assessed; all strains showed a strong biofilm formation ability, higher than that comparatively 
observed for the reference strain ATCC19606 (19). Averages of the three replicate values ranged 
from 0.4 to 0.7 OD600. Full results are reported in Supplementary Table 1. 
Analysis of gene content. Coding sequences were called and ortholog proteins were predicted in 
the 26 genomes of ST78. Results indicate that the gene content of the SMAL isolates is highly 
conserved (gene dispersion of 37.38 genes/taxon), while the dispersion of the whole ST78 is 73.58 
genes/taxon. Moreover, the three Arizonan isolates, besides having a very low dispersion 
themselves (30.67 genes/taxon), when combined with the SMAL genomes (thus the ST78A clade), 
show a  dispersion of 35.84 genes/taxon. Distribution of the accessory genes was plotted on the 
tree (Figure 3A). The high internal and reciprocal similarity of the two genome clusters is clearly 
shown, and it is strongly highlighted in the second plot, where a distance analysis of the accessory 
gene content was run, using gene presences as characters (Figure 3B). We thus wondered if the 
limited gene content variation of ST78A was indeed indicative of low genomic plasticity, or if it was 
due to a small evolutionary distance. To address this question, the phylogenetic distance between 
each pair of genomes of the two main clusters (ST78A and ST78B) was calculated and plotted 
against the binary distance of gene content (Figure 3C). The plot shows that the lower gene 
presence distance of ST78A does not correspond to a lower phylogenetic distance, supporting the 
hypothesis of a lower genomic plasticity of ST78A. 
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Figure 3. Representation of 
presence of accessory genes in 
the Sequence Type 78. A) From 
left to right: the phylogeny of the 
sequence type (with tips aligned) 
and the matrix of gene presence 
(blue squares are detected 
genes); B) From left to right: the 
phylogeny of the sequence type 
(with tips aligned) and the 
distance matrix of the genomes, 
obtained using gene presence as 
characters; C) Plot of the 
intergenomic distances. Each 
genome pair is represented on 
the X axis by their phylogenetic 
distance (expressed as number of 
non-homoplasic core SNP 
between the two genomes) and 
on the Y axis by the gene content 
distance (expressed by the binary 
distance between the two 
genomes, calculated on a matrix 
of accessory gene presence). 
Genome pairs inside the ST78A 
clade are reported in red; pairs 
inside the ST78B clade are 
reported in blue 
 
  
 52 
Resistome. Resistance gene content of the 26 genomes of ST78 was analyzed by manually 
curated Blast alignments against custom and public databases. Full results are reported in 
Supplementary Table 2. Genes encoding the intrinsic OXA-51-like beta-lactamase were detected 
in all the ST78 genomes. One of the novel genomes presents a previously unknown variant of this 
gene, that was assigned the code blaOXA-545. This result prompted to test the presence and 
genomic position of the known resistance-enhancer insertion sequence ISAba1. Such IS is present 
in all the genomes of the ST78A cluster, while absent in all the other ST78 genomes, except 
UH1752. The sequence was found to be upstream the resistance gene blaOXA-90 in five genomes 
(25C30, 103SM, TG22142, TG22146, TG22150). The carbapenem-resistance gene blaOXA-58 was 
found to be encoded in four genomes of the dataset, all belonging to the SMAL cluster (2RED09, 
20C15, 14336, and 3909). These genomes are clustered with a fifth one (MGTN) blaOXA-58 
negative, in a low supported monophyletic clade. The gene blaOXA-23, instead, was detected in the 
genome of strains 5MO and 20C15. This pattern of gene presence is in accordance with the 
results of MIC tests. Indeed, five of the six intermediate/resistant strains carry genes encoding for 
carbapenemases and one (25C30) has the ISAba1 enhancer upstream the blaOXA-90 gene. 
Surprisingly, the isolate 103SM, which also presents the resistance enhancing genotype, resulted 
to have a susceptible phenotype. 
The gene blaADC-52 was detected in all the 26 genomes in analysis. In the ST78A cluster, the gene 
presents an unpublished single-SNP mutation. Furthermore, the carO gene and the adeS-adeR 
regulation system are present in all genomes. The sequence of adeS was found to be interrupted 
by the end of the contig in the assemblies of five strains (3909, 855125 and the three Arizonan 
ones) suggesting a possible presence of an insertion sequence and a consequent loss of function. 
Detection of other genes of interest. Gene content of the ST78 genomes was further 
investigated for the presence of virulence factors, competence and biofilm formation capability. Full 
results are reported in Supplementary Table 2. Virulence genes present a very conserved 
distribution. In fact, 26 genes, including the whole set of pilum-related pil genes and the 
transporter-encoding ptk are present in all the ST78 genomes. Notable exceptions are the genes 
cap8J (present only in the genomes of the ST78A clade) and epsA (present in the seven genomes 
of the ST78B clade). Twelve Genes coding for biofilm formation were also searched, detecting 
multiple point mutations and two frame-shifting insertions, thus showing no particular pattern 
relationship to the phylogeny. Based on the results of the in vitro biofilm formation assay (i.e. all 
isolates are strong producers) we can conclude that none of the detected mutation inhibit biofilm 
formation.  
Lastly, all genomes in the ST78A cluster present the genes of the O-antigen group A. The 
remaining seven genomes present matches with some genes of the group C but the evidence was 
not strong enough to assign the classification. 
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Analysis of mobilome. All 26 genomes were analyzed for presence of insertion sequences (IS) 
obtaining the results depicted in Figure 4 (full results reported in Supplementary Table 3). 
Interestingly, the ST78A contains strikingly more IS than the others. Furthermore, the 19 genomes 
in this cluster possess a set of exclusive IS classes which is absent in the other seven organisms.  
This result prompted us to investigate whether the genes of interest that were found to be 
truncated, were interrupted by IS. The interruption in the competence gene comEC/rec2 was found 
to be caused by an insertion sequence of the class IS66 in all the genomes of the SMAL clade. 
The gene adeS, interrupted in five strains, was found to have an insertion of IS66 in the three 
Arizonan genomes. For the other two genomes, the assembly did not allow to retrieve the 
sequence that interrupts the genes adeS and ompF because the contigs end with the interrupted 
gene. 
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Figure 4. Histogram of the insertion sequences detected by ISSaga on the genomes of the 
Sequence Type 78. On the left, the phylogeny tree of the sequence type is reported 
 
Plasmid analysis. Three of the four detected plasmids (pIBAC_oxa58_2RED of 25311 bp in strain 
2RED09, pIBAC_oxa58_1433 of 26496 bp in strain 14336 and pIBAC_oxa58_20C15 of 26781 bp 
in strain 20C15) contained one single copy of gene blaOXA-58. This result is congruent with the 
already published sequence of the plasmid of strain 3909 (24). Plasmid sequences (including the 
one of strain 3909) showed to have a good reciprocal synteny when analyzed with the software 
Mauve (25) (see Supplementary Figure 2), with some small internal reorganization. Conversely, 
the gene blaOXA-23, detected in the strains 20C15 and 5MO, was found to be chromosomally 
encoded in both cases. The blaOXA-23 site was recognised in both cases to have a 100% sequence 
similarity with the previously described transposon Tn2006 which was found to transfer the 
resistant determinant from Acinetobacter radioresistens to A. baumannii (26). Plasmid annotation 
analysis showed strong backbone similarity among the three sequences, and with the one found in 
strain 3909 as well. All four sequences presented two replication initiation sites repAci1 and 
repAci2 and two genes encoding for conjugal transfer proteins, trbL and traA (except for 3909 
harboring only traA), followed by two ISAba25 insertion sequences. Some differences, however, 
were found around the blaOXA-58 locus. Indeed, the plasmid of isolate 14336 (pAB14336) had 
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opposite orientation of the ISAba2/ISAba3-blaOXA-58-ISAba3 cluster when compared to the 
previously described plasmid p183Eco (27). Moreover, one IS26 sequence is missing. On the 
plasmid of strain 2RED09, instead, blaOXA-58 is surrounded by two ISAba3 with opposite orientation 
(see Supplemental Figure 3). On the plasmid of strain 20C15, blaOXA-58 is surrounded by ISAba3 
and ISAba2. Lastly, on the plasmid of 3909, blaOXA-58 is surrounded by ISAba2 and ISAba3 with 
different orientation for blaOXA-58 when compared to p14336. 
Two plasmid replication sites were found in the assembly of strain 5MO. One was the replication 
site of plasmid pAB5MO (published in the present work). The second was found on a contig 
possibly integrated in the chromosome. Indeed, the read coverage on the contig carrying the 
repAci (aci6) was similar to the average of the chromosomic contigs. The presence of aci6, even 
though it does not directly correspond to the resistant gene, suggests that it could be responsible 
for the transfer of plasmid carrying the carbapenemase gene, as previously described by Bertini 
and coworkers (28).  Indeed, the strain 5MO was found to encode a copy of gene blaOXA-23 
integrated in its chromosome. 
 
DISCUSSION 
The genomes of 15 strains of A. baumannii with SMAL pulsotype were sequenced and compared 
with the genomic variability of the species as a whole, and of the ST they were found to belong to, 
ST78. A phylogenomic approach focused on 26 ST78 genomes led to the identification of an 
evolutionary monophyletic group of 16 Italian genomes (previously assigned to the SMAL 
pulsotype. Three other genomes isolated in Arizona (USA) formed a closely related clade, while 
the remaining seven strains resulted more divergent. These data lead to conclude that the SMAL 
clone was imported in Italy in one single event. 
Four of the 15 sequenced genomes were found to carry plasmids. The complete sequence of the 
three plasmids carrying the gene blaOXA-58 was compared with the existing ones. Limited 
differences in the global structures of the plasmids harboured by the Italian ST78 strains were 
detected. The site including the resistance gene, on the other hand, showed high variability, 
especially concerning the IS. These variations surrounding the blaOXA-58 locus suggest a lack of 
stability of this site. Such instability, together with the high energetic burden of maintaining a 
plasmid, could lead to a possible loss of carbapenem resistance. These observations could 
indicate an ongoing switch, in epidemiological terms, from the plasmid encoded blaOXA-58 to the 
more stable and chromosomally mediated blaOXA-23. Other cases of replacement between the two 
determinants have been reported for other Clones both in Italy and elsewhere (29, 30). 
The 16 Italian strains present three interesting genome features: i) limited or absent recombination 
signal (Figure 2), ii) highly conserved gene content (Figure 3), and iii) a strong proliferation of 
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multiple classes of IS elements, including class 66 (Figure 4). These three characteristics seems to 
be in contrast, as the first two features suggest genome stability, while IS proliferation is 
considered a trademark of genomic plasticity. Here we propose a genome evolution scenario that 
starts with the proliferation of ISs, including IS66 elements. One IS66 then inactivated the gene 
comEC/Rec2, an event clearly shown by our genome data to have occurred just once, at the basis 
of the Italian clade. ComEC is the inner membrane protein responsible for the intake of DNA in the 
cytoplasm (31, 32). In our scenario, the interruption of this gene reduced the capability of DNA 
exchange of the Italian strains. In parallel, IS elements proliferation played other roles in the 
evolution of the clade, such as affecting the stability of the blaOXA-58 gene and causing the loss of 
function of other genes, which could have in turn contributed to the current low genomic plasticity 
of the entire ST78A clade, or to branches of it. 
These key elements depict a scenario in which the force driving the evolution of the SMAL clone is 
selfish DNA, in the form of IS elements. IS are known to be, usually, anchors for homologous 
recombination processes and are thus considered carriers of genomic plasticity and responsible for 
the evolution of virulent clones in multiple bacterial species. In the case described in the present 
work, the SMAL clone possesses a high number of IS elements but surprisingly there is no 
evidence of homologous recombination. On the contrary, the interruption of the comEC/rec2 gene 
by IS66 may contribute to the reduction of import of exogenous DNA. Thus, in this case, 
recombination events are not coupled with IS proliferation but seem to be in a competitive 
relationship. 
  
 57 
MATERIALS AND METHODS 
Pulsed Field Gel Electrophoresis. PFGE of A. baumannii was performed after ApaI digestion 
using a method described previously (33). Genomic DNA was prepared in agarose plugs, and DNA 
restriction was carried out at 30°C for 16 h. PFGE was performed in a CHEF DRII system (Bio-
Rad, Hercules, CA, USA), with pulses ranging from 0.5 to 15 s at a voltage of 6 V/cm at 14°C for 
20 h. Lambda 48.5-kb concatemers (New England BioLabs, Beverly, MA, USA) were used as 
molecular size markers. Isolates showing three or fewer band differences were regarded as a 
single PFGE type, according to the criteria described previously by Tenover et al. (34).  
Biofilm formation capability assay. One millilitre of fresh medium in borosilicate (15×125 mm), 
polystyrene (12×75 mm) or polypropylene (12×75 mm) sterile tubes was inoculated with 0.01 ml of 
an overnight culture. Triplicate cultures for each sample were incubated for 8 h shaking (at 200 
r.p.m. in an orbital shaker) at 37 °C. The supernatant of the tube was aspirated and rinsed 
thoroughly with distilled water. The cells attached to the tube walls were visualized and quantified 
by staining with crystal violet and solubilization with ethanol–acetone as described by Thomas and 
coworkers (35). The OD600 was detected using a spectrophotometer and compared to that of 2MG 
and 65SM01 (i.e. known biofilm forming SMAL strains, already included in the work by Nucleo and 
coworkers (19)). 
Identification and Antibiotic resistance profiling. Identification and susceptibility profiles were 
initially established using MicroScan4 (Beckman Coulter) NBC46 panels. MICs of imipenem (IPM) 
and meropenem (MER) (carbapenem resistance) were obtained by Etest strips (bioMérieux). 
Results were interpreted according to the latest recommendations EUCAST guidelines 
(http://www.eucast.org/clinical%20breakpoints/). 
DNA extraction, sequencing and assembly. Bacterial strains were cultivated in MacConkey 
medium in petri dishes. One single colony per strain was used for the downstream genomic 
analyses treated in this work. DNA was extracted using NucleoSpin Tissue (Macherey-Nagel) kit, 
library were prepared using Nextera XT kits and sequenced with the Illumina MiSeq technology 
with 2x250 paired-end runs. Reads were assembled with the Mira 4.0 assembler (36) using the 
default settings for Illumina reads and excluding the control for high coverage. 
Global database of Acinetobacter baumannii genomes. All available A. baumannii genomes 
(April 2016) were downloaded from the NCBI ftp site. All genomes were merged to those 
sequenced in this work to form the global database of sequenced strains of this species. The 
Multilocus Sequence Type of all genomes was determined using an in-house script and the 
Pasteur profiling scheme (37). Genomic sequences were aligned to each other using an in-house 
Perl script and the Mauve software (25). Small Nucleotide Polymorphisms (SNPs) were extracted 
from regions where all genomes aligned to the others. SNPs were used to investigate the evolution 
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of the species. The software fasttree 2.1.7 SS3 (38) was used to build a maximum likelihood 
phylogeny using the alignment of single nucleotide variants as input. 
Fine phylogeny of the SMAL and closely related strains. 26 genomes were aligned to the 
evolutionary closest available complete genome (i.e. AB031, according to the global phylogeny). 
Each global genomic alignment was performed using the software Mauve and a set of in-house 
Perl and Python scripts for output formatting. A global alignment of the 26 genomes of interest was 
obtained and used to extract SNPs, which are used for phylogeny. The evolutionary analysis was 
performed using the software RAxML (39) with the ASC_GTRGAMMA evolution model and 100 
bootstrap replicates, using the ascertainment bias correction of Lewis. 
Recombination analysis. The presence of recombination in the dataset was tested by plotting the 
concentration of core SNPs along the genomes. Assemblies were aligned to the complete genomic 
sequence of strain AB031 as for the phylogeny of ST78 (see paragraph for details). Concentration 
of core SNP was calculated in windows of 1000bp along the whole genome (using the genome of 
strain ABBL025 as a reference) and plotted using the R software. 
Pan/core-genome analysis. All 26 genomes of ST78 were annotated with the automatic pipeline 
Prokka (40) using the default settings for bacteria and avoiding to call rRNA sequences. Gene 
presence and absence was calculated using PanOCT (41), using the Prokka annotation and a 
reciprocal blastp analysis as input and adopting the same parameters as the work by Chan and 
colleagues (42). Reciprocal blast was performed using blast+ program instead of blastall in order 
to minimize the time of calculations). Pan-genome and core-genome of the whole dataset and of 
single genomic clusters were calculated using PanOCT and R. An analysis of binary distance 
using gene presence as characters was carried out using R. Dispersion in gene content for each 
clade of interest was calculated as follows: (pan-genome of the clade – core-genome of the clade) 
/ number of organisms in the clade. The evolutionary distance between two genomes was 
expressed as number of non-homoplasic core SNPs between the two genomes. Non-homoplasic 
sites were obtained using Noisy (43) on the core SNP alignment previously used for the phylogeny 
of ST78. The evolutionary distance was plotted against the binary distance of gene content for 
each couple of genomes inside the clusters ST78A and ST78B. 
Gene content analyses. The presence of genes coding for antimicrobial resistance and 
competence factors was tested using blast with ad hoc prepared set of genes (see Supplementary 
Table 2). Virulence gene database was obtained (44) and tested with blast. More research was 
performed on the whole ResFinder and VirulenceFinder databases 
(https://cge.cbs.dtu.dk/services/data.php), using a permissive blast search and checking positive 
results manually. O-antigen genes were extracted from the reference genomes of the strains 
ABNIH1 (Biosample SAMN00855421), ABNIH2 (Biosample SAMN00857848), and ABNIH3 
(Biosample SAMN00857859). 
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In-silico Plasmid extraction and characterization. Assembled genomes and contigs were 
blasted against in-house generated database of plasmid replication sites of A. baumannii, while 
resistant genes were determined by uploading the contigs to ResFinder database 
(www.cge.cbs.dtu.dk/services/ResFinder, (45)). Genomes positive to the plasmid replication site 
search, were reassembled using SPAdes (46). The contigs containing plasmid sequences were 
detected, analyzed and closed using the software Bandage (47). ORFs and their relative amino 
acids were predicted using Artemis (48). The annotation was performed manually using the online 
blast tool on the nr database. Genbank files were formatted and uploaded using the Sequin tool. 
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ABSTRACT 
Multidrug-resistant (MDR) Klebsiella pneumoniae is one of the most important causes of 
nosocomial infections worldwide. After the spread of strains resistant to beta-lactams at the 
end of the previous century, the diffusion of isolates resistant to carbapenems and colistin is 
now reducing treatment options and the containment of infections. Carbapenem-resistant K. 
pneumoniae strains have spread rapidly among Italian hospitals, with four subclades of 
pandemic clonal group 258 (CG258). Here we show that a single Italian hospital has been 
invaded by three of these subclades within 27 months, thus replicating on a small scale the 
“Italian scenario.” We identified a single clone responsible for an epidemic outbreak involving 
seven patients, and we reconstructed its star-like pattern of diffusion within the intensive 
care unit. This epidemiological picture was obtained through phylogenomic analysis of 16 
carbapenem-resistant K. pneumoniae isolates collected in the hospital during a 27-month 
period, which were added to a database of 319 genomes representing the available global 
diversity of K. pneumoniae strains. Phenotypic and molecular assays did not reveal virulence 
or resistance determinants specific for the outbreak isolates. Other factors, rather than 
selective advantages, might have caused the outbreak. Finally, analyses allowed us to 
identify a major subclade of CG258 composed of strains bearing the yersiniabactin virulence 
factor. Our work demonstrates how the use of combined phenotypic, molecular, and whole-
genome sequencing techniques can help to identify quickly and to characterize accurately 
the spread of MDR pathogens. 
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INTRODUCTION 
Klebsiella pneumoniae is a major nosocomial pathogen that is rapidly spreading in hospitals 
worldwide, mainly due to the common occurrence of multidrug-resistant (MDR) strains (1). 
Infections caused by this pathogen are difficult to eradicate, since K. pneumoniae carries 
genes for resistance to the majority of antimicrobial drugs, including carbapenems (2, 3). 
The first strain of carbapenem-resistant K. pneumoniae was isolated in 1996; the plasmid-
encoded determinant was named K. pneumoniae carbapenemase (KPC) and was indicated 
as the blaKPC gene (4). Since then, KPC-producing K. pneumoniae strains have been 
spreading worldwide. Additional carbapenemases (blaNDM, blaOXA-48, blaVIM, and blaIMP-1) have 
now been reported for MDR Enterobacteriaceae, including K. pneumoniae (5–8). A last-
resort treatment for infections caused by MDR Gram-negative bacteria is represented by 
membrane-acting polymyxins such as colistin, but resistance to this antibiotic in K. 
pneumoniae is also emerging (9, 10). 
In addition to the study of genes providing resistance to antibiotics, genetic factors involved 
in the variable levels of virulence of different isolates of K. pneumoniae are currently highly 
investigated but only partially understood. Among the most important virulence factors are 
fimbrial genes (mrk and fim operons), which mediate adherence to surfaces and host tissues 
(11, 12). Another important aspect involved in the colonization of the host is the presence of 
genes for iron uptake systems such as aerobactin (13), enterobactin (ent operon) (14), and 
yersiniabactin (irp and ybt genes) (15). Capsular types, particularly K1 and K2, and 
hypermucoviscosity, favored by the positive regulator genes rmpA and rmpA2, are also 
important for K. pneumoniae virulence. Capsule production increases resistance to 
phagocytosis and other immune response components (16, 17). For detailed descriptions of 
these and other potential virulence factors of K. pneumoniae, see references 18 and 19. 
Most of the KPC-producing K. pneumoniae strains isolated worldwide have been attributed 
to clonal group 258 (CG258) (19, 20). Recent phylogenomic analyses showed that four 
different subclades of pandemic CG258 are present in Italy, indicating entrance into the 
country on at least four different occasions during the period of 2008 to 2010 (21). The 
spread of MDR K. pneumoniae in hospitals and nursing homes in Italy is known to have 
occurred very rapidly, with a diffusion pattern that has been described as the “Italian 
scenario” (22). The worldwide spread of K. pneumoniae is due, in part, to failures in the early 
identification of MDR strains, as well as high rates of recombination and horizontal gene 
transfer (21, 23, 24). 
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Whole-genome sequencing is now offering the possibility of in-depth characterization of 
bacterial isolates, and it holds the potential to reconstruct the origin and diffusion of 
nosocomial infections and outbreaks (19, 25). Here we present a phylogenomic study of 16 
isolates from a single hospital in northwestern Italy that were collected between 2011 and 
2013, including an epidemic outbreak in 2013 that involved seven patients. Genomes from 
these isolates were compared with 319 publicly available genomes, representing the 
available global genomic diversity of K. pneumoniae. Phylogenomic analysis, together with 
phenotyping assays and molecular characterization of drug resistance determinants and 
virulence genes, allowed us to trace the origins of sporadic infections and the outbreak, to 
describe the monophyletic origin of a yersiniabactin-positive subclade of CG258, and to 
detect a common genetic trait in colistin-resistant strains. 
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MATERIALS AND METHODS 
Nosocomial infections with K. pneumoniae and hospital outbreak. Between January 
2011 and March 2013, 16 cases of infection due to carbapenem-resistant K. pneumoniae 
occurred at the Ospedale di Circolo e Fondazione Macchi (Varese, Italy). Seven cases that 
occurred in the intensive care unit (ICU) during a short period were part of a single epidemic 
event that started in February 2013 (Fig. 1). Evidence indicated that a 69-year-old man was 
patient zero (indicated as KpVA-8 in Fig. 1). He had been transferred to the ICU from a 
nearby hospital, with an already diagnosed infection due to KPC-producing K. pneumoniae. 
During his stay in the ICU, infection spread to six other patients. 
 
 
FIG 1. Time frames of stays in the ICU for the seven patients involved in the K. pneumoniae 
outbreak. Horizontal bars, length of stay for each patient. Black squares, day of the first 
isolation of K. pneumoniae for each patient. 
 
Bacterial isolates. A total of 16 non-duplicated isolates of K. pneumoniae were 
investigated, specifically, the first isolate obtained from each patient. Multiple K. pneumoniae 
isolates were obtained subsequently from each patient, for clinical reasons (e.g., spread of 
infection to novel body sites) or in the course of surveillance studies. Clinical specimens 
included urine, blood, bronchoalveolar lavage fluid, sputum, tracheal aspirate, and wound 
specimens. During the outbreak period, ICU patients were screened every 3 days for 
surveillance, using nasal, armpit, inguinal, and rectal swabs. Species identification and 
antibiotic susceptibility tests were performed with the FDA-approved Phoenix automated 
microbiology system (Becton, Dickinson, Sparks, MD). Additional quantitative assays were 
performed using Etest strips (bioMérieux, Marcy l'Etoile, France) on Mueller-Hinton agar II 
plates (Becton, Dickinson), according to clinical breakpoints from the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST). Short descriptions of the investigated 
isolates are presented in Table 1, while Etest MICs are reported in Table 2. 
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Patient no. Clinical isolate 
status 
Date of isolation 
(mo/day/yr) 
Source* Sequence type 
KpVA-4 Sporadic 1/11/11 B ST258 
KpVA-5 Sporadic 1/28/11 B ST258 
KpVA-6 Sporadic 3/14/11 B ST258 
KpVA-7 Sporadic 5/3/11 B ST258 
KpVA-1 Sporadic 10/31/12 SP ST512 
KpVA-2 Sporadic 1/30/13 BAL ST258 
KpVA-8 Epidemic 2/1/13 BAL ST512 
KpA-10 Epidemic 2/8/13 BAL ST512 
KpVA-9 Epidemic 2/12/13 BAL ST512 
KpVA-11 Epidemic 2/13/13 B ST512 
KpVA-12 Epidemic 2/15/13 TA ST512 
KpVA-13 Epidemic 2/16/13 WS ST512 
KpVA-14 Epidemic 2/19/13 BAL ST512 
KpVA-3 Sporadic 3/14/13 B ST258 
KpVA-15 Sporadic 3/24/13 U ST512 
KpVA-16 Sporadic 3/24/13 U ST512 
TABLE 1. Clinical isolates and main properties. * B, blood; WS, wound sample; SP, 
sputum; BAL, bronchoalveolar lavage fluid; TA, tracheal aspirate; U, urine. 
 Characteristic KPVA-4 KPVA-5 KPVA-6 KPVA-7 KPVA-1 KPVA-2 KPVA-8 KPVA-10 KPVA-9 KPVA-11 KPVA-12 KPVA-13 KPVA-14 KPVA-3 KPVA-15 KPVA-16 
Date of 
isolation 
(mo/day/yr) 
1/11/11 1/28/11 3/14/11 5/3/11 10/31/12 1/30/13 2/1/13 2/8/13 2/12/13 2/13/13 2/15/13 2/16/13 2/19/13 3/14/13 3/24/13 3/24/13 
Sensitivity and MIC (mg/liter)* 
Ampicillin R, >16 R, >16 R, >16 R, >16 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 
Amoxicillin-
clavulanate 
R, >16/8 R, >16/8 R, >16/8 R, >16/8 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 R, >8/2 
Ceftazidime R, >16 R, >16 R, >16 R, >16 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 R, >8 
Cefotaxime R, >32 R, >32 R, >32 R, >32 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 R, >4 
Aztreonam R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 R, >16 
Ertapenem R, >1 R, >32 R, >1 R, >1 R, >1 R, >1 R, >32 R, >32 R, >32 R, >32 R, >32 R, >32 R, >32 R, >1 R, >1 R, >1 
Imipenem R, >32 R, 8 R, 32 R, 8 R, >8 R, >8 R, >32 R, >32 R, >32 R, >32 R, >32 R, >32 R, >32 R, 8 R, >8 R, >8 
Meropenem R, >32 R, 32 R, >32 I, 6 R, >8 R, >8 R, >32 R, >32 R, >32 R, >32 R, >32 R, >32 R, >32 R, 12 R, >8 R, >8 
Ciprofloxacin R, >2 R, >2 R, >2 R, >2 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 R, >1 
Levofloxacin R, >4 R, >4 R, >4 R, >4 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 R, >2 
Amikacin R, 48 R, 64 R, 48 R, 64 R, >16 R, >16 S, 1 S, 1 S, 1 S, 1 S, 1 S, 1 S, 1 R, 48 R, >16 R, >16 
Gentamicin S, 0.5 S, 1.5 S, 1 S, 2 S, 2 S, 2 S, 0.25 S, 0.25 S, 0.25 S, 0.25 S, 0.25 S, 0.25 S, 0.25 S, 1.5 S, 4 S, 2 
Tobramycin S, 0.5 R, 16 R, 16 R, 24 R, >4 R, >4 S, 0.38 S, 0.38 S, 0.38 S, 0.38 S, 0.38 S, 0.38 S, 0.38 R, 12 R, >4 R, >4 
Colistin S, 0.12 S, 0.19 S, 0.38 S, 0.19 R, >4 S <1 R, 8 R, 8 R, 8 R, 8 R, 8 R, 8 R, 8 S, 0.19 R, >4 R, >4 
        
TABLE 2. Antimicrobial susceptibility profiles of 16 investigated K. pneumoniae isolates. * R, resistant; I, intermediate; S, susceptible. 
 
 72 
Direct sequencing of 16S rRNA, drug resistance genes, and virulence factors. Starting 
from pure cultures on Mueller-Hinton agar, bacterial DNA was obtained by lysozyme 
pretreatment (Sigma-Aldrich, Milan, Italy) followed by extraction with a QIAmp DNA Blood 
minikit (Qiagen, Milan, Italy). Confirmatory identification was performed via direct sequencing 
of the 16S rRNA gene. PCR was performed using AmpliTaq Gold with buffer I (Applied 
Biosystems, Life Technologies, Monza, Italy) in 50-μl mixtures, according to the 
manufacturer's instructions. PCR primers were synthesized by Sigma-Genosys (Haverhill, 
United Kingdom). Published primers and thermal protocols were used (26). DNA fragments 
were analyzed by electrophoresis on a 1.5% agarose gel in TBE buffer (89 mM Tris-borate 
and 2 mM EDTA [pH 8.3]) containing GelRed (10,000× in water; Biotium, DBA Italy, Segrate, 
Italy). PCR products were purified and sequenced on an ABI Prism 310 sequencer (Life 
Technologies). Sequences were compared with those in GenBank. 
PCR assays for detecting antimicrobial resistance genes (27) and virulence factors were 
performed according to published protocols. Genes coding for adhesion fimbriae, 
enterobactin, and yersiniabactin siderophores were searched for, as follows: fimH gene, 
coding for type 1 fimbriae (28); mrkA gene, coding for the major subunit protein, and mrkD 
gene, coding for the adhesin, for type 3 fimbriae (29, 30); entE gene, coding for synthase 
subunit E, and entB gene, coding for isochorismatase, for enterobactin siderophore 
synthesis (14); ybtS gene, coding for salicylate synthase, for yersiniabactin siderophore 
synthesis; irp-1 and irp-2 genes, related to yersiniabactin siderophore (15). Direct 
sequencing was performed as reported above. 
Whole-genome sequencing and assembly. Whole-genome DNA was sequenced using an 
Illumina MiSeq platform (Illumina Inc., San Diego, CA), with a paired-end run of 2 by 250 bp, 
after Nextera XT paired-end library preparation. Sequencing reads were assembled using 
MIRA 4.0 software (31) with accurate de novo settings. 
In silico MLST and gene mining. Multilocus sequence typing (MLST) profiles were 
obtained in silico by analyzing appropriate gene variants 
(http://bigsdb.web.pasteur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef_public&pa
ge=downloadAlleles) for each genome, using an in-house Python script. The presence of 
selected genes coding for antibiotic resistance and virulence factors was determined by 
using BLAST with a specifically designed database, BIGSdb-Kp 
(http://bigsdb.web.pasteur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef_public&pa
ge=sequenceQuery) (19). All hits were manually checked, and genes requiring specificity for 
a particular variant (e.g., blaKPC versus blaOXA-48) were requested to have 100% identity with 
the database sequences. BLAST searches and filters were also used to test for the 
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presence of yersiniabactin genes in all genomes used for the global phylogenetic analysis 
(see Results for details). Analysis of the presence of insertion sequences within the mgrB 
gene (a putative determinant of colistin resistance) (32) was performed with a manually 
corrected BLAST search. 
Core SNP detection and phylogeny. Whole-genome sequences of the 16 isolates were 
added to a previously described database of 319 genomes of K. pneumoniae strains isolated 
throughout the world (21). Single-nucleotide polymorphisms (SNPs) were detected using an 
in-house pipeline based on Mauve software (33), using the published NJST258_1 complete 
genome as a reference (21). Briefly, each genome was individually aligned with the 
reference and alignments were merged with Perl scripts to obtain a global alignment. Core 
SNPs, defined as single-nucleotide variations flanked by at least one identical nucleotide on 
both sides in all genomes analyzed (34), were detected. Maximum likelihood phylogenetic 
analysis was performed using core SNPs merged in a multialignment file. RAxML software 
was used (35) with the generalized time-reversible (GTR) model and 100 bootstraps. 
Core genome MLST. Core genome MLST (cgMLST) analysis was performed using the 
BIGSdb software and database (19, 36). cgMLST profiles made of allelic variants at 694 loci 
were obtained for 219 genomes of CG258, representing the 16 genomes presented in this 
work. cgMLST profiles were used to produce a tree of all 219 genomes, using the 
unweighted pair group method with arithmetic mean (UPGMA) approach. 
Outbreak reconstruction. The spreading routes of outbreak strains were reconstructed by 
combining core SNPs and the dates of sample collection, applying the SeqTrack method 
implemented in the R package Adegenet (37). The outbreak chain of transmission was then 
obtained using the R package Outbreaker (38). 
Nucleotide sequence accession number. Genome assemblies were deposited in the 
EMBL database under accession number PRJEB7661. 
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RESULTS 
Species identification and antimicrobial susceptibility. In this work, the first isolate 
obtained from each patient was investigated. Species identification was performed with 
biochemical and molecular assays. The seven isolates collected in February 2013 were 
suspected to belong to a single outbreak; these strains are referred to as epidemic. The 
remaining isolates are termed sporadic. Five of 16 isolates were obtained from blood 
cultures (3 of 7 for patients involved in the ICU outbreak). 
Phenotypic assays detected resistance to imipenem, meropenem, and ertapenem in all 
isolates, regardless of the isolation date. All were thus classified as carbapenem resistant. 
The seven epidemic isolates were resistant to colistin but susceptible to aminoglycosides 
(gentamicin, amikacin, and tobramycin). Three of 9 sporadic isolates were also resistant to 
colistin. 
Drug resistance determinants and virulence factors. Isolates were subjected to a set of 
PCR assays to detect drug resistance genes and virulence factors. The blaKPC gene was 
detected in all isolates, while other carbapenem resistance genes (blaNDM, blaIMP-1, blaOXA-48, 
and blaVIM) were not detected. Genes coding for type 1 and type 3 fimbriae (fim and mrk 
operons, respectively) were detected in all isolates, as was the enterobactin siderophore 
located in the ent operon (Table 3). Three sporadic isolates carried genes for yersiniabactin, 
i.e., ybtS and the iron-repressible genes irp1 and irp2 (14, 39, 40). In K. pneumoniae, the 
yersiniabactin siderophore is expressed together with or instead of enterobactin. Finally, 
genomes were scanned for the presence of any beta-lactamase gene with the web tool 
BIGSdb (19). Genes coding for BlaSHV were detected in all isolates, while genes coding for 
BlaTEM were detected in 13 of the 16 genomes, being absent only in KpVa-2, KpVA-3, and 
KpVA-4. None of the analyzed genomes were found to carry genes of any of the other 17 
beta-lactamase families. 
 Characteristic KPVA-4 KPVA-5 KPVA-6 KPVA-7 KPVA-1 KPVA-2 KPVA-8 KPVA-10 KPVA-9 KPVA-11 KPVA-12 KPVA-13 KPVA-14 KPVA-3 KPVA-15 KPVA-16 
Date of 
isolation 
(mo/day/yr) 
1/11/11 1/28/11 3/14/11 5/3/11 10/31/12 1/30/13 2/1/13 2/8/13 2/12/13 2/13/13 2/15/13 2/16/13 2/19/13 3/14/13 3/24/13 3/24/13 
Presence and type of antibiotic resistance determinants 
blaKPC 2 3 3 3 3 2 3 3 3 3 3 3 3 2 3 3 
blaVIM No No No No No No No No No No No No No No No No 
blaNDM1 No No No No No No No No No No No No No No No No 
blaIMP No No No No No No No No No No No No No No No No 
blaOXA No No No No No No No No No No No No No No No No 
blaSHV 12 11 11 11 11 12 11 11 11 11 11 11 11 11 11 11 
blaTEM No 1 1 1 1 No 1 1 1 1 1 1 1 No 1 1 
mgrB insertion No No No No Yes No Yes Yes Yes Yes Yes Yes Yes No Yes Yes 
Presence of virulence determinants 
fimACDEFH Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
mrkABCDF Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
rpmA No No No No No No No No No No No No No No No No 
magA No No No No No No No No No No No No No No No No 
entABCDEF Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
ybtA Yes No No No No Yes No No No No No No No Yes No No 
ybtS Yes No No No No Yes No No No No No No No Yes No No 
irp1 Yes No No No No Yes No No No No No No No Yes No No 
irp2 Yes No No No No Yes No No No No No No No Yes No No 
 
TABLE 3. Antimicrobial resistance and virulence determinants in 16 investigated K. pneumoniae isolates 
 76 
Whole-genome sequencing and characterization. Whole-genome sequences were 
obtained for all 16 K. pneumoniae isolates. The assembled genomes were characterized in 
silico for MLST and were searched for genes coding for drug resistance determinants and 
virulence factors (Tables 1 and 3). MLST analysis enabled identification of two groups of 
isolates. Six isolates (KpVA-2, KpVA-3, KpVA-4, KpVA-5, KpVA-6, and KpVA-7) were of 
sequence type 258 (ST258); 10 isolates, including the epidemic ones, belonged to ST512. 
ST512 differs from ST258 at a single nucleotide, thus belonging to the same clonal group, 
CG258 (19, 20). Confirming the results obtained by molecular analysis, all strains were 
found to carry the blaKPC gene. The blaKPC2 variant (KPC2) was found in three of six isolates 
belonging to ST258, while the remaining 13 isolates carried the blaKPC3 variant (KPC3). 
The three isolates belonging to ST258 and possessing the blaKPC2 variant also presented 
unique profiles of virulence and drug resistance factors. Strains KpVA-2, KpVA-3, and KpVA-
4 harbored the irp1, irp2, ybtA, and ybtS genes, which were not detected in other strains. 
These four genes encode yersiniabactin, a virulence factor expressed by Yersinia and other 
enterobacteria, including K. pneumoniae (19, 41). All 16 strains analyzed here possessed 
the mrk and fim operons, coding for fimbrial genes (11, 12), and the ent operon, coding for 
enterobactin (14), consistent with previous results showing that these genes are highly 
conserved in K. pneumoniae (19, 30). None of the isolates demonstrated rmpA and wzy-K1 
(magA) genes, which are hypermucoviscosity-associated genes (16, 17, 19). 
Genes related to colistin resistance were also investigated. The entire set of pmr genes was 
highly conserved among the 16 strains, including the pmrB locus, which has been indicated 
as a colistin resistance determinant (42). All colistin-resistant strains harbored a variant of 
the mgrB gene interrupted by an IS5-like transposon (Table 3). Insertion of a transposon in 
this gene has been reported as a determinant of colistin resistance (32). 
Global core SNP phylogeny. A global genome phylogeny of K. pneumoniae, including the 
16 isolates investigated in this study, was obtained by adding the novel genomes to a 
previously constructed database of 319 isolates (21). Phylogeny was obtained in order to 
contextualize our strains among the previously sequenced K. pneumoniae isolates. The 16 
novel genomes clustered in 5 monophyletic groups on the global tree (Fig. 2). As expected, 
they fit within CG258. Interestingly, these 16 isolates were assigned to three of the four 
previously identified groups of Italian isolates of CG258 (21). Inclusion of the investigated 
genomes in the global phylogeny allowed us to define the relationships among the isolates 
at the investigated hospital. KpVA-2, KpVA-3, and KpVA-4, the three isolates that were 
yersiniabactin positive, clustered together in a clade containing nine additional Italian strains 
and two U.S. strains, all demonstrating the yersiniabactin genes (which could also contribute 
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to copper toxicity) (38). Thirty-nine additional isolates, belonging to different sequence types 
and scattered on the global K. pneumoniae phylogeny, also demonstrated yersiniabactin. 
The genomes of the seven isolates collected in February 2013 and hypothesized to 
represent a single epidemic event clustered together in a single, well-supported, 
phylogenetic clade (Fig. 2). This result confirmed the original hypothesis of a single clone 
being responsible for the seven infections that occurred in the ICU. 
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FIG 2. Representation of the 
phylogenetic relationships 
between isolates of clonal group 
258 of Klebsiella pneumoniae, 
reconstructed using RaxML 
software with 100 bootstrap 
replicates and the generalized 
time-reversible model. The 16 
novel isolates investigated in this 
study are highlighted in bold type. 
Highlighted in blue boxes are the 
four clades encompassing Italian 
isolates (both newly sequenced 
and taken from databases). 
Triangles represent coherent 
monophyletic clades of isolates 
from other countries, and orange 
dots indicate the presence of 
yersiniabactin genes. Bootstrap 
values are indicated only on 
nodes of interest, for the sake of 
image clarity. For a complete 
phylogeny of 335 K. pneumoniae 
isolates worldwide, see Fig. S1 in 
the supplemental material. 
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In analyses of the numbers of SNPs differentiating the isolates, the seven strains belonging 
to the investigated outbreak presented an average of 20 SNPs per genome in comparisons 
among them. Interestingly, a similar average number (27 SNPs per genome) differentiated 
strains KpVA-1, KpVA-15, and KpVA-16, which are grouped in a single clade but have been 
sampled over a longer time (about 5 months). This could indicate a difference in the 
measured paces of the molecular clock between the two clusters. Multiple hypotheses could 
explain the observed situation, such as the presence of different environmental conditions or 
a conservative pressure from purifying selection. 
Core genome MLST. cgMLST analysis was performed with the same genomic data set 
used for the SNP phylogeny presented in Fig. 2 (219 K. pneumoniae genomes belonging to 
CG258). The resulting UPGMA tree (see Fig. S2 in the supplemental material) is largely 
consistent with the tree resulting from the SNP-based phylogenomic analysis. Specifically, in 
both analyses, the main subdivisions of CG258 (23) were clearly detectable, while the 16 
genomes presented in this work were clustered in four monophyletic groups, one of which 
corresponded to the seven outbreak strains. 
Outbreak reconstruction. To define the investigated ICU outbreak in greater detail, a 
genomic network was built using the core SNPs identified among the epidemic isolates, 
which were ordered according to the isolation date. The resulting structure showed a star-
like topology (Fig. 3) centered around the isolate obtained from patient zero (KpVA-8). This 
structure suggested a nonlinear spread of infection. Thus, multiple events of contagion 
probably took place, all starting from patient zero and infecting six ICU patients (Fig. 3). It is 
important to note that patient zero (KpVA-8) stayed in the ICU for >2 months and the stays 
of the other infected patients coincided with his presence (Fig. 1). In addition, the location of 
his bed in the ward was not related to the date of infection (i.e., patients in beds closer to the 
bed of patient zero were not infected before patients in beds more distant from the bed of 
patient zero). Interestingly, the phylogenetic analysis of SNPs (Fig. 2) showed KpVA-8 (i.e., 
the isolate from patient zero) as the sister taxon of a single clade including the other six 
epidemic strains (Fig. 2). The result confirms that isolate KpVA-8 was at the origin of the 
outbreak. 
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FIG 3. (A) Reconstruction of the star-like diffusion pattern, starting from isolate KpVA-8, 
among the seven K. pneumoniae isolates belonging to a single outbreak event that occurred 
in the ICU of Ospedale di Circolo e Fondazione Macchi in February 2013. The star-like 
topology was obtained using the R package Outbreaker. Numbers in bold indicate the 
temporal order of contagion. (B) Graphic representation of the bed-to-bed spread of infection 
on a map of the ICU. 
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DISCUSSION 
This work was aimed at characterizing 16 carbapenem-resistant K. pneumoniae isolates 
collected from a single hospital during a 27-month period, including an epidemic that 
occurred in February 2013. This allowed us to identify the genomic characteristics of the 
isolates, to elucidate the epidemiological relationships among them, and to place them in the 
context of the global phylogeny of K. pneumoniae. In particular, whole-genome analyses 
allowed us to characterize the diversity of this bacterial species within a single hospital, to 
contextualize the local features within the global genomic spectrum of the species, and to 
reconstruct the spreading route of seven isolates within the ICU. 
The 16 carbapenem-resistant isolates were shown to belong to CG258, the most prevalent 
KPC-producing K. pneumoniae lineage. Indeed, all 16 genomes demonstrated the gene 
blaKPC, and none of them had other known carbapenem resistance genes. This is not 
surprising, considering previous reports that showed the worldwide diffusion and high 
prevalence of KPC isolates of this clonal group among carbapenem-resistant K. pneumoniae 
strains (21, 23). 
When the drug resistance profiles of the investigated isolates were compared, the main 
difference was colistin resistance. In 10 of the 16 isolates, the colistin MIC was 4 mg/liter or 
higher (Table 2), thus above the EUCAST MIC breakpoint. Genomic analysis aimed at 
detecting the determinants for this resistance trait found that the 10 resistant isolates 
demonstrated insertion of an IS5-like transposon in the mgrB, a gene that regulates a 
pathway of lipopolysaccharide biosynthesis (43). Insertion of an IS5-like sequence in the 
mgrB gene has indeed been proposed as a determinant of colistin resistance (32). Our 
results appear to support this causative link, considering that none of the six colistin-
sensitive strains presented the aforementioned insertion. 
The global phylogeny of K. pneumoniae (Fig. 2) reveals that the 16 isolates are assigned to 
three of the four previously characterized Italian clades of CG258. These four clades have 
been proposed to represent four different dissemination events for KPC isolates in Italy, from 
2008 to 2010 (21). Therefore, within a time span of 27 months, three of the four main Italian 
lineages of CG258 KPC-producing K. pneumoniae were detected in a single hospital in 
northwestern Italy. This result clearly indicates that at least three of the four lineages are 
currently circulating, creating a scenario of multiple, contemporary, overlapping epidemics. 
With regard to virulence genes, all 16 isolates possessed the operons fim, ent, and mrk but 
lacked the genes rmpA and wzy-K1 (magA). The only detected difference among the 16 
isolates was the presence in three isolates of four genes responsible for yersiniabactin 
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synthesis (ybtA, ybtS, irp1, and irp2). Yersiniabactin has been reported to provide 
advantages in metabolism and multiplication, particularly in mixed infections and under iron-
deprived conditions and especially in pulmonary infections, according to recent studies (14, 
39, 40). When investigating the presence of yersiniabactin genes in the global CG258 K. 
pneumoniae phylogeny (Fig. 1), we detected a monophyletic group encompassing the three 
novel isolates as well as all other Italian isolates belonging to the same subclade, in addition 
to two U.S. isolates. This result clearly indicates that these genes were acquired before the 
diversification of this specific subclade and have been maintained since, which allows the 
characterization of this group of isolates as a yersiniabactin-positive monophyletic lineage of 
strains within CG258. 
Seven of the 16 isolates, which were collected from ICU patients over a period of 17 days, 
were hypothesized to represent a single epidemic event. The monophyletic relationships 
among the seven epidemic isolates (Fig. 2) confirmed the hypothesis. A specific analysis for 
outbreak reconstruction showed that the epidemic isolates were connected in a star-like 
diagram (Fig. 3) originating from the isolate from patient zero. This is congruent with the 
rapid spread among the seven ICU patients. 
Epidemic isolates could not be differentiated from sporadic isolates based on a specific 
pattern of the presence/absence of genes coding for virulence factors. The drug resistance 
profiles of these isolates also were identical to those of some sporadic isolates. This 
indicates that the spread of the outbreak was not related to genes conferring a specific 
advantage to the epidemic clone. Rather, it suggests that external factors might have caused 
the spread of the clone among ICU patients. 
In conclusion, this study shows how whole-genome analysis can facilitate accurate 
reconstruction of the spread of bacterial pathogens. The wealth of data from genome 
sequencing allows reconstruction of the relationships of isolates from single hospitals and 
outbreaks and placement of the isolates in overall global phylogenies, and comparisons of 
genomes permit determination of whether strains involved in a specific outbreak share 
common characteristics that might confer specific selective advantages. The introduction of 
bacterial genomics into clinical settings will thus allow reconstruction of the routes and 
causes of nosocomial infections, with estimation of the relative roles of human- and microbe-
related factors. 
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ABSTRACT 
We retrospectively analyzed a rare Salmonella enterica serovar Manhattan outbreak that 
occurred in Italy in 2009 to evaluate the potential of new genomic tools based on differential 
single nucleotide polymorphism (SNP) analysis in comparison with the gold standard 
genotyping method, pulsed-field gel electrophoresis. A total of 39 isolates were analyzed 
from patients (n = 15) and food, feed, animal, and environmental sources (n = 24), resulting 
in five different pulsed-field gel electrophoresis (PFGE) profiles. Isolates epidemiologically 
related to the outbreak clustered within the same pulsotype, SXB_BS.0003, without any 
further differentiation. Thirty-three isolates were considered for genomic analysis based on 
different sets of SNPs, core, synonymous, nonsynonymous, as well as SNPs in different 
codon positions, by Bayesian and maximum likelihood algorithms. Trees generated from 
core and nonsynonymous SNPs, as well as SNPs at the second and first plus second codon 
positions detailed four distinct groups of isolates within the outbreak pulsotype, 
discriminating outbreak-related isolates of human and food origins. Conversely, the trees 
derived from synonymous and third-codon-position SNPs clustered food and human isolates 
together, indicating that all outbreak-related isolates constituted a single clone, which was in 
line with the epidemiological evidence. Further experiments are in place to extend this 
approach within our regional enteropathogen surveillance system. 
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INTRODUCTION 
Salmonellosis is a major food-borne disease worldwide, with an estimated 93.8 million cases 
occurring each year, resulting in 155,000 deaths (1). The European Union summary report 
on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks (2) indicated 
that nontyphoid salmonellosis was the second most reported food-borne zoonosis in Europe 
in 2012, trailing only behind Campylobacter jejuni infection. The 2012 overall notification rate 
for human salmonellosis in the European Union (EU) was 22.2 episodes per 100,000 
population, for a total of 91,034 confirmed cases, with hospitalization and mortality rates of 
45.1% and 0.14%, respectively. The highest proportions of Salmonella-positive foodstuff 
samples were reported for fresh turkey, poultry, and pork at 4.4%, 4.1%, and 0.7%, 
respectively (2). In order to manage this food-borne infection and to limit its health and 
economic burdens, surveillance programs have developed and implemented DNA-based 
subtyping methods to identify outbreaks in a timely manner and to trace infections back to 
their food sources. Over the past decades, the two most intensively used protocols for 
Salmonella subtyping have been pulsed-field gel electrophoresis (PFGE) and multilocus 
variable-number tandem-repeat analysis (MLVA) (3). Unfortunately, these methods rely on 
just few features of the entire bacterial genome (rare restriction sites for PFGE or few 
polymorphic loci for MLVA) to assess the relatedness of different isolates. During 
epidemiological investigations of food-borne outbreaks, this limitation might lead to 
difficulties in distinguishing outbreak-related from outbreak-unrelated Salmonella enterica 
subsp. enterica isolates due to the high genetic homogeneity of this subspecies (4). 
Multilocus sequence typing (MLST) is another molecular tool for bacterial typing based on 
allelic differences in the loci of specified housekeeping genes (5). While proposed as an 
alternative to classical serotyping (6), MLST does not seem to be discriminatory enough 
when all isolates being tested belong to the same serotype (7). With the aim of improving 
resolution in molecular epidemiology, the technological advancements of whole-genome 
sequencing (WGS) may provide an unprecedented opportunity to access the entire genome 
information at a reasonable cost, as well as to set a new series of high-resolution standards 
in molecular epidemiology. As PFGE and MLVA are able to resolve more genotypes within a 
single serovar, WGS has already proved its resolution power to detect variations within 
otherwise undistinguishable bacterial clones (by PFGE or MLVA), as shown by recent 
examples in the literature (8, 9). Large studies based on WGS within S. enterica subspecies 
(10) and within serovars in S. enterica subsp. enterica (11, 12) contributed to the elucidation 
of Salmonella phylogenetic diversity and also accomplished important steps forward in the 
area of bacterial disease tracking. Moreover, serovar-specific studies on S. enterica subsp. 
enterica have highlighted microevolutionary differences among clinical, environmental, and 
 91 
food isolates in S. enterica serovars Montevideo (13, 14), Enteritidis (4), Newport (15), 
Typhimurium (16–18), and Heidelberg (12), which would have been missed by more 
traditional approaches. 
While outbreaks of more common serovars, such as Salmonella Typhimurium and 
Salmonella Enteritidis, have been reported and investigated, only a few human outbreaks 
due to S. enterica serovar Manhattan have been reported (19, 20) worldwide in the past 60 
years, and none have been characterized at the genomic level. Here, we present a WGS-
based retrospective analysis of the only Salmonella Manhattan outbreak ever documented in 
Italy, which occurred from June to July 2009 in a relatively small geographic area in the 
province of Modena. 
The outbreak investigation at the time of the event was carried out by international standard 
epidemiological techniques (21) and by PFGE on the isolates from patients and food, feed, 
animal, and environmental sources. 
The aim of this study was 2-fold: (i) to evaluate the effectiveness of WGS to accurately 
identify the relationships among all the outbreak-related isolates with enough resolution to 
clarify the ambiguities that PFGE was not able to unravel, and (ii) to explore and test new 
genomic tools for bacterial molecular epidemiology based on synonymous and 
nonsynonymous single-nucleotide polymorphisms (SNPs) and SNPs in different codon 
positions. 
We selected this specific Salmonella Manhattan outbreak to test our WGS pipeline because 
of three main features that made this outbreak a particularly suitable case study. First, 
Salmonella Manhattan is considered a rare serotype, as confirmed by the regional 
surveillance system for Salmonella of Emilia-Romagna, which over the past 3 years 
recorded a yearly average of only 5.6 sporadic cases over a total of 924 isolates per year, 
from a regional population of about 5,000,000 (M. Morganti, E. Scaltriti, L. Bolzoni, G. 
Casadei, and S. Pongolini; Enter-net Italia, unpublished data). This low prevalence of 
Salmonella Manhattan infection provides a reasonable confidence that virtually all isolates 
collected in the outbreak area at the time of the episode belonged to the outbreak, therefore 
preventing the noise effect due to unrelated isolates wrongly assigned to the epidemic. 
Second, the investigation conducted at the time of the outbreak was successful in tracing the 
infection back to a food point source using internationally coded epidemiological methods 
(21); bacterial isolates were also recovered not only from food (pork sausage) at the retail 
level but also along the food chain up to the raw meat used to prepare the implicated food 
(at the production establishment). Third, the regional surveillance system for Salmonella of 
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Emilia-Romagna, hosted at the Istituto Zooprofilattico Sperimentale della Lombardia e 
dell'Emilia Romagna (IZSLER), holds a full collection of Salmonella Manhattan strains 
covering the years 2001 to present. This set of isolates was pivotal in the conduct of a 
successful epidemiological investigation and for testing our WGS-based analyses of this rare 
serovar. 
 
CASE REPORT 
The diagnostic unit of Parma of IZSLER is the Regional Reference Center for Surveillance of 
Enteropathogens (Enter-net) of clinical, environmental, animal, and food origins. Within this 
activity, a cluster of 15 human infections caused by Salmonella Manhattan was detected in 
the province of Modena from June to July 2009. All 15 isolates showed the same PFGE 
profile, SXB_BS.0003, strengthening the hypothesis that the unusually high incidence of this 
rare serovar was due to an epidemic outbreak. Consequently, an epidemiological 
investigation was undertaken and, considering the rarity of the serovar involved, all 21 
isolates of Salmonella Manhattan available from the surveillance collection of IZSLER were 
genotyped by PFGE to get possible clues about the source of the outbreak. Thirteen isolates 
from the collection had the same PFGE profile as that of the outbreak strain, but only three 
of them had been isolated just before the onset of the outbreak (May/June 2009). Two had 
been isolated from pork sausage at the establishment of an industrial producer that 
distributed in the outbreak area, while one had been recovered from swine intestine at an 
establishment near the outbreak area that processed guts for the salami industry. According 
to the epidemiological investigation, the gut processing establishment had no correlation with 
the outbreak. However, as its isolate presented the same PFGE pulsotype as that of the 
outbreak-related isolates, health authorities were left with a certain degree of uncertainty 
about its possible role. Following the results of the epidemiological and molecular analyses, 
food samples were collected at retail sources in the outbreak area and at the establishment 
producing the sausage in order to confirm the source and clonality of the outbreak strain. 
Two samples from retail-collected sausages, along with a sample from fresh pork supplies of 
the sausage producer, scored positive for the outbreak pulsotype. Based on these results, 
the sausage from the implicated producer was recalled, leading to the outbreak extinction. 
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MATERIALS AND METHODS 
Bacterial isolates. A total of 39 Salmonella Manhattan isolates were included in the study. 
Fifteen isolates were involved in the epidemic episode, another three isolates were collected 
within the epidemiological investigation, and 21 were collected between 2001 and 2009 
during the surveillance activity of IZSLER (Table 1). The isolates were isolated and streak 
purified with standard microbiological techniques and stocked at −80°C. They were cultured 
on plates with Trypticase soy agar with 5% defibrinated sheep blood (TSA-SB) and 
incubated overnight at 37°C before being typed by pulsed-field gel electrophoresis, 
according to the PulseNet protocol (22). The isolates selected for WGS were inoculated into 
brain heart infusion broth and cultured overnight at 37°C with agitation (200 rpm). 
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Lab no. Isolate no. 
(this study) 
Date of 
isolation 
(DD/MM/YYYY) 
Isolation 
place 
(province) 
Matrix PFGE 
pulsotype 
160969_3 SM1b 06/30/2009 Modena Human SXB_BS.0003 
160969_5 SM2b 06/30/2009 Modena Human SXB_BS.0003 
160969_6 SM3b 06/30/2009 Modena Human SXB_BS.0003 
165051_2 SM4b 07/03/2009 Modena Human SXB_BS.0003 
165051_3 SM5b 07/03/2009 Modena Human SXB_BS.0003 
165051_5 SM6b 07/03/2009 Modena Human SXB_BS.0003 
165051_7 SM7b 07/30/2009 Modena Human SXB_BS.0003 
111113 SM8b 07/03/2009 Modena Human SXB_BS.0003 
165051_11 SM9b 07/03/2009 Modena Human SXB_BS.0003 
165051_12 SM10b 07/03/2009 Modena Human SXB_BS.0003 
180073_1 SM11b 07/22/2009 Modena Human SXB_BS.0003 
180073_2 SM12b 07/22/2009 Modena Human SXB_BS.0003 
180073_3 SM13b 07/22/2009 Modena Human SXB_BS.0003 
180073_4 SM14b 07/22/2009 Modena Human SXB_BS.0003 
180073_6 SM15b 07/22/2009 Modena Human SXB_BS.0003 
250920 SM42b 08/31/2009 Milano Pork SXB_BS.0003 
227021 SM32b 05/06/2009 Milano Pork sausage SXB_BS.0003 
188801 SM52b 05/06/2009 Milano Pork sausage SXB_BS.0003 
216630_1 SM53b 09/03/2009 Modena Pork sausage SXB_BS.0003 
216630_2 SM54b 09/03/2009 Modena Pork sausage SXB_BS.0003 
226957 SM16 03/07/2006 Mantova Swine SXB_PR.0753 
226963 SM17b 03/20/2006 Mantova Swine SXB_PR.0753 
226972 SM19b 03/20/2006 Sondrio Pork salami SXB_PR.0753 
226979_1 SM21b 07/31/2006 Cremona Swine gut SXB_BS.0003 
226985 SM23b 08/03/2006 Milano Pork sausage SXB_BS.0003 
226987 SM24b 08/03/2006 Milano Pork sausage SXB_BS.0003 
226993 SM26 01/22/2007 Ravenna Hamburger SXB_BS.0003 
226998 SM27b 06/29/2007 Milano Pork SXB_BS.0003 
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227002 SM28 09/18/2002 Pavia Surface water SXB_BS.0003 
227009 SM29b 09/02/2002 Bologna Bovine sausage SXB_PR.0754 
227015 SM31 09/11/2001 Pavia Surface water SXB_PR.0751 
227033 SM35b 11/29/2008 Ravenna Swine stool SXB_BS.0003 
227039 SM36b 09/30/2008 Brescia Swine stool SXB_PR.0752 
227052 SM38b 09/24/2008 Milano Swine stool SXB_BS.0003 
188806 SM48b 06/03/2009 Reggio Emilia Swine intestine SXB_BS.0003 
188790 SM47 10/01/2002 Pavia Surface water SXB_BS.0003 
188795 SM49b 03/09/2009 Brescia Chicken farm SXB_PR.0753 
188787 SM51 09/17/2002 Pavia Surface water SXB_BS.0003 
188781 SM50b 07/31/2001 Modena Minced pork SXB_PR.0751 
 
TABLE 1. Complete data set of Salmonella Manhattan isolates analyzed in this studya.  
aThe isolates above the line break are the outbreak-related isolates (15 human-origin and 5 
food-origin isolates), and those below the line break are the 19 Salmonella Manhattan 
collection isolates. SM32 and SM52 were also collection isolates, but they were eventually 
attributed to the outbreak, following the results of this study. bThese Salmonella Manhattan 
isolates were selected for whole-genome sequencing. 
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Pulsed-field gel electrophoresis. All isolates were genotyped by PFGE, according to the 
PulseNet protocol (22). Genomic DNA underwent XbaI restriction before electrophoresis in a 
Chef Mapper XA system (Bio-Rad, CA, USA). The PFGE patterns were analyzed using the 
BioNumerics Software version 6.6 (Applied-Maths, Sint-Martens-Latem, Belgium) and 
associated with isolate information in our surveillance database. Clustering of the PFGE 
profiles was generated using the unweighted-pair group method using averages (UPGMA) 
based on the Dice similarity index (optimization, 1%; band matching tolerance, 1%). 
Following a comparison of the electrophoretic profiles, a PFGE pattern (pulsotype) was 
assigned to each isolate within the Regional Surveillance Database of Emilia-Romagna. 
Whole-genome sequencing. All outbreak-related isolates and a selection of the IZSLER 
Salmonella Manhattan collection, representative of the different pulsotypes detected, were 
subjected to WGS (Table 1), for a total of 33 isolates. Genomic DNA was extracted from 
overnight cultures using the Qiagen DNeasy blood and tissue kit (Qiagen) and quality 
controlled and quantified using a Synergy H1 hybrid multimode microplate reader (BioTek, 
Winooski, VT, USA). The sequencing libraries were prepared with the Nextera XT sample 
preparation kit (Illumina, San Diego, CA, USA), and sequencing was performed on the 
Illumina MiSeq platform, with a 2 × 250-bp paired-end run. 
Read quality check and assembly. All read sets were evaluated for sequence quality and 
read-pair length using the softwares FastQC and Flash (23). FastQC allowed us to assess 
the overall quality of the generated sequences, while Flash was used to measure the 
distance between the sequence read pairs. All the read sets that passed the quality check 
(visual check for FastQC and average read pair distance >100 nucleotides [nt] for Flash) 
were assembled with MIRA 4.0 (24) using accurate settings for de novo assembly mode. 
In silico multilocus sequence typing. In silico MLST was performed using the MLST 
scheme optimized by the University of Warwick 
(http://mlst.warwick.ac.uk/mlst/dbs/Senterica). 
Comparative genomics by local variation calling. In a previous work, we sequenced and 
published the first improved high-quality draft genome (25) of Salmonella Manhattan (strain 
111113) (26). The 18 contigs of the Salmonella Manhattan 111113 genome, belonging to a 
human isolate of the outbreak presented here, were concatenated in a pseudochromosome 
and used as a reference for alignment of each of the other 32 genome assemblies included 
in this study, using progressiveMauve (27). A previously described bioinformatic pipeline 
(28) was then used to merge the results of all isolates for comparison and to extract the 
coordinates of all local variations spanning from SNPs to longer variations (mutations, 
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insertions, and deletions), based on the annotation of the reference genome of strain 
111113. Core SNPs were identified as single nondegenerate mutated bases flanked by 
identical bases and present in all 33 genomes (including that of strain 111113). Genes 
presenting at least one core SNP were selected and compared against the Virulence Factors 
Database (VFDB) (29–31), using a BLAST search with a 10−5 E value cutoff. 
Analysis of variations. Open reading frames (ORFs) were predicted and translated on all 
assembled genomes (including the previously published Salmonella Manhattan strain 
111113 genome [26]) using Prodigal (32). Next, every genomic variation (SNPs, mutations, 
insertions, and deletions) was parsed in order to assign it to one of the following subsets of 
isolates: (i) all outbreak-related isolates, irrespective of the human, food, or raw meat origin; 
(ii) outbreak-related human-origin-only isolates; and (iii) outbreak-related food-origin-only 
isolates (including those from sausage and raw meat). 
Phylogenetic analysis. From the core SNP data set, different subsets were generated: (i) 
nonsynonymous SNPs, (ii) synonymous SNPs, and (iii) SNPs at the first, second, or third 
codon position. The core and subsets of SNPs were used as inputs for generating SNP-
based phylogenies using the maximum likelihood (ML) or the Bayesian methods. Model 
choice was evaluated in JModelTest (33). Maximum likelihood analyses were run in PhyML 
(34), with a generalized time-reversible (GTR) substitution model and 100 bootstrap 
iterations, while Bayesian analyses were run in MrBayes (35, 36), using the same model for 
2,000,000 generations, with chains sampled every 1,000 generations. The final parameter 
values and trees were summarized after discarding 25% of the posterior sample. The ML 
and Bayesian trees were displayed and edited for publication with FigTree version 1.4.0. 
Nucleotide sequence accession numbers. The genome sequences of Salmonella 
Manhattan (strain 111113; study identification [ID], SM8) contigs were previously deposited 
at EBI under the accession no. CBKW010000001 to CBKW010000021 (project 
PRJEB1854). The newly 32 sequenced genomes (contigs) of Salmonella Manhattan were 
deposited at EBI under the project number PRJEB5339 and are summarized here in the 
format isolate lab no./study identification no.: WGS accession number: 160969_3/SM1: 
CCBJ010000610 to CCBJ010000701, 160969_5/SM2: CCBJ010000175 to 
CCBJ010000212, 160969_6/SM3: CCBJ010000291 to CCBJ010000308, 165051_2/SM4: 
CCBJ010001977 to CCBJ010002069, 165051_3/SM5: CCBJ010002070 to 
CCBJ010000089, 165051_5/SM6: CCBJ010000001 to CCBJ010000100, 165051_7/SM7: 
CCBJ010004043 to CCBJ010004081, 165051_11/SM9: CCBJ010003194 to 
CCBJ010003512, 165051_12/SM10: CCBJ010000309 to CCBJ010000327, 
180073_1/SM11: CCBJ010002338 to CCBJ010002378, 180073_2/SM12: CCBJ010003726 
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to CCBJ010003749, 180073_3/SM13: CCBJ010001070 to CCBJ010001515, 
180073_4/SM14: CCBJ010001516 to CCBJ010001924, 180073_6/SM15: CCBJ010000702 
to CCBJ010000770, 250920/SM42: CCBJ010000328 to CCBJ010000609, 227021/SM32: 
CCBJ010004870 to CCBJ010004957, 188801/SM52: CCBJ010002097 to CCBJ010002229, 
216630_1/SM53: CCBJ010002817 to CCBJ010003193, 216630_2/SM54: CCBJ010000213 
to CCBJ010000238, 226963/SM17: CCBJ010002257 to CCBJ010002337, 226972/SM19: 
CCBJ010002230 to CCBJ010002256, 226979_1/SM21: CCBJ010000101 to 
CCBJ010000174, 226985/SM23: CCBJ010003750 to CCBJ010004042, 226987/SM24: 
CCBJ010003702 to CCBJ010003725, 226998/SM27: CCBJ010000771 to CCBJ010001069, 
227009/SM29: CCBJ010001925 to CCBJ010001976, 227033/SM35: CCBJ010000239 to 
CCBJ010000268, 227039/SM36: CCBJ010000269 to CCBJ010000290, 227052/SM38: 
CCBJ010002379 to CCBJ010002816, 188806/SM48: CCBJ010003540 to CCBJ010003701, 
188795/SM49: CCBJ010004082 to CCBJ010004692, and 188781/SM50: CCBJ010004693 
to CCBJ010004869. 
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RESULTS 
We present here reanalysis by WGS of an outbreak caused by Salmonella Manhattan in the 
province of Modena (Italy) in 2009. The isolates from the human cases were SM1, -2, -3, -4, 
-5, -6, -7, -8, -9, -10, -11, -12, -13, -14, and -15. Out of the 21 collection isolates available, all 
were genotyped by PFGE to search for clues on the source of infection, and SM21, -23, -24, 
-26, -27, -28, -32, -35, -38, -47, -48, -51, and -52 showed the outbreak pulsotype; however, 
SM36, -16, -17, -19, -29, -31, -49, and -50 belonged to different pulsotypes, and a selection 
of them were included in this study as outgroup isolates. SM42, -53, and -54 were isolated 
during the microbiological follow-up of the episode and presented the outbreak pulsotype. 
Pulsed-field gel electrophoresis. The 39 Salmonella Manhattan isolates of the study 
showed five different XbaI-PFGE profiles: SXB_BS.0003, SXB_PR.0753, SXB_PR.0754, 
SXB_PR.0751, and SXB_PR.0752 (Fig. 1). All the human isolates (SM1 to SM15) showed 
the same PFGE profile (SXB_BS.0003), supporting the hypothesis that the unusually high 
incidence of this rare serovar was due to a single epidemic clone. 
 
 
FIG 1. Similarity of Salmonella Manhattan isolates, examined in this study, inferred by 
pulsed-field gel electrophoresis profiles (PFGE-PR). The samples underwent XbaI restriction 
and pattern analysis according to the standard PulseNet protocol. The UPGMA dendrogram 
of all the profiles of the study is reported on the left; the ruler indicates the similarity values. 
The laboratory numbers of the isolates and their pulsotypes are reported on the right. 
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Another 13 isolates from the IZSLER surveillance collection belonged to genotype 
SXB_BS.0003. Among these, three (SM32, SM48, and SM52) dated back to just before the 
outbreak period (May/June 2009) and were pivotal in guiding the epidemiological 
investigation. SM48 originated from an establishment near the outbreak area that processed 
swine guts for the salami industry. Due to this microbiological and molecular finding, the 
establishment was suspected of having a role in the outbreak, although no evident 
correlation with the human infections was made. More significantly, SM32 and SM52 were 
isolated just before the onset of the episode from pork sausages produced at an industrial 
establishment that shipped to retail stores in the outbreak area. Consequently, sausages 
from this producer, which were on sale in the outbreak area, were sampled along with the 
pork purchased by the producer. Both the sausages and the pork were positive for 
Salmonella Manhattan with the outbreak pulsotype (SXB_BS.0003) (isolates SM53 and 
SM54 from the sausages and SM42 from pork). Interestingly, two Salmonella Manhattan 
isolates from our collection, isolated within the own-check hygiene procedures of the 
producer (SM23 and SM24) 3 years before the outbreak, presented the same genotype. 
Also, the surveillance collection isolates SM21, -26, -27, -28, -35, -38, -47, and -51 shared 
the outbreak pulsotype, but they did not seem to be correlated with the outbreak or source of 
infection. 
Among the other non-outbreak PFGE profiles detected, the pulsotype SXB_PR.0752 (isolate 
SM36) had 95% similarity with the outbreak pulsotype, while the genotypes SXB_PR.0751 
(isolates SM31 and SM50), SXB_PR.0753 (isolates SM16, SM17, SM19, and SM49), and 
SXB_PR.0754 (isolate SM29) were less similar (90%, 84%, and 84%, respectively) (Fig. 1). 
Whole-genome sequencing. The genomes of the 33 Salmonella Manhattan isolates 
considered for genomic analysis, including the already deposited genome of strain 111113 
(26), were sequenced, quality checked, and assembled to draft status, from an average of 
2,593,738 MiSeq paired-end reads per genome. The average sequenced genome 
characteristics were 4,678,201 nt in length, 150 large (>1,000 nt) contigs, and an N50 of 
212,360. The genome data for each isolate are listed in Table S1 in the supplemental 
material. The MLST profile was determined for all draft genomes, which were found to 
belong to the same sequence type (ST), ST18. All assembled genomes underwent 
comparative and phylogenetic analyses. 
Analysis of variations. A comparative genomic analysis was implemented to detect the 
differences between the Salmonella Manhattan genomes, in terms of nucleotide variations, 
exclusive to (i.e., present in all the isolates of a group and absent in all the others) the 
outbreak-related isolates, as divided into the following main groups: (i) all outbreak-related 
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isolates, irrespective of the human, food, or raw meat origin; (ii) outbreak-related human-
origin-only isolates; and (iii) outbreak-related food-origin-only isolates (including sausages 
and raw meat). 
Of all the non-degenerate nucleotide variations (total 9,410) discovered by the 
progressiveMauve algorithm, 14 were outbreak specific, and all were core SNPs (two 
intergenic, two synonymous, and 10 nonsynonymous), divided as six variations exclusive to 
all outbreak-related isolates, three variations characteristic of the food-origin-only outbreak-
related isolates, and five characteristic of the outbreak-related human-origin-only isolates 
(Table 2). 
 Group of 
isolates 
Amino acid 
change 
Codon change Position 
CDSa 
Type of SNP Gene Locus tag Strand Product name 
All outbreak C→R TGT→CGT 625 Genic cobT SMA01→2283 − Nicotinate-nucleotide–dimethylbenzimidazole 
phosphoribosyltransferase 
 N→N AAT→AAC 156 Genic gntR SMA01→3706 − Gluconate utilization system Gnt-transcriptional 
repressor 
 A→T GCC→ACC 577 Genic ansB SMA01→3765 − L-Asparaginase 
 V→A GTC→GCC 988 Genic dcuC SMA01→4465 − Putative cryptic C4-dicarboxylate transporter 
    Intergenic     
 K→E AAA→GAA 70 Genic betI SMA01→1140 + Transcriptional regulator, TetR family 
Human origin M→T ATG→ACG 584 Genic dsbI SMA01→0572 + Thiol-disulfide oxidoreductase, DsbB-like 
 A→T GCC→ACC 310 Genic sthD SMA01→3447 − β-fimbriae usher protein 
 V→V GTT→GTC 465 Genic ispH SMA01→3526 + 4-hydroxy-3-methylbut-2-enyl diphosphate 
reductase 
 Q→STOP CAA→TAA 252 Genic rfbD SMA01→4557 + UDP-galactopyranose mutase 
    Intergenic     
Food origin S→I AGC→ATC 872 Genic fliK SMA01→2244 + Flagellar hook-length control protein FliK 
 P→L CCT→CTT 17 Genic  SMA01→0101 + Hypothetical protein 
 A→V GCC→GTC 1544 Genic fdrA SMA01→4374 + Protein FdrA: acyl-CoA synthetaseb 
 
TABLE 2. Characteristic SNPs of three groups of outbreak-related isolates. a CDS, coding sequence. b CoA, coenzyme 
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Phylogenetic analysis. Phylogeny was reconstructed using an SNP-based approach. 
SNPs were extracted from the assembled genomes using a bioinformatic pipeline (28) 
based on progressiveMauve (27). Of the 9,410 detected variations, 953 were core SNPs, 
with 224 being synonymous and 467 being nonsynonymous; the remaining 262 SNPs were 
marked as intergenic. Among the synonymous SNPs, 6% and 94% were located in the first 
and third codon positions, respectively, while among the nonsynonymous SNPs, 43% were 
in the first, 42% in the second (total, 85% for the two positions), and 15% in the third codon 
position. The number of synonymous and nonsynonymous core SNPs at the first, second, 
and third positions were 214, 194, and 283, respectively. 
The phylogenetic analysis of the study isolates was performed separately based on the 
different subsets of SNPs considered, namely, core, synonymous, nonsynonymous, and 
different codon positions using both Bayesian (Fig. 2 to 4) and maximum likelihood 
algorithms (see Fig. S1 and S2 in the supplemental material). Both algorithms returned the 
same phylogenetic results on each subset. 
 
FIG 2. Bayesian phylogeny of the 33 Salmonella Manhattan sequenced genomes based on 
core SNPs. The posterior probabilities are indicated in each principal node of the tree. The 
scale bar units are the nucleotide substitutions per site. #, WGS analyses clustered isolate 
SM36 (pulsotype SXB_PR.0752) together with the isolates of the outbreak pulsotype 
(SXB_BS0003). 
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All data sets identified two major clades: one grouping all the isolates belonging to pulsotype 
SXB_BS.0003 and the highly related SXB_PR.0752 (95% similarity), and the other 
constituted by isolates with different pulsotypes (SXB_PR.0753, SXB_PR.0754, and 
SXB_PR.0751). Interestingly, WGS analyses clustered isolate SM36 (pulsotype 
SXB_PR.0752) together with the isolates of pulsotype SXB_BS0003, meaning they are 
highly related compared to isolates of the other pulsotypes of the study. Therefore, we 
considered SXB_PR.0752 together with SXB_BS.0003 for the subsequent analyses of 
phylogeny and presence of variants. 
Phylogeny based on core SNPs revealed four main groups inside the outbreak pulsotype. 
Isolates that were not epidemiologically related to the outbreak formed two monophyletic 
clusters, with the outermost one grouping isolates from various locations and previous years 
but always from swine stool within the own-check procedures of pig farms (isolates SM35, 
SM36, and SM38) or at food processing plants (isolate SM48). The other group included 
isolates collected at the sausage-producing establishment within its hygiene monitoring 
system 3 years before the outbreak (SM23 and SM24), along with an isolate collected on a 
pig farm in the same period (SM21). Isolate SM27 originated from another food processing 
plant in the same area of the sausage producer, but that was never linked to the outbreak. 
The two innermost clusters included all the outbreak-related isolates. Five strains isolated 
from sausages prepared by the implicated producer (SM32, SM42, SM52, SM53, and 
SM54), both at a retail locations in the outbreak area and at the establishment, which were 
distinct from the cluster of human isolates of the outbreak (from SM1 to SM15). All outbreak-
related isolates are monophyletic, confirming their derivation from a common ancestor. In 
order to better investigate the relationships among those isolates, we performed additional 
analyses on specific subsets of the core SNPs to take into account the possible effects of 
selective evolutionary pressure. We separately considered nonsynonymous SNPs, 
synonymous SNPs, and SNPs at the first, second, and third codon positions as 
presumptively subjected to decreasing selective pressures (37). The trees corresponding to 
the different subsets of SNPs are shown in Fig. 3 and 4. The trees generated by 
nonsynonymous SNPs and SNPs at the first plus second and second codon positions 
showed the same topology described by the whole data set of core SNPs, with a clear 
distinction between outbreak-related isolates of human and food origins. The phylogenies 
generated by SNPs under minor selective pressure (i.e., third position) revealed different 
scenarios, with the loss of a node inside the outbreak cluster showing isolates of human 
origin as a subgroup within the food-origin outbreak isolates. Considering synonymous SNPs 
only, the outbreak isolates of human and food origins are grouped in one cluster, being 
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indicative of a single circulating clone. The phylogenetic inferences made by Bayesian and 
maximum likelihood algorithms gave identical results (see Fig. S1 and S2 in the 
supplemental material). 
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FIG 3. Phylogenetic Bayesian analysis of the 33 Salmonella Manhattan sequenced genomes 
based on synonymous (A) and nonsynonymous (B) SNP data sets. The posterior 
probabilities are indicated in each principal node of the tree. The scale bar units are the 
nucleotide substitutions per site. #, WGS analyses clustered isolate SM36 (pulsotype 
SXB_PR.0752) together with the isolates of the outbreak pulsotype (SXB_BS0003). 
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FIG 4 (A-B). Phylogenetic Bayesian analysis of the 33 Salmonella Manhattan sequenced 
genomes based on SNPs in first (A), second (B), third (C), and first plus second codon 
position (D) data sets. The posterior probabilities are indicated in each principal node of the 
tree. The scale bar units are the nucleotide substitutions per site. #, WGS analyses clustered 
isolate SM36 (pulsotype SXB_PR.0752) together with the isolates of the outbreak pulsotype 
(SXB_BS0003). 
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FIG 4 (C-D). Phylogenetic Bayesian analysis of the 33 Salmonella Manhattan sequenced 
genomes based on SNPs in first (A), second (B), third (C), and first plus second codon 
position (D) data sets. The posterior probabilities are indicated in each principal node of the 
tree. The scale bar units are the nucleotide substitutions per site. #, WGS analyses clustered 
isolate SM36 (pulsotype SXB_PR.0752) together with the isolates of the outbreak pulsotype 
(SXB_BS0003). 
  
 109 
DISCUSSION 
Microbiologists often need to determine the relatedness of bacterial isolates to define the 
network of relationships of an infectious outbreak and effectively assist epidemiological 
investigations. Standard protocols for typing Salmonella rely on internationally accepted 
methods, like PFGE and MLVA, which a few decades ago flanked the more limited 
serotyping. The possibility of accessing the vast amount of information provided by WGS of 
bacterial isolates promises to be the next frontier of subtyping methods, probably capable of 
surpassing PFGE and MLVA for molecular epidemiological purposes. In this study, we 
reanalyzed a well-defined Salmonella Manhattan outbreak detected in the summer of 2009 
in the province of Modena (Italy) using WGS in order to test the power of this approach for 
resolving the ambiguities left by PFGE. The epidemic episode involved 15 human cases 
from June to July 2009, with all presenting the same PFGE profile (SXB_BS.0003). The 
molecular epidemiological investigation of the outbreak involved several isolates, some from 
the infectious episode and others from the historic collection of the regional surveillance 
system of the food chain. As expected, PFGE analysis attributed the same pulsotype 
(SXB_BS.0003) to all the outbreak-related isolates, but the same pulsotype was shared by 
many historic isolates as well. On the contrary, the WGS-based phylogeny inferred from the 
total core SNPs clearly showed the presence of four distinct groups of isolates (Fig. 2) within 
the outbreak pulsotype. The first branch of the tree, within the outbreak pulsotype, separates 
nonoutbreak historic isolates recovered from swine stool at different locations and times. 
Among these, we find isolate SM48, which was originally suspected of being implicated in 
the infectious episode, based on PFGE, and eventually cleared by WGS. Interestingly, 
isolate SM36, which does not belong to pulsotype SXB_BS.0003 but to the highly similar 
(95% similarity) pulsotype SXB_PR.0752, is included in this clade. This is a clear 
discrepancy between WGS and the more limited PFGE that relies on only few genomic loci 
(rare restriction sites) for its typing inferences. By placing SM36 together with pulsotype 
SXB_BS.0003 isolates, our WGS approach indicates that a limited genomic difference 
between isolates is able to jeopardize the typing outcome of PFGE. This observation 
confirms what Tenover et al. (38) already pointed out, the fact that as PFGE may be heavily 
influenced by a single mutational event (e.g., SNP occurring in a restriction site), isolates 
should be considered to be possibly related even if they differ by two or three bands. 
However, according to this conservative interpretation of PFGE results, the vast majority of 
the isolates of our study should be regarded as potentially belonging to the outbreak. This 
would have not been sufficiently discriminatory to help the epidemiological investigations. 
The interpretation criteria of Tenover et al. (38) are derived from logical considerations; as 
such, they are intrinsically valid, and our observations regarding isolate SM36 confirms their 
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validity. At the same time, their use leaves molecular epidemiologists with considerable 
uncertainty about how to interpret PFGE results with regard to whether or not different 
pulsotypes are part of a single outbreak. In our case, WGS removed that uncertainty about 
SM36. 
Moving deeper along the phylogenetic tree based on the total core SNPs, three other groups 
of isolates are evident. The outermost set of this node includes isolates (SM21, -23, -24, and 
-27) not related to the outbreak, as they were collected 3 years before (2006). It is 
interesting, however, to notice that WGS-based phylogeny indicates these strains to be 
closer to the outbreak node (inner branch) than was the previous set of swine-stool isolates. 
On a better look, we were struck by the fact that SM23 and SM24 were collected in 2006, 
within the own-check procedures of the sausage producer involved in the 2009 outbreak. 
Moreover, SM21, which is subbranched with SM23 and SM24, was routinely recovered from 
a local pig farm (from swine stool) at the same time as SM23 and SM24. While this specific 
molecular similarity was not inferred by PFGE, WGS highlighted a possible link between 
these two commercial entities. Moving one branch forward in the phylogenetic tree, WGS 
shows another bifurcation actually separating outbreak-related isolates of human origin from 
those of food origin. While still speculative, based on this WGS-based phylogeny, coupled 
with epidemiological data, we could argue that this outbreak was due to a persistent 
Salmonella Manhattan clone, which may have infected one or more pig farms and reached 
the food producer and the retail customers as animals arrived at the slaughterhouse in a 
nonclinical septic condition. This is a typical mode of transmission of Salmonella along the 
food chain, as it may asymptomatically persist (thus going unnoticed) within a herd of pigs 
for long periods of time (even years). Sporadically, animals carrying a high level of the 
pathogen arrive at the slaughterhouse and contaminate a defined set of food products, thus 
causing an infectious outbreak as the final consumers (39, 40) become exposed to it. In this 
scenario, WGS seems to depict a more detailed and articulated epidemiological story. In 
fact, the tree inferred from core SNPs (Fig. 2) leaves a certain level of uncertainty relative to 
the actual causative relationship between the isolates of food origin and of human origin 
within the outbreak, as they cluster in two distinct groups, although very closely to each 
other, as evidenced by the limited number of exclusive core SNPs accumulated by the two 
groups (3 for food and 5 for human isolates). In the absence of epidemiological insights, we 
argue that the two sets of isolates are very similar to each other but still are separate 
entities. This substantially contradicts the epidemiological evidence that the two sets of 
isolates belong to the same outbreak clone. Therefore, we further investigated this apparent 
inconsistency of the WGS-based results by comparing new alternative phylogenies based on 
two different subsets of polymorphisms, synonymous and nonsynonymous, instead of the 
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total core SNPs. The trees generated from these two subsets of SNPs were different (Fig. 
3A and B). Phylogenetic analysis based on nonsynonymous SNPs (Fig. 3B) still divided the 
outbreak isolates of food and human origins, as in the approach based on total core SNPs. 
On the contrary, the tree obtained from synonymous SNPs (Fig. 3A) clustered the human 
isolates together with the food isolates, indicating that all outbreak-related Salmonella 
Manhattan strains constituted a single clone, in line with epidemiological evidence. While 
intriguing, this new outcome may have been the misleading effect of the smaller amount of 
data present in these new subsets than that with the total set of core SNPs, of which there 
were 953, whereas the number of synonymous and nonsynonymous SNPs were 224 and 
467, respectively. Therefore, to confirm these results, we took a step forward in this 
approach by considering not just synonymous versus nonsynonymous SNPs but also taking 
into account the different codon position of each SNP in the core genome. Salmonella 
Manhattan synonymous SNPs were at the 3rd codon position 94% of the time, while 
nonsynonymous SNPs were at the 2nd 42% and at the first position 43% of the time (total, 
85%). In this study, 1st, 2nd, and 3rd position SNPs accounted for 214, 194, and 283 
nucleotide substitutions, respectively. The comparison of subsets of SNPs based on their 
codon site would then not be impaired by too-large differences in the amount of data 
processed by the phylogenetic algorithms. The tree obtained from second codon position 
(Fig. 4B) was comparable to that of the nonsynonymous SNPs, as expected, whereas the 
tree obtained from third codon position showed human isolates as a subgroup of the food 
isolates (Fig. 4C), essentially confirming the tree based on synonymous SNPs. These results 
show that at least limited to our outbreak, synonymous and third-position SNPs were the 
only ones able to describe the causal relationship between food (source of the outbreak) and 
clinical isolates in a way that was consistent with the epidemiological evidence. At the same 
time, our results indicate that nonsynonymous and total core SNPs may have led to 
misleading conclusions about the relationships between the human and food isolates of the 
outbreak. One last aspect that caught our attention by deciphering topologies of this WGS-
based retrospective analysis was that SNP-based clustering of isolates separated human 
from food outbreak-related isolates when considering total core SNPs (Fig. 2). As we just 
discussed, this topology was mainly influenced by nonsynonymous mutations, which means 
it is possible to find distinctive nonsynonymous SNPs for each group of isolates (human 
versus food). Using progressiveMauve, we identified a set of 953 core SNPs, among which 
we selected those that were exclusive to specific clusters of interest: six SNPs exclusive to 
all outbreak isolates (human and food origin), three exclusive to all food origin outbreak 
isolates, and only five exclusive to all human origin outbreak isolates (Table 2). The 
extremely limited number of exclusive SNPs in food and human isolates within the outbreak 
is an additional compelling element indicative of the fact that these two groups of isolates did 
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not have enough evolutionary time to significantly differentiate, indicating they belong to the 
same clone. A BLAST analysis of these SNPs against the Virulence Factors Database 
revealed three genes of particular interest: (i) fliK, coding for a flagellar hook-length control 
protein (41), (ii) sthD, a gene coding for a fimbrial outer membrane usher protein (42), and 
(iii) rfbD, coding for a UDP-galactopyranose mutase precursor involved in the synthesis of 
the O antigen of the lipopolysaccharide (LPS). All three proteins are virulence determinants 
in Salmonella (43–46). WGS has already proved its usefulness for elucidating the 
evolutionary diversity of large populations of bacterial isolates (11, 47, 48). In the specific 
case of Salmonella, WGS was successfully applied to illuminate the diversity of the 
pathogen within a vast epidemic episode, allowing highly efficient traceback of clinical and 
food isolates (4, 13). The results obtained in this study underscore the power of WGS-based 
methods, when applied together with the most appropriate phylogenetic tools, to resolve 
small outbreaks characterized by few and highly clonal bacterial isolates. Our comparative 
genomics approach was able to correctly cluster the clinical isolates within the composite 
scenario of outbreak-related and collection isolates. Accurate backtracking to the source of 
infection at the retail and industrial levels was made possible while flagging an originally 
overlooked suspicious correlation with a farm supplier and clearing an originally suspect food 
operator. Moreover, by selectively choosing the different types of detected nucleotide 
variations, we were able to read the message hidden within neutral mutations as opposed to 
the general use of total core SNPs. Further use of the differential analysis of synonymous 
and nonsynonymous mutations will test the validity of this approach in deciphering the 
details of infection transmission in the context of other outbreaks caused by Salmonella and, 
potentially, other pathogens. 
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ABSTRACT 
Introduction. Listeria monocytogenes (Lm) is a bacterium widely distributed in nature and 
able to contaminate food processing environments, including those of dairy products. Lm is a 
primary public health issue, due to the very low infectious dose and the ability to produce 
severe outcomes, in particular in elderly, newborns, pregnant women and 
immunocompromised patients. 
Methods. In the period between April and July 2015, an increased number of cases of 
listeriosis was observed in the area of Pavia, Northern Italy. An epidemiological investigation 
identified a cheesemaking small organic farm as the possible origin of the outbreak. In this 
work we present the results of the retrospective epidemiological study that we performed 
using molecular biology and genomic epidemiology methods. The strains sampled from 
patients and those from the target farm’s cheese were analyzed using PFGE and whole 
genome sequencing (WGS) based methods. The performed WGS based analyses included: 
a) in-silico MLST typing; b) SNPs calling and genetic distance evaluation; c) determination of 
the resistance and virulence genes profiles; d) SNPs based phylogenetic reconstruction. 
Results. Three of the patient strains and all the cheese strains resulted to belong to the 
same phylogenetic cluster, in Sequence Type 29. A further accurate SNPs analysis revealed 
that two of the three patient strains and all the cheese strains were highly similar (0.8 SNPs 
of average distance) and exhibited a higher distance from the third patient isolate (9.4 SNPs 
of average distance). 
Discussion. Despite the global agreement among the results of the PFGE and WGS 
epidemiological studies, the latter approach agree with epidemiological data in indicating that 
one the patient strains could have originated from a different source. This result highlights 
that WGS methods can allow to better. 
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INTRODUCTION 
Listeria monocytogenes (Lm), widely distributed in the environment including soil, plants, 
and water, is a foodborne bacterial pathogen that can contaminate different kinds of food 
among which milk and dairy products (1). Lm is capable of adapting to and growing at 
refrigeration temperatures and, moreover, it can form biofilm to help colonization of surfaces. 
Consequently, Lm can colonize food processing environments, contaminating the finished 
products (2). Although Lm is an uncommon cause of illness in the general population, it can 
represent an important public health problem in case of large scale distribution of 
contaminated food, due to the very low infectious dose (3,4). Listeriosis is a severe disease 
and it primarily affects the elderly (5), newborns, pregnant women and immunocompromised 
patients, categories that can be up to 20 times more susceptible to the disease (6). Clinical 
manifestations are highly variable and host-dependent: from non-specific and mild 
symptoms, to febrile gastroenteric syndromes or even cases of seps is and meningitis with 
mortality rates up to 30% (7). 
Most reported cases of listeriosis are sporadic, however, outbreaks have been described 
with increasing incidence worldwide (5,8,9,10,11). ECDC and EFSA report 2,161 confirmed 
human cases of listeriosis in the EU Summary report on zoonoses, zoonotic agents and 
food-borne outbreaks 2014 (12). The EU notification rate was 0.52 cases per 100,000 
population which represents a 30% increase compared with 2013 (0.40 cases per 100,000 
population). ECDC and EFSA report 210 deaths due to listeriosis in 2014, and a fatality rate 
above 12.5%. This was the highest number of deaths reported since 2009 (annual average: 
163). An average of 131 cases with 0.22 cases per 100,000 population were reported in Italy 
from 2010 to 2013 (12). A regional study regarding the Lombardia region reported 134 
isolates in the 2006-2010 period (6). The notification of listeriosis in humans is mandatory in 
most countries in Europe, in Italy since 1991, as regulated by Italian D.M. 15/12/1990. Since 
2009, was established a digital platform, ENTER-NET Italia system (Enteric Pathogen 
Network) connected to European ENTER-NET network, dedicated to the assessment of 
microbiological clusters of food-borne diseases (13). 
Pulsed-Field Gel Electrophoresis (PFGE) represents the gold standard for subtyping of Lm 
and other foodborne pathogens (14), however, studies employing other molecular and 
genomic methods have proliferated recently, allowing to characterize Lm strains not only by 
pulsotype, but also by multilocus sequence type (MLST) and core genome MLST (cgMLST) 
(15,16,17,18). 
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In this study we describe an outbreak of Listeria monocytogenes occurred in 2015 in 
Northern Italy, using a combination of molecular biology and genomics techniques. Despite 
the results obtained from the two approaches resulted coherent at large scale, the Whole 
Genome Sequencing (WGS) approach resulted more accurate in the discrimination of the 
strains involved in the outbreak. 
 
THE OUTBREAK 
Between 28th April and 11th July 2015 six patients showing symptoms compatible with 
Listeriosis (sudden onset of fever, chills, severe headache, vomiting, and other influenza-like 
symptoms) were admitted to hospitals in Pavia province of Lombardia region, Northern Italy. 
The first three cases were observed at the Fondazione IRCCS Policlinico San Matteo 
Hospital in Pavia (Italy), the fourth an the Ospedale SS Annunziata di Varzi, the fifth an the 
Ospedale unificato di Broni-Stradella and the sixt at the Ospedale Civile di Voghera. We will 
refer to the patients enumerating them chronologically from 1 to 6 (Table 1). 
Patient 1, upon admission, informed the hospital personnel of having recently consumed 
goat cheese produced by a small organic farm. The patient provided the leftover cheese (~ 
20g), that was tested and Lm was not detected. It must be noted that the small amount of 
available cheese could have influenced the sensitivity of the test, as the standard protocol 
indicates 25g as the correct amount for the analysis. 
During the following two weeks, two apparently unrelated listeriosis cases were observed at 
Pavia hospital, involving a drug-abusing subject (patient 2) and a 1.5 year old child (patient 
3). The child’s parents informed the hospital personnel that the child had recently consumed 
home-made cheese, and provided a cheese sample (>25g) which was tested, and no Lm 
was detected. During the previous three years an average of 3.3 cases per year were 
observed in Pavia province, thus, three cases in 16 days were considered a possible 
outbreak, and an epidemiological investigation was performed. 
The farm that produced the raw-milk goat cheese eaten by patient 1 was subjected to a first 
inspection during which goat cheese and raw milk, as well as the food contact surfaces in 
the processing plant19 were sampled. Lm was isolated from two samples from a single 
cheese shape (Cheese_1 and Cheese_2 in Table 1), while one of three samples collected 
from the plant (wood ripening surface) was found to be positive by PCR. In order to monitor 
the possible persistence of Lm contamination three additional sampling were performed 
during the two months after the first inspection. One wood ripening surface resulted positive 
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by PCR in June, and Lm was isolated from a cheese shape in July. (Cheese_3 in Table 1). 
All samples collected in the farm are showed in Table 2. 
        
Sample 
name 
Geographic 
origin 
Sampling 
date 
Source Age Gender Risk factor Diagnosis and 
symptoms 
Outcome 
Patient_1 Pavia 28/04/15 blood 
and CSF 
71 M no one Meningitis and 
sepsis 
cured 
Patient_2 Pavia 29/04/15 blood 47 M HIV and 
HCV 
infection, 
hepatic 
impairment 
HIV, HCV and 
HBV co-
infection, 
jaudice, 
sepsis 
cured 
Patient_3 Pavia 14/05/15 CSF 1.5 M < 2 year 
aged 
Diarrhea, 
fever and 
confusion 
hydroceph
alus 
Patient_4 Varzi 21/05/15 blood 78 M no one Sepsis cured 
Patient_5 Broni - 
Stradella 
11/07/15 blood 61 F cancer Sepsis death 
Patient_6 Voghera 28/07/15 blood 70 M Parkinson 
disease 
Diarrhea, 
Meningitis 
cured 
Cheese_1 Target farm 26/05/15 Cheese 
(inner) 
na na na na na 
Cheese_2 Target farm 26/05/15 Cheese 
(rind) 
na na na na na 
Cheese_3 Target farm 17/07/15 Cheese 
(rind) 
na na na na na 
Table 1. Characteristics of the patients and of the cheese samples where Listeria 
monocytogenes was detected. 
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Collection 
date 
Cheese 
samples 
Milk 
samples 
Food-contact surface 
samples 
Non food-contact surface 
samples 
22/05/15 2/2/2  3/1/0  
15/05/15  1/0/0   
19/06/15 2/0/0  6/01/0 4/0/0 
17/07/15 4/1/1  5/0/0 2/0/0 
23/09/15   7/0/0 8/0/0 
Table 2. Samples from the putative target farm. Numbers indicate collected samples / PCR 
positive samples / isolation positive samples 
 
During the epidemiological investigation three other cases of listeriosis were diagnosed in 
the province of Pavia. None of the three patients reported to have eaten organic cheese, or 
other useful information for investigators to trace the origin of the infections. Four patients 
out of the six completely recovered, while patient 3 developed a hydrocephalus and patient 5 
died. All the isolates were subjected to molecular characterization and, subsequently, a 
retrospective genomic investigation was performed. 
 
METHODS 
Ethics statement. The study was designed and conducted in accordance with the Helsinki 
declaration. This study was performed according to the guidelines of the IRCCS Foundation 
Policlinico San Matteo Hospital in Pavia Institutional Review Board of on the use of biological 
specimens for scientific purposes in keeping with Italian law (art.13 D.Lgs 196/2003). The 
work described here is a retrospective study performed on bacterial isolates from human 
samples that were obtained as part of hospital routine. No extra human samples were 
obtained for this research. Therefore, informed consent (either written or verbal) was not 
required. 
Strain isolation. Blood and Cerebrospinal Fluid (CSF) samples obtained from the six 
patients were inoculated in aerobic or pediatric broth, and incubated in BACTEC FX (Becton 
Dickinson, Heidelberg, Germany). Positive broths from blood and CSF were analyzed by 
Gram staining method and culture, matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) mass spectrometry (MS) MicroflexTM LT (Bruker Daltonik GmbH, Bremen, 
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Germany) was used for species identification through the Bruker biotyper 3.1 database. 
Antibiotic susceptibility tests of each isolate was performed via standard disk diffusion on 
Mueller-Hinton agar incubated at 37°C for 24 h using the Kirby-Bauer method (20). The 
results were interpreted with standardized criteria from breakpoint committee EUCAST (21). 
All isolates were then stocked at -80° C. The cheese samples provided by patient 1 and 3 
were subjected in parallel to molecular diagnosis and isolation protocols, respectively PCR 
Real Time – iQCheckTM L. monocytogenes II kit (BIORAD) AFNOR BRD 07/10 – 04/05 and 
ISO 11290-1:116/Amd 1:2004 (22). eight cheese, one raw milk and 35 environmental 
samples were collected from the putative origin dairy processing plant. All these samples 
were subjected to the above PCR method and PCR positive samples were subjected to 
standard Lm isolation protocol, according to ISO 11290-1:1996/Amd 1:2004 (22). 
Molecular characterization. All isolates were subjected to DNA extraction using the Qiagen 
DNeasy kit according to manufacturer’s instructions, and to Lm specific PCR using an 
accredited protocol (PCR real-time – iQ-CheckTM L. monocytogenes II kit (BIO-RAD) 
AFNOR BRD 07/10 – 04/05). All isolates were genotyped by PFGE according to the 
Pulsenet protocol (23). Genomic DNA underwent restriction with AscI and ApaI enzymes 
before electrophoresis in a CHEF Mapper® XA System (Bio-Rad, California, USA). PFGE 
patterns were analyzed using Bionumerics Software ver. 7.0 (Applied-Maths, Sint-Martens-
Latem, Belgium) and associated to strain information in our surveillance database. 
Clustering of the PFGE profiles was generated using the Unweighted Paired Group Method 
with arithmetic averages (UPGMA) based on the Dice Similarity Index (Optimization=1% and 
Band Matching Tolerance=1%). Following comparison of the electrophoretic profiles, a 
PFGE pattern (pulsotype) was assigned to each isolate within the database of the laboratory 
of the Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (Sezione 
Diagnostica di Parma). Two isolates were indicated as belonging to the same pulsotype if 
the band pattern differed by less than two bands. 
Genomics. Whole-genome DNA was extracted from each isolate using a QIAamp DNA 
minikit (Qiagen) following the manufacturer’s instructions, and sequenced using an Illumina 
Miseq platform with a 2 by 250 paired-end run after Nextera XT paired-end library 
preparation. Genome assemblies were obtained using Mira software (24) and subjected to 
open reading frame (ORF) calling using Prodigal (25). The MLST profiles of the sequenced 
strains were determined in silico (using an in-house Perl script), on the basis of the MLST 
profiles defined in the Institut Pasteur MLST database (http://bigsdb.pasteur.fr/listeria/ (26)). 
The 713 Lm genomes available in the Patric database (in date 11th July 2016) were 
retrieved and subjected to in silico MLST profile determination and the genomes belonging 
to the same clonal complexes of our strains were selected for further analyses. The selected 
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strains were subjected to core genome SNP-based phylogeny. The analysis was performed 
on a robust dataset of core genes selected from the cgMLST1748 genes (27). The 
cgMLST1748 genes were extracted from BIGSdb-Lm platform and searched, using Blastn, 
in the genomes of the selected strains. Bidirectional Best Hit (BBH) method (28) was then 
used to group the genes into clusters of orthologous genes. For each cgMLST1748-ortholog 
gene present in single copy in all the genomes, the sequences of all isolates were retrieved, 
aligned and translated using in-house Perl scripts and Muscle software (29). The cgMLST 
gene alignments were then screened and the genes with the following features were 
selected: a) all the aligned sequences begin with a start codon; b) all the aligned sequences 
finish with a stop codon; c) all the aligned sequences have a single stop codon; d) for each 
aligned sequence, the gaps cover less than 10% of the alignment length. The nucleotide 
alignments of the selected cgMLST1748 orthologs were then concatenated and subjected to 
phylogenetic analysis using Maximum Likelihood approach, with RaxML 8 software (30), 
setting GTRGAMMA model and 100 pseudo bootstrap replicates. 
Four databases of Lm sequences, namely virulence genes, antibiotic resistance genes, 
genes for resistance to Benzalkonium and genes for resistance to metals and detergents 
were retrieved from the ListeriaMLST database. For each genome sequenced in this study, 
the obtained paired-end reads were aligned against the curated genes databases using 
Bowtie2. Genes with >10X coverage for >95% of the sequence length were considered as 
present in the isolate.The genomes were searched for presence of phages using Phast (31). 
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RESULTS 
Case characteristics. The median age of the six patients involved in the study was 54 
years (range 1-78), five out of the six were males and all of them lived in the Pavia province. 
In four out of six patients Lm was isolated from blood cultures, in one patient from 
cerebrospinal fluid (CSF) and in another one from both blood and CSF. For full details on 
patients and symptoms see Table 1. An epidemiological investigation identified the 
cheesemaking small organic farm that possibly originated the outbreak, where sampling of 
milk, cheese and food processing environment was performed. Lm isolation was achieved 
from two cheese shapes, in the first case from both crust and paste, in the second case from 
the crust only. PCR positivity was obtained for 2 farm environment samples. 
Isolate characterization. All isolates were susceptible to ampicillin, erythromicin, 
meropenem, cotrimoxazole, penicillin. The result of the clustering analysis based on the 
PFGE patterns obtained with ApaI and AscI enzymes resulted congruent, grouping the 
isolates collected from patients 1, 2, 4, together with those from the three cheese samples in 
both analyses, indicating a clear relationship between the six. Isolates from the three other 
patients showed a clearly different PFGE pattern, excluding their belonging to the outbreak 
(Figure 1). 
Whole genome sequencing analysis. Whole genome sequencing was performed for the 
nine strains, six from patients and three from cheese. Genome assemblies, submitted to the 
EMBL-EBI database, resulted to be on average of high quality (Table 3). In-silico MLST was 
performed on the genome assemblies, revealing that the three isolates obtained from the 
cheese samples and three of the six isolates from patients belong to sequence type 29 
(ST29), and the remaining three isolates belong to ST1, ST7 and the ST398 (see Table 3 for 
genome statistics and STs). 
 128 
Fig. 1: PFGE profiles. Pulse Field Gel Electrophoresis analysis of the nine strains, obtained 
using the AscI and ApaI restriction enzymes. 
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Table 3. Statistics of the genomes assemblies obtained from nine Listeria monocytogenes 
strains and MLST profiles. 
 
The 713 Lm genomes present in the Patric database were retrieved, in-silico MLST typed, 
and the 81 genomes belonging to the clonal complexes of the study strains (i.e. CC1, CC7, 
CC29 or CC398) were selected. A cgMLST-based phylogenetic reconstruction was 
performed using a subset of the cgMLST1748 scheme genes, including only the 928 genes 
present in single copy in all the strains and giving a good quality alignment. The cgMLST-
based phylogeny shows that the isolates from patient 1, patient 2, patient 4, cheese 1, 
cheese 2 and cheese 3 are tightly related (Figure 2), while the other isolates are scattered 
on the tree. The six closely related strains were then investigated more in depth in order to 
reconstruct the outbreak structure, using whole genome sequencing (WGS) typing, and data 
from the epidemiological investigation. In particular, the following evidence was considered: 
a) Single nucleotide polymorphism (SNP) distance revealed that the strains from patient 1, 
patient 2, cheese 1, cheese 2 and cheese 3 differ by 0.8 SNPs on average (values ranging 
from 0 to 2), while their average distance from patient 4 isolate is ten times higher, at 9.4 
SNPs (values ranging from 9 to 10) (see Figure 3). 
b) Patient 1 reported to have eaten the cheese produced by the suspect farm, while patient 
4, referred to have never bought cheese from the farm. No information on whether patient 2 
ate the cheese became available. A potential, albeit unlikely, link would be that patient 4 
could have eaten foods prepared with raw materials in common with the contaminated 
cheese, such as salt solution. 
The combination of the higher SNP distance, and the absence of an epidemiological link, led 
us to consider patient 4 as not associated to the outbreak. 
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Regarding the presence of resistance genes, all the strains collected in this study showed 
the same profile of antibiotic resistance genes, harboring the fosX, lmo1708, norB, and sul 
genes. This genetic uniformity is in accordance with the results obtained in the antibiograms, 
which were identical for all strains. Conversely, the virulence genes profiles resulted less 
conserved among the lineages: the isolates belonging to ST29 (collected from patient 1, 
patient 2, patient 4, cheese 1, cheese 2, cheese 3 samples) and ST7 (patient 6) presented 
the same virulence gene profile, while the isolate from patient 5 (ST398) also possessed the 
vip gene. The isolate from patient 3 (ST1) had multiple additional virulence genes: aut IVb, 
gltA, gltB, mdrM, vipand genes of the cluster LIPI-3 (Figure 4). This gene cluster have been 
reported in the literature to be one of the three major virulence factors (LIPI-1, LIPI-2, LIPI-3) 
(3). Seven phages were detected, showing an identical pattern of presence/absence in all 
the strains belonging to ST29. See Figure 4 for a list of the detected phages. 
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Fig. 2 (a): Phylogeny. (a) Phylogenetic reconstruction of the relationships between the 
study isolates and database isolates of the corresponding clonal complexes. Tree obtained 
using Maximum Likelihood approach, with RAxML 8 software, setting GTRGAMMA model 
and 100 pseudo bootstrap replicates on an alignment of 928 conserved core genome MLST 
genes. (b) Sub-tree including only the CC29 strains. 
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Fig. 2 (b): Phylogeny. (a) Phylogenetic reconstruction of the relationships between the 
study isolates and database isolates of the corresponding clonal complexes. Tree obtained 
using Maximum Likelihood approach, with RAxML 8 software, setting GTRGAMMA model 
and 100 pseudo bootstrap replicates on an alignment of 928 conserved core genome MLST 
genes. (b) Sub-tree including only the CC29 strains. 
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Fig. 3: Heatmap of the SNP distances. Heatmap showing the single nucleotide 
polymorphism between the isolates obtained in this study. Bright red corresponds to the 
highest number of SNPs. The number of SNPs supporting tree branched are reported on the 
relative branch 
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Fig. 4: Presence/absence of resistance genes, virulence genes and phages. Profiles of 
presence of genes of interest, including genes for antibiotic resistance and virulence, and 
phages for each genome. LIPI genes are reported in orange, virulence genes in blue, 
resistance genes in green and phages in red. 
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DISCUSSION 
Six cases of listeriosis occurred between 28th April 2015 and 28th July 2015 in four hospitals 
of the province of Pavia, Northern Italy. This represented an important increase of the 
incidence in the area, from an average of 0.28 per month in the three previous years to 2 per 
month in the examined period. This suggested that an Lm strain could be emerging in the 
area, and an epidemiological investigation was performed. In particular, a first investigation 
was carried out using molecular techniques and patient interviews, and, after one year, a 
WGS investigation followed. The results of the two reconstructions were then compared. 
PFGE clustered together the strains from three patients (patient 1, 2 and 4) and from all the 
cheese samples collected from the farm identified as the outbreak origin, indicating that the 
outbreaking strain originated from that farm and then infected the three patients. Patients 3, 
5, and 6 resulted to be unrelated to the outbreak. Additionally, the farm environment was Lm 
positive by PCR, prompting the owner to refurbish the structure. The main inconsistency of 
this reconstruction was patient 4, who declared with confidence to have never eaten the 
cheese produced at the farm, while he stated to have consumed raw meat, but could not 
indicate the origin. 
The results of the retrospective WGS investigation allowed to better investigate this point. 
The core genes SNPcgMLST phylogenetic reconstruction clustered the strains from patient 
1, 2, 4 and the cheese strains together, in accordance with the PFGE clustering. We then 
calculated the number of SNPs between each pair of strains of the PFGE cluster. This 
analysis showed that the isolate from patient 4 presents an average SNP distance ten times 
higher than the average distance within the cluster (Figure 3). This pattern suggests that 
patient 4 could had been not part of the outbreak but, having a sole outlier strain, it was not 
possible to statistically test this hypothesis. Despite this, epidemiological data resulted 
coherent to the scenario we inferred from WGS data: since these six strains were collected 
in a span of three months, and the isolate from patient 4 was obtained in the middle of this 
period, such difference is unlikely to have arisen from multiple mutations of the isolate from 
patient 4. 
On the basis of the collected data we propose the following epidemiological scenario: patient 
1 and 2 were infected by the cheese from the target farm, while patient 4 acquired the 
bacterium from an unidentified source. Furthermore, we suggest that a WGS-based 
surveillance program could allow to detect this unidentified source, and solve similar cases 
in the future. 
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In summary, WGS allowed to characterize the six human isolates of Lm showing that they 
represent five different clonal clades that circulate in the studied area, all belonging to STs 
that were previously reported in the region (6). ST 29 is commonly described in Lm 
outbreaks in USA and Europe, and it was previously described as capable of causing 
invasive illness (32,33). Two closely related clones, both belonging to ST29, were 
discriminated through genomics leading to accurate assignment of cases to the outbreak 
source. The close relatedness of the two clones in absence of a demonstrated 
epidemiological link opens a question about their possible common ancestry and its 
associated shared environmental niche. Prospective genomic epidemiology investigations 
focused on ST29 in the area could allow to understand whether these clones are still 
circulating in the human population and potentially find clues about their environmental 
niche. 
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ABSTRACT 
Bacteriology has embraced the next-generation sequencing revolution, swiftly moving from 
the time of single genome sequencing to the age of genomic epidemiology. Hundreds and 
now even thousands of genomes are being sequenced for single bacterial species, allowing 
unprecedented levels of resolution and insight in the evolution and epidemic diffusion of the 
main bacterial pathogens. Here, we present a review of some of the most recent and 
groundbreaking studies in this field. 
 
INTRODUCTION 
It seems that lately all scientific articles presenting results based on next-generation 
sequencing start with slight variations of the same formula ‘In recent years the advent of 
novel sequencing technologies has revolutionized the field of …’. This uniformity can teach 
us a couple of lessons. First of all that scientists do not apply their unquestionable creativity 
to the writing of introductions, but more importantly that maybe we are actually really facing a 
scientific revolution. These technologies allow to obtain unprecedented levels of resolution 
and standardization in genomic data at affordable prices and turnaround times. 
Many researchers quickly understood the power of these novel sequencing approaches, 
generating wealth of data for a number of different biological systems, and designing novel 
methods to exploit these information. Among them, many bacteriologists fully embraced the 
revolution, understanding that the generation of high numbers of genomes from a single 
species, strain or clonal group would allow to reconstruct the history of a bacterium in time 
and space, to trace its movements and relevant evolutionary events, and to understand the 
success of specific strains. This genomic epidemiology approach has been applied to a 
plethora of bacteria, first and foremost to pathogens, with the final goal of obtaining novel 
strategies to effectively deal with diseases. In this review, we present a small collection of 
some of the most novel and groundbreaking results obtained in this field, to provide the 
reader with basic knowledge of the new advances and hopefully to inspire others to pursue 
innovative lines of research. 
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LOCAL STUDIES 
Third-generation sequencing to tackle the plasmid issue. Multidrug-resistant (MDR) 
bacteria are currently considered a health problem of primary importance both in Europe and 
USA (1). Enterobacteriaceae are among the most common MDR bacteria involved in 
nosocomial infection worldwide. These bacteria, Escherichia coli and Klebsiella pneumoniae, 
in primis are often commensals in healthy subjects, as part of the gut flora composition. 
When colonizing subjects with depressed or weakened immune system, they can turn into 
dangerous pathogens. These bacteria are able to rapidly develop antibiotic resistance, both 
by acquiring resistant factors from other bacteria and by developing favourable chromosome 
mutations. Among the most feared are carbapenem-resistant Enterobacteriaceae (CRE), 
capable of surviving even treatments with the most recently discovered molecules. 
Due to antimicrobial resistance and opportunistic pathogenicity, many of the fatal infections 
caused by CRE occur within the hospital intensive care units, hosting patients in precarious 
health conditions, where antibiotic pressure is continuous, often resulting in nosocomial 
outbreaks. Indeed, during 2013, MDR Enterobacteriaceae were responsible for over 9000 
nosocomial infections in the USA, causing over 600 deaths (2). Multiple genomic 
epidemiology studies have been performed on Enterobacteriaceae global evolution, in 
particular focusing on the most common antibiotic-resistant clones (3–6). Additionally, the 
application of genomic approaches has allowed to characterize nosocomial outbreaks in 
detail, identifying dangerous clones and detecting transmission patterns (7–9). These 
studies used the ‘standard’ next-generation technologies for genome sequencing (Illumina 
and 454). These now established technologies, sometimes now referred to as ‘second-
generation technologies’ (10), output very large sets of short sequences, suitable to obtain 
draft genome assemblies. Such methods, however, do not allow to fully characterize the 
genomic structure, that is to completely detect genomic rearrangements and fully reconstruct 
complete plasmid sequences. In order to overcome these issues, we can turn to the latest 
advancements in DNA sequencing, the so called third-generation sequencing platforms (10). 
Among them is the single molecule real time (SMRT) sequencing technology which allows to 
obtain very long sequences (> 10,000 nt) (11) and thus to perform genome assemblies that 
easily result in the full reconstruction of ‘closed’ chromosomes and plasmids. 
Recently, Conlan and co-workers (12) exploited this technology to bring local genomic 
epidemiology to a higher level. Twenty strains of CRE were sampled in the NIH Clinical 
Center in the time span between 2011 and 2013 both from patients and from the hospital 
environment. Initial sequencing, performed with Illumina or 454 technologies was, as 
expected, not precise enough to characterize the genomic content on a structural basis. For 
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this reason, genomes were sequenced a second time using SMRT technology and polished 
on two levels. Illumina MiSeq reads allowed to ensure the highest precision in base content, 
while OpGen physical maps (13) gave fundamental information on chromosome and plasmid 
structures. The effort allowed to obtain complete genomes at a very high level of accuracy, 
which were used together with epidemiological information to reconstruct the transmission 
routes of the pathogens. In five cases, the aid of complete genomes and plasmids was 
essential to detect the exact pattern of transmission. Among the 20 isolates analysed, four 
showed novel genomic features, never described before. A Klebsiella oxytoca strain carrying 
a plasmid with two copies of the blaKPC gene, an isolate of K. pneumoniae with three 
plasmids each carrying a copy of the blaKPC gene and two isolates with a chromosomal 
copy of the resistance gene. Is such an high-percentage of novel features (4/20) surprising? 
Are the bacteria isolated at the NIH Clinical Center so unique? The more parsimonious 
explanation is actually that these features are more common than we think, and that we had 
never seen them before because the quality of our sequencing was previously insufficient. 
The approach by Conlan and colleagues also allowed to detect the movement of KPC 
plasmids between isolates of different species through the environment. A p55-like plasmid 
of K. pneumoniae isolated from a patient was the same found in Citrobacter freundii and 
Enterobacter cloacae sampled from the sink in the patient’s room, differentiating only for two 
adaptive changes in the entire sequence. This suggested that the transmission happened in 
the sink, as a consequence of a transient presence of K. pneumoniae in the local biofilm. 
This finding underlines, once more, the importance of environmental controls in the hospital 
wards and suggests specific inspections that should be included in the safety protocols. 
Lastly, thanks to the finesse of the sequencing, it was possible to analyse a case of co-
colonization in a 2011 patient who was found to carry both a carbapenem-resistant K. 
pneumoniae and a E. cloacae. Since the patient resulted not colonized at admission, and the 
two pathogens present two different copies of KPC plasmids, the authors concluded that 
there was no plasmid transfer and that both resistant strains were circulating in the institution 
prior of the patient’s arrival. 
Hubs of gene flow in Streptococcus pneumoniae. Streptococcus pneumoniae is a gram-
positive bacterium that resides, usually as an innocuous commensal, in the nasopharynx of 
healthy carriers, with prevalence varying from 5 to 90% (14, 15). When S. pneumoniae 
colonizes immunocompromised individuals, children or elderly, it can act as an opportunistic 
pathogen, leading not only to pneumonia, but also to a variety of other important diseases, 
such as meningitis and febrile bacteraemia (16). Multiple vaccines are currently available. 
For example, conjugate vaccine PCV7 was introduced in the United States in 2000, rapidly 
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proving its effectiveness. Indeed, by 2003, the occurrence of infant pneumococcal disease in 
Massachusetts was 69% lower (17). Nevertheless, S. pneumoniae remains a leading 
infectious disease worldwide, with higher impact in developing countries. Multiple studies 
have used genomics to study this important pathogen, starting with the first complete 
genome sequence presented in 2001 (18). Subsequent comparative works allowed to 
discover that this species exhibits a high frequency of genomic recombination, which in turn 
favours the rapid acquisition of novel genetic features. This is often followed by rapid 
diffusion of those characteristics that give a distinct selective advantage, such as traits 
conferring resistance to antibiotics and vaccines (19–22). Such behaviour was described 
even within the course of a single-patient chronic paediatric polyclonal infection (23). 
Recently a study presented the sequencing of over 3000 genomes of S. pneumoniae 
isolated during the course of 4 years from the population of a single refugee camp in 
Thailand (24). This is, to our knowledge, the largest study of bacterial genomic epidemiology 
to date, structured so that it allows an unprecedented level of sampling density, providing 
novel insight in the genomic evolution of S. pneumoniae and of bacterial populations in 
general. The authors used the Bayesian approach BAPS (25, 26) to investigate the structure 
of the bacterial population of the refugee camp, identifying 33 clusters, that could be divided 
in 183 secondary, mostly clonal, subclusters. An analysis focused on the capsule 
biosynthesis locus and detected a strong presence of non-typeable (NT) isolates, lacking the 
capsule, but also the impressive number of 191 ‘plausible capsule switching events’, with 
numerous of these recombinations causing switches between the capsulated and non-
capsulated states. 
While nucleotide substitution rate did not differ between clusters, rate of recombination was 
variable. This ratio, intended as the ratio between recombination and mutation events (r/m), 
resulted to be very different among population clusters and significantly higher in NT 
isolates. The more striking result of this analysis was, however, the consistently higher rate 
of recombination of six genomic loci, specifically antigens and antibiotic-resistance genes. 
Among these ‘recombination hotspots’ were genes providing resistance to beta-lactams and 
cotrimoxazole. Interestingly, the recombination histories of genes providing resistance to the 
two antibiotics were different, and the authors found them to match the variable use of beta-
lactams and cotrimoxazole, respectively, increasing and decreasing during the time of the 
study within the refugee camp area. 
The extreme genome density of this study allowed also to tackle one important issue of 
recombination studies, the detection of the donor isolates. Indeed, the authors identified 443 
blocks that were identical between the recipient and the donor, nine of which were the 
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results of recombination between nine donors and one single recipient. These blocks were 
not uniformly distributed in the population, and the NT isolates resulted to be not only good 
recipients, but good donors as well. In summary, this study reported the presence of 
‘recombination hotspots’ that can easily move among isolates, but also the presence of 
specific lineages that can act as ‘hubs of gene flow’. Since these lineages are not 
necessarily those that present higher virulence, such as NT isolates in S. pneumoniae, these 
results provide novel insights that can help to change the way we look at the dynamics of 
bacterial populations. 
 
GLOBAL TRENDS 
The explosion of Salmonella Typhi H58. Salmonella enterica is a widely studied 
pathogenic agent, of such importance that has caused multiple health and economic crises 
worldwide (27). The three S. enterica clusters of greater importance for human health are 
serovar Typhi (or S. Typhi), serovar Typhimurium (or S. Typhimurium) and serovar 
Enteritidis (or S. Enteritidis). S. Typhi is the causative agent of typhoid fever, a disease 
particularly diffused in Asia, and endemic in the Indian subcontinent (28). It was estimated 
that, just during 2010, typhoid fever affected 26.9 million people worldwide, with fatality rates 
ranging from 1 to 30% (29). S. Typhi is able to infect human blood and intestine, producing 
an array of symptoms including nausea, vomiting, fever and death. A portion of colonized 
people usually remain asymptomatic for long periods of time (up to years), shedding the 
bacterium into their stool and urine (27), with the effect of sustaining the pathogen 
transmission. 
Blantyre is a ~1.3 million people district, localized in the south of Malawi. In this area, 
between 1998 and 2010, several cases of bloodstream infection (BSI) caused by 
nontyphoidal serovars of Salmonella were reported, while the typhoidal S. Typhi serovar was 
rare (30). Starting from 2011, an increase in the number of BSI caused by MDR S. Typhi has 
been reported. In particular, the S. Typhi lineage H58 resulted to be predominant in the 
infected population. Feasey and colleagues (30) used a genomic epidemiology approach to 
reconstruct the origin of the emergence of S. Typhi H58 in this area: they collected 
epidemiological data from the Blantyre district (covering the period 1998–2011) and 
sequenced the genome of 112 S. Typhi strains, isolated there from 2004 to 2011. Whole-
genome analysis was performed using a genome mapping approach, and the obtained 
SNPs were subjected to maximum-likelihood phylogenetic analysis. Merging the information 
from the resulting tree and the epidemiological data, the authors were able to reconstruct 
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that the increase of typhoid fever reported from 2011 was due to the rapid diffusion of a 
monophyletic S. Typhi lineage, the aforementioned H58-haplotype. H58 resulted to be 
associated with MDR with a much higher frequency (89.3%) than the other circulating S. 
Typhi types (21.4%). 
Strong phylo-geographical clusters were described within the H58 lineage, indicating it to be 
endemic in the areas included in the study. H58 isolates, collected in the same areas, 
resulted to be clustered on the phylogenetic tree, independently of the date of isolation. This 
geographical clusterization is consistent with the existence of reservoirs. Furthermore, 
genomes of the H58 strain result to be very conserved within the lineages, in contrast with 
the other S. Typhi monophyla. Indeed, the H58 tree branch lengths are shorter than the 
other S. Typhi lineages. These data can be explained hypothesizing that a strong purifying 
selective pressure affects the H58 lineage, and/or that frequent genomic recombinations 
occurred among the H58 strains. 
Due to the undeniable importance of this haplotype, a second study was performed to 
describe its emergence at the global level. Wong and colleagues (31) considered the 
impressive collection of 1,832 S. Typhi isolates collected in the period 1905–2014, from 63 
countries spanning 6 continents. Whilst the most ancient isolate included in the study was 
collected in 1905, the first S. Typhi H58 isolate was from 1992, indicating a very recent origin 
of this lineage. Since 1992, the H58 haplotype represents ~40% of all the isolates collected 
each year, a remarkable explosive diffusion. Indeed, H58 genomes differ by a mean of only 
six SNPs, with 93% of them having less than five isolate-specific SNPs. These data show 
that H58 isolates are very closely related, consistent with the hypothesis of an impressive 
recent clonal expansion. It must be noted that the number of isolates obtained before 1992 is 
limited (n = 50), and this may skew the perception of the H58 diffusion, nevertheless the 
result is remarkable. The authors then inferred the date of the H58 origin to be between 
1985 and 1992. After 1993, they observed a drastic increase of the H58 effective population 
size. Furthermore, on the basis of the phylogenetic reconstruction, the authors traced the 
major geographical transfers of the S. Typhi H58 haplotype: the strain originated in India, 
and through independent events reached Southeast Asia, Fuji, Western Asia, East Africa 
and Malawi. In Africa, it then invaded Malawi a second time through East Africa and then 
diffused from Malawi to South Africa. 
Novel insights into the genomic evolution of Staphylococcus aureus. Staphylococcus 
aureus is among the most important antibiotic-resistant pathogens worldwide. Methicillin-
resistant strains (MRSA), in particular, are spread in all continents and can be up to 70% of 
all S. aureus isolates in the most affected countries (32). The first report of MRSA was an 
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hospital-acquired infection in 1960 (33), but the pathogen has since then developed endemic 
status and can be transmitted outside of the nosocomial environment (the first cases were 
reported in the mid-1990) (34). The terms HA-MRSA (health care-associated MRSA) and 
CA-MRSA (community-associated MRSA) reflect this distinction. And if this was not enough, 
LA-MRSA (livestock-associated) is the zoonotic variant, which is common in farms (35). 
Resistance to methicillin is encoded in the staphylococcal cassette chromosome mec 
(SCCmec) which contains the mecA gene. Several variants of the cassette have been 
discovered and found to be able to transmit and move between strains. The spread of MRSA 
strains has been the focus of a number of high-profile studies that used genomic approaches 
to investigate their diffusion and evolution, starting from the pioneering study of Harris (36), 
already discussed in previous reviews (e.g. (37)). 
Holden and colleagues (38) used genomics to reconstruct the evolution of EMRSA-15, a 
strain belonging to sequence type 22, which is considered the most rapidly spreading and 
tenacious S. aureus in Europe, currently invading other continents. Genomes were obtained 
from 193 ST22 strains of S. aureus isolated from 1990 to 2009 and a SNP-based phylogeny 
was reconstructed. A molecular clock analysis allowed to distinguish and date different 
clades with variable virulence levels, corresponding to different stages in the epidemic 
diffusion. Genomic variability among the clades was analysed both at the SNP level and the 
gene content level, with the aim of correlating genomic changes with fitness and virulence. 
The study concluded that sequence type 22-A (ST22-A) was the first of this lineage to obtain 
resistance to methicillin, from the primitive community-associated methicillin-sensitive ST22, 
and dated this event to before 1977. This led to a health care-associated MRSA epidemic 
that spread in England in the 1980s (ST22-A1). In the mid 1980s, a sublineage acquired 
resistance to fluoroquinolones, and EMRSA-15 (also called ST22-A2) was born. The authors 
performed a bayesian analysis and detected a considerable difference in population size 
between ST22-A1 and ST22-A2, putative consequence of a fitness boost which caused the 
worldwide diffusion of the latter strain. Lastly, genomic traits were correlated with 
antimicrobial resistance profiles, thus highlighting the potential of genome sequencing as a 
diagnostic tool. Appearance on the tree of genetic variants responsible for antimicrobial 
resistance was found to agree with the variations of antibiotic prescription policy-making in 
the different regions during the years. Indeed, EMRSA-15 spread through the UK when 
fluoroquinolones where highly used, while a subsequent spread in Germany was a 
consequence of the development of yet another resistance, to clindamycin, which was 
heavily used in that country. Recently, other similar works reconstructed and dated the origin 
of other MRSA epidemic clones. Genomic variants were mapped on the trees and correlated 
with phenotypic changes. For example, Planet and coworkers (39) worked on USA300 and 
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USA300-LV clones, while Stinear and colleagues (40) on CA-MRSA ST93. Stegger et al. 
(41) studied CC80 and Baines et al. (42) focused their efforts on HA-MRSA ST239. 
In addition to these phylogeny-based works, the genomics of S. aureus has been used to 
investigate variations in genome structure. Indeed recombinations, transmission of plasmids 
and pathogenicity islands represent big adaptive steps in the history of MRSA, as they do for 
CRE and S. pneumoniae. Recently, Méric and coworkers (43) studied the evolution and 
genomic flow between two species that share the same niche: S. aureus and 
Staphylococcus epidermidis. These species are indeed both common commensals on the 
human skin and in the nasal pharynx. The authors selected and sequenced 324 isolates 
from archives and databases, in order to represent the global diversity of the two species, 
choosing among different genomic variants, location and sources of isolation. Shared genes 
and alleles were searched between each pair of isolates, and the two species resulted to 
share a maximum of nine core genome alleles between them, thus suggesting that genomic 
recombination is very rare between individuals of the two species. On the contrary, mobile 
elements were highly shared, in particular genes associated with the SaPIn1 pathogenicity 
island, metal detoxification and the methicillin-resistance island SCCmec. The authors use 
these interesting results to discuss the concept of evolution in relation with the host as a 
niche, that is two strains or species that share the same host, also share the same selective 
pressure. Recombination can be driven by direct contact between donor and receiver, but 
also by evolution of niches, as genomic material can be shared in these enclosed 
environments. 
In this review, we report multiple examples of how exchange of genomic material can involve 
the accessory parts of the genomes, but also homologous recombinations in core genome 
loci. The latter is a common thread in global genomic epidemiology as it is commonly found 
in most bacterial species involved in nosocomial infections. This was recently pointed out by 
Croucher and Klugman (44) who observed that large recombinations (even bigger than one 
megabase) seem to be an evolutive weapon that pathogens use to rapidly gain fitness and 
survive in the hospital environment. The two authors compare recombined bacteria to the 
‘hopeful monsters’ of the Cambrian period, citing the use by Stephen Gould of the term 
introduced earlier by Richard Goldschmidt(45). 
The presence of recombinations should be taken into account because they need to be 
removed from the genomic alignment in order to obtain resolved and correct phylogenies, 
which represent the real evolutive history of the pathogen. 
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HISTORICAL PERSPECTIVES 
Mycobacterium tuberculosis through history. Mycobacterium tuberculosis is an obligate 
aerobic pathogenic bacterium and the causative agent of tuberculosis (TB) (46). The 
presence of mycolitic acids in M. tuberculosis coating confers the bacterium resistance to 
weak disinfectants and dehydration and prevents the effective activity of hydrophobic 
antibiotics. Additionally, it allows the bacterium to grow inside of macrophages, effectively 
hiding it from the host’s immune system (47). All these characteristics contribute to the ease 
with which it is transmitted, despite its extremely slow replication time compared to other 
bacteria. Tuberculosis is a disease that accompanied human populations since antiquity, it 
has been prevalent worldwide and, if left untreated, causes death in 50% of cases. In the 
last two centuries, progress has been made both in diagnosis and treatment with the advent 
of screening programs, antibiotics and vaccines, relegating the emergency to third world 
countries. Nevertheless, deaths are increasing after an almost 40 years decline (46), and the 
emergence of multiple antibiotic-resistant strains (48) makes M. tuberculosis one of the most 
important re-emerging bacterial pathogens to date, and the leading bacterial killer worldwide 
with 1.3 million deaths a year. The so called M. tuberculosis Beijing family is a 
heterogeneous group of strains, among which hypervirulent subtypes stand out, equipped 
with multiple antibiotic resistances and the ability to cause disease outbreaks (49). The 
whole family, considered the predominant genotype in East Asia and still currently 
spreading, can be accounted for more than a quarter of the total tuberculosis cases 
worldwide. Despite previous epidemiology studies showed high genetic similarity even 
among strains isolated in different geographic areas (49), pathobiological characteristics 
appeared heterogeneous (50). The increasing availability of standard genotyping leads to 
the identification of several Beijing sublineages (51). This approach, however, proved itself 
limited for fully understanding the diversity of this family due to the insufficient amount of 
nucleotide variation detected by this technique. Once again, genomic epidemiology can 
come to our rescue. 
Given the relevance of this family for public health globally, several studies focused on 
reconstructing the origin and spread of M. tuberculosis Beijing strains (52–56). Merker et al. 
(57) focused on the biogeographical structure of strains belonging to the Beijing family, with 
a in-depth analysis on the association between sublineages and antibiotic resistance. The 
authors assembled a huge data set, comprising almost five thousand genotyped isolates 
plus 110 whole-genome sequences, the biggest and broadest collection of Beijing family 
strains to date, both in terms of sheer size and variety of geographical origins. Initially, a 
minimum-spanning tree (MStree) was constructed using genotyping data, grouping the 
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genomic diversity into 6 major clonal complexes (CCs) and 3 distant branches which were 
collectively designated as basal sublineage 7 (BL7). CC1 through CC5 were classified as 
typical/modern Beijing while CC6 and BL7 comprised typical ancestral Beijing variants. The 
shape of the Mstree and the mean allelic richness confirmed this hypothesis, suggesting that 
CC1, CC2 and CC5 are in a state of population expansion, while CC6 and BL7 are more 
ancient and/or in a situation of milder expansion. 
The authors then used the information for all the five thousand genotyped isolates to 
estimate past expansions and time to the most recent common ancestor (TMRCA). CC6 and 
BL7 were confirmed once again as the oldest sublineages with, respectively, a TMRCA of 
~6,000 and 5,000 years, while CC5 resulted the youngest with a TMRCA of ~1500 years. 
For all sublineages, an estimate of the time elapsed since the beginning of the latest 
expansion was computed. This analysis showed a much recent timeframe, roughly 200 
years ago, for CC1, CC2 and CC5, compared to the estimate detected for the more ancient 
lineanges, CC6 and BL7, which dated back to the middle age. Once again, genome 
information, available for 110 isolates, made it possible to obtain a more sensitive estimate 
of population changes in the recent past, by means of a Bayesian skyline plot. Two 
significant population growth phases were detected in conjunction with the Industrial 
Revolution and the First World War. The only decrease in population size was observed 
contemporary with the spreading of anti-tuberculosis drug usage, while a slight expansion 
coincides with the advent of the HIV epidemics and the first tuberculosis outbreaks in the 
former Soviet Union and the United States in the 1990s. A subset of roughly one thousand 
clinical isolates with known drug resistance profiles was analysed to shed light on possible 
association between the identified CCs and antibiotic resistance, resulting in CC2 having the 
highest proportions of MDR strains. It is important to note that CC1, while having a similar 
proportion of MDR strains to the ancient lineages, showed a high clustering rate (95%) 
meaning that almost all isolates shared a single resistant haplotype, in contrast with CC6 
and BL7 (42% and 57%, respectively). Additionally, strains from CC1 (central Asian 
outbreak) and CC2 (Russian-European outbreak) showed a higher similarity between them 
than with other clonal complexes, supporting the MDR outbreak hypothesis and a recent 
specific expansion of these two clonal complexes. 
It is interesting to note that M. tuberculosis population growths are closely related to 
historical events and human migrations. Genotype data allowed to estimate the start of the 
last expansion events for the recent sublineages to 200–250 years ago, roughly around the 
time of the industrial revolution and matching known episodes of Chinese immigration 
towards Pacific islands, Americas and Russia. It is both interesting and not surprising that 
Beijing family strains experienced increases in population size in conjunction with the 
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Industrial revolution and with the First World War. This is consistent both with Chinese 
immigration episodes, as noted above, and with the deprivations caused by war conditions 
and the co-mortality due to the influenza pandemics of that time (58). The only decrease in 
population size detected coincides with the advent of antibiotics and mass vaccinations 
around the 1960s. It has to be kept in mind that the expansion of the two sublineages more 
associated with antibiotic resistance, CC1 and CC2, predates this event. This indicates that 
MDR is not the reason of the success of these clonal complexes but just the consequence of 
public health policies implemented on an already growing bacterial population. Finally, the 
most recent increasing trend is consistent with the onset of the global HIV epidemic and 
follows it closely. 
The strange case of the amphibious Mycobacterium. Albeit recent studies such as the 
one described above are shedding light in the history of M. tuberculosis, there are still plenty 
of dark patches that need to be illuminated. It is clear that the co-evolution of the bacterium 
with humans started with the shift from the hunter/gatherer behaviour to the onset of 
agriculture and animal husbandry, especially cattle (59). Until recent years, the most 
accredited theory had a zoonotic transfer of Mycobacterium bovis following animal 
domestication during the Neolithic (60). However, recent comparative genomic analyses 
lean towards the opposite theory. That is, strains adapted to bovines and other animals may 
have originated from human strains (61, 62). For what concerns the Americas, given that 
strains currently present in the area are closely related to the European ones, the consensus 
is that the pathogen was brought by colonizers and settlers after the Columbian discovery 
(63). This, however, is not consistent with several evidences of skeletal samples dated 
before 1492 with obvious signs of the disease. If tubercolosis was not brought on caravels, 
who or what carried it to the New World? And how can we explain the genomic similarity 
between American and European strains of M. tuberculosis? Bos et al. (64) try to give us an 
answer. 
Progresses in protocols for isolation of ancient DNA made it possible to collect three M. 
tubercolosis genomes from skeletal samples with signs of tuberculosis infection collected in 
Peru and dated back to roughly one thousand years ago. They completed a the data set by 
adding 259 modern M. tuberculosis complex (MTBC) genomes, 14 animal isolates and an 
additional ancient genome originated from an eighteen century Hungarian mummy. An 
alignment of 22,480 variable positions was the input for a phylogenetic analysis. The 
resulting tree came with a surprise: the ancient Peruvian samples did not cluster with other 
human isolates; they were closer to the animal strains, in particular to the modern 
Mycobacterium pinnipedii sample. As the latin suggests, M. pinnipedii has been isolated 
from seals and sea lions. Bayesian dating analysis, using radiocarbon dates as tip 
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calibration, was implemented for dating the most recent common ancestor (MRCA). Using a 
relaxed molecular clock model, the MRCA was dated between 4000 and 4500 years ago. 
Since the Bering land bridge closed some 15,000 years ago, 10000 years before the 
estimated time of the MRCA, the researchers discarded a human migration hypothesis for 
the appearance of TB in the New World. The remaining, unexpected hypothesis is the 
amphibious one: seals contracted the disease on the coasts of Africa and carried it to South 
America where populations living in the seaside contracted by exploiting the marine 
mammals. This is consistent with similar cases in literature for other pathogens (65). The 
later eradication of this strain and the almost total substitution with European-like lineages 
could be accounted by a spread-after-contact of the latter following favourable conditions 
(66). 
 
CONCLUSIONS: FROM EPIDEMIOLOGY TO DIAGNOSTICS 
The examples presented here testify how the use of genome sequencing in bacteriology for 
epidemiological purposes is now widespread. Favoured by the wealth of data that are being 
generated and by the continued advances in sequencing technologies, the next step will be 
to branch into microbiological diagnostics (67–69). Efforts are being made in multiple 
directions, two of the most promising being direct sequencing from clinical samples and the 
use of genomic data to predict phenotypic characteristics. 
The utility of direct sequencing of clinical samples for diagnosis purposes is obvious, and 
particularly important for bacteria that are difficult, slow or impossible to culture. A possible 
approach, when investigating a single pathogen, is the use of specific baits to sequence the 
target bacterium starting from a mixed clinical sample, an approach that was used for 
example to detect M. tubercolosis from sputum (70). In many clinical cases, it is, however, 
impossible to know a priori which bacterium is causing a pathological state. In these 
situations, a whole metagenomic sequencing approach could allow to identify the causative 
agent/s quickly and without bias. Ad-hoc bioinformatic methods are being developed to 
tackle the problematic issue of analysing the complex metagenomes that can be obtained 
from clinical samples, with the goal of correctly sorting and identifying bacterial populations 
(71, 72)(73)(71, 72).  
Some phenotypic characteristics of a pathogen can be readily inferred from its genome 
sequence. This is the case for example of antibiotic resistance traits that are determined by 
the acquisition of one single gene. Many other phenotypes are, however, multi-factorial, 
making such correlations more complex. These difficulties have not discouraged pioneering 
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projects that use genome-wide association studies to link genotype to phenotype, in an effort 
to obtain diagnostic informations from the now quick and cheap whole-genome sequences. 
Laabei and colleagues (74) applied such an approach to MRSA, developing a model that 
can predict with a high degree of accuracy the toxicity of an isolate based on the sequence 
of signature sites. Another study integrated a genomic approach with gene expression 
analysis, performed with RNA-seq, to determine antibiotic resistance profiles in E. coli (75). 
These are not the only examples, as other approaches are being tried and validated on 
multiple pathogens (76, 77). 
Multiple issues will need to be addressed to allow the transition from genomic epidemiology 
to genomic diagnostics in bacteriology, and one that needs the most concerted effort is 
standardization of genomes, related metadata and bioinformatic analysis. Indeed, the full 
potentiality of genomics will only be exploited in clinical microbiology when all the wealth of 
data generated worldwide will be fully compatible, allowing real time evaluation and 
comparison of the characteristics of sequenced isolates, in a single global database. This 
will in turn allow to fully correlate genotype with phenotype, to optimize diagnostic and 
therapeutic approaches and to monitor movement of dangerous strains worldwide. Efforts 
towards this goal are already being made from the setting of standards for genome 
qualities(78) to the establishment of platforms using standarized bioinformatic protocols for 
genome analyses (79, 80). 
It is only fitting to conclude this review how it started: Next-generation sequencing is 
revolutionizing bacteriology… and the best is yet to come. 
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Different evolutionary scenarios. In this thesis, I have presented five research papers and 
one review article. Two of the research articles are focused on the genomic evolution of a 
nosocomial pathogen strain. These works are focused on Klebsiella pneumoniae CC258 
(Gaiarsa et al., 2015; see Article 1) and Acinetobacter baumannii ST78 (Gaiarsa et al., 
submitted; see Article 2). In the K. pneumoniae paper, the main finding is the presence of a 
1.3 million base recombination in the genomes of the CC258 isolates. This discovery was 
used to complete the picture of the evolutionary history that led to the current genome of this 
worldwide spread pathogen. Moreover, it was possible to date the newly detected and the 
previously reported recombination events. The so-depicted scenario is reminiscent of the 
evolutionary model of punctuated equilibrium in which fast evolutionary events (in this case 
recombinations) lead to the establishment of an highly fit variant. The model of punctuated 
equilibrium was theorized by Stephen Gould to explain the high morphologic variability of the 
fossils of the Cambrian era. Such species were the result of a very quick and diverging 
evolutionary process, but only a few of them were fit enough to survive in the ages. Gould 
named those species “hopeful monsters” after a name invented by evolutionist Richard 
Goldschmidt (1, 2). Indeed, the isolates of CC258 can be compared to the “hopeful 
monsters”. This evolutionary strategy is not exclusive of the CC258: as a matter of facts, it is 
known that recombination of wide portions of genomes are a common feature in bacterial 
pathogens, such as Vibrio cholerae, Clostridium difficile, Salmonella enterica and 
Streptococcus pneumoniae. These and other examples are listed in a commentary article 
published by Nicholas Croucher in 2014, called ‘The Emergence of Bacterial “Hopeful 
Monsters”’ (3). 
Not all pathogens evolve in this way, though. In fact, the bacterial strain analyzed in Article 2 
showed to have a very low recombination lifestyle and a low gene content variability. Indeed, 
in this work about A. baumannii ST78, we were able to identify two different clusters of 
isolates, some of them (ST78A) with a low gene content variability and a very high number 
of copies of insertion sequences (ISs). In our evolutionary model, the acquisition of 
exogenous DNA is slowed down by the inactivation of the comEC/rec2 gene, which codes 
for a protein used for the importation of DNA through transformation and thus involved in the 
pathway of homologous recombination. ST78 has a “strong” phenotype (e.g. high production 
of biofilm) which grants it a very high persistence. Yet, the loss of genomic plasticity in this 
bacterium limits its ability to adapt to environmental changes and could be the cause of its 
low incidence.  
Almost forensic genomics.  The remaining three research articles (Article 3: Onori et al., 
2015; Article 4: Scaltriti et al., 2015; Article 5: Comandatore et al., 2017) are focused on the 
reconstruction of epidemic events of bacterial infections. Article 3 reconstructs the chain of 
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contagion of K. pneumoniae in an intensive care unit of an Italian hospital. In this case, 
global phylogeny and isolation dates helped in identifying what isolates were involved in the 
outbreak event. Then, an approach based on core SNPs and isolation dates allowed to 
reconstruct the spreading route, which resulted to be a star-like radiation from the patient 
zero to all the other ones and suggested that the hospital staff may be responsible of the 
spread, through negligence in respecting the safety procedures. In Article 4, phylogeny 
allowed to identify the source of a food poisoning by Salmonella enterica. In this case, only 
synonymous mutations were used as input to the phylogeny, in order to filter out 
pathoadaptative mutations. Lastly, in Article 5, epidemiological data, molecular typing and 
SNP-based phylogeny were used to reconstruct the dynamics of infection of nine Listeria 
monocytogenes isolates, which were believed to be part of the same outbreak and in the 
end proved to be genomically unrelated, and thus indicating different epidemic events. 
All three articles underline the high potential of genomic epidemiology, which is able to 
provide the resolution to reconstruct the chain of events happened in very short time spans 
and small spaces. In all three cases it was possible to identify the source and responsibility 
for the contagion. No result of these papers was used as evidence in a trial, but the level of 
precision in this kind of investigations is so high to suggest a possible forensic application 
(4). 
Future developments in the projects. Bacterial “hopeful monsters”, such as K. 
pneumoniae CC258, are pathogens with a very high rate of HGT. Thus, besides studying the 
evolutionary history of the strains, it is necessary to understand how these “superbugs” are 
formed: i.e. in what environments and conditions do recombinations happen. This could be 
achieved by studying the patterns of coinfections of the same patient by more than one 
variant of the same species. Of course the copresence in the same environment is the 
conditio sine qua non DNA exchange can happen. One other way of studying this 
phenomenon would be to use phylogenetic approaches to track the movements of 
transferred DNA portions instead of those of entire genomes. 
Moreover, the human body is not the only environment where “superbugs” should be 
searched. K. pneumoniae, for example, is almost ubiquitous and can be normally found in a 
wide array of other niches, such as other animals (either pets, farm animals or bugs) but also 
vegetation and water. Thus, it would be important to understand in what environments can 
resistant and/or virulent variants be found, i.e. what  the reservoirs of pathogens are. With 
this investigative strategy, it would be also possible to detect what the spreading routes are 
for dangerous bacteria and what are the hub points of transmission that could be tackled in 
order to limit the diffusion of the pathogens. Lastly, it would be possible to understand if one 
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of the studied environments can host recombination events. Indeed, the more diverse  the 
environments are, the more diverse is the gene pool that can be mixed when “superbugs” 
are formed. 
Article 2 underlines the importance of selfish DNA, such as ISs, in the evolution of genomes. 
Indeed the phenomenon of reduced genome plasticity caused by the proliferation of ISs 
should be investigated further. It should be understood if it is common to other variants of A. 
baumannii or even to other species. Moreover in A. baumannii ST78, all genes inactivated 
by ISs could be detected in order to understand what pathways are targeted by this 
mechanism. 
Potential translational application of microbial genomics. All works presented in this 
thesis and, more in general the vast majority of articles published in the field of microbial 
genomics and genomic epidemiology, prove that the resolution power of these techniques is 
very high. The characterization of an isolate and the detection of molecular determinants for 
antimicrobial resistance are quick and cheap tasks when performed with genomics. In light 
of the continuous drop of costs for DNA sequencing, there is a moral duty to exploit these 
new technologies to develop cheap diagnostic and surveillance tools (5). The new tests will 
eventually substitute the traditional molecular and microbiological assays, thus cutting the 
time span between isolation and cure administration. This will lower the chance of death of 
the patient as well as limit the possibility of spread of the pathogens. 
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TABLE S1
Table  of  Klebsiella  pneumoniae isolates  sequenced  in  this  study  and  selected
characteristics.
PUBLICATION_NAME ENTRY YEAR OF COLLECTION MLST HOSPITAL PHENOTYPE
100SGR ERS480596 2012 16 SAN GIOVANNI ROTONDO ESBL
101BO ERS480597 2012 512 BOLOGNA KPC
102BO ERS480598 2012 512 BOLOGNA KPC
103BO ERS480599 2012 512 BOLOGNA KPC
104BO ERS480600 2012 512 BOLOGNA KPC
10PV ERS480601 2012 307 PAVIA ESBL
11PV ERS480602 2013 258 PAVIA KPC
12PV ERS480603 2013 258 PAVIA KPC
13PV ERS480604 2013 258 PAVIA KPC
14PV ERS480605 2012 1624 PAVIA Susceptible
15PV ERS480606 2012 976 PAVIA Susceptible
16BO ERS480607 2011 37 BOLOGNA ESBL
17PV ERS480608 2012 307 PAVIA ESBL
18PV ERS480609 2013 15 PAVIA ESBL
19PV ERS480610 2013 15 PAVIA ESBL
20PV ERS480611 2012 1631 PAVIA Susceptible
21PV ERS480612 2012 240 PAVIA Susceptible
22PV ERS480613 2012 1625 PAVIA Susceptible
23PV ERS480614 2013 258 PAVIA KPC
24PV ERS480615 2013 258 PAVIA KPC
25BO ERS480616 2013 35 BOLOGNA Susceptible
26BO ERS480617 2013 35 BOLOGNA Susceptible
27BO ERS480618 2011 45 BOLOGNA ESBL
28BO ERS480619 2011 37 BOLOGNA ESBL
29BO ERS480620 2012 512 BOLOGNA KPC
30BO ERS480621 2012 512 BOLOGNA KPC
31AVR ERS480622 2013 512 CESENA KPC
32AVR ERS480623 2013 466 CESENA Susceptible
34AVR ERS480624 2013 405 CESENA Susceptible
36AVR ERS480625 2013 37 CESENA Susceptible
37AVR ERS480626 2013 323 CESENA ESBL
39AVR ERS480627 2013 395 CESENA Susceptible
40AVR ERS480628 2013 307 CESENA ESBL
41AVR ERS480629 2013 16 CESENA ESBL
42AVR ERS480630 2013 512 CESENA KPC
43AVR ERS480631 2013 512 CESENA KPC
44AVR ERS480632 2013 512 CESENA KPC
45AVR ERS480633 2013 160 CESENA Susceptible
46AVR ERS480634 2013 395 CESENA ESBL
47AVR ERS480635 2013 323 CESENA ESBL
48AVR ERS480636 2013 512 CESENA KPC
49BG ERS480637 2012 147 BERGAMO Susceptible
50BG ERS480638 2011 258 BERGAMO KPC
51BG ERS480639 2007 1626 BERGAMO Susceptible
52BG ERS480640 2006 268 BERGAMO Susceptible
53BG ERS480641 2009 321 BERGAMO Susceptible
54BG ERS480642 2011 258 BERGAMO KPC
55BG ERS480643 2012 466 BERGAMO Susceptible
56BG ERS480644 2011 258 BERGAMO KPC
PUBLICATION_NAME ENTRY YEAR OF COLLECTION MLST HOSPITAL PHENOTYPE
57BG ERS480645 2011 258 BERGAMO KPC
58BG ERS480646 2011 512 BERGAMO KPC
60BG ERS480647 2012 45 BERGAMO ESBL
62BG ERS480648 2011 147 BERGAMO ESBL
63BG ERS480649 2011 1627 BERGAMO ESBL
65BO ERS480650 2013 1243 BOLOGNA Susceptible
66BO ERS480651 2013 416 BOLOGNA Susceptible
67BO ERS480652 2013 1628 BOLOGNA Susceptible
68BO ERS480653 2011 37 BOLOGNA ESBL
69BO ERS480654 2011 277 BOLOGNA ESBL
70BO ERS480655 2011 37 BOLOGNA ESBL
71RE ERS480656 2011 258 REGGIO EMILIA KPC
72RE ERS480657 2011 258 REGGIO EMILIA KPC
73RE ERS480658 2011 258 REGGIO EMILIA KPC
74RE ERS480659 2011 512 REGGIO EMILIA KPC
75RE ERS480660 2011 258 REGGIO EMILIA KPC
76RE ERS480661 2012 1243 REGGIO EMILIA Susceptible
77RE ERS480662 2012 1629 REGGIO EMILIA Susceptible
78RE ERS480663 2012 1164 REGGIO EMILIA Susceptible
79RE ERS480664 2012 35 REGGIO EMILIA Susceptible
81RE ERS480665 2011 147 REGGIO EMILIA ESBL
82RE ERS480666 2012 405 REGGIO EMILIA ESBL
83RE ERS480667 2012 147 REGGIO EMILIA ESBL
84RE ERS480668 2012 322 REGGIO EMILIA ESBL
85RE ERS480669 2012 37 REGGIO EMILIA ESBL
86SGR ERS480670 2011 512 SAN GIOVANNI ROTONDO KPC
87SGR ERS480671 2011 512 SAN GIOVANNI ROTONDO KPC
88SGR ERS480672 2011 512 SAN GIOVANNI ROTONDO KPC
89SGR ERS480673 2011 512 SAN GIOVANNI ROTONDO KPC
90SGR ERS480674 2011 512 SAN GIOVANNI ROTONDO KPC
91SGR ERS480675 2012 29 SAN GIOVANNI ROTONDO Susceptible
92SGR ERS480676 2012 70 SAN GIOVANNI ROTONDO Susceptible
93SGR ERS480677 2012 35 SAN GIOVANNI ROTONDO Susceptible
94SGR ERS480678 2012 45 SAN GIOVANNI ROTONDO Susceptible
95SGR ERS480679 2012 1307 SAN GIOVANNI ROTONDO Susceptible
96SGR ERS480680 2012 1630 SAN GIOVANNI ROTONDO ESBL
97SGR ERS480681 2012 512 CESENA ESBL
98SGR ERS480682 2012 20 SAN GIOVANNI ROTONDO ESBL
99SGR ERS480683 2012 15 SAN GIOVANNI ROTONDO ESBL
9PV ERS480684 2012 307 PAVIA ESBL
TABLE S2
Genes with potential effect on virulence or antibiotic resistance phenotype comprised in
recombined region of ~1.3 Mb described in this work. Coordinates and strand are referred
to the genome of the reference strain NJST258_1, annotation was obtained by BLAST
search against a specifically designed database, as reported in the materials and methods
section.
START END STRAND PRODUCT NAME
18482 20224 + Integral membrane protein with trka domains
29471 30706 - Multidrug resistance protein emrD
69212 72319 - multidrug transporter
72319 73443 - acriflavine resistance protein E
138949 140223 - 3-deoxy-D-manno-octulosonic acid transferase WaaA
142431 143558 - glycosyl transferase family 1 WabG
143555 144631 - glycosyl transferase family 9 WaaQ
148902 149873 - ADP-heptose--LPS heptosyltransferase WaaC
149877 150935 - ADP-heptose--LPS heptosyltransferase WaaF
150945 151877 - ADP-L-glycero-D-manno-heptose-6-epimerase RfaD
188732 190165 + Xylose isomerase
291995 293161 + UDP-4-amino-L-arabinose synthase PmrH
293109 294146 + Undecaprenyl-phosphate alpha-4-amino-L-arabinosyltransferase ArnC
294143 296128 + UDP-4-amino-4-deoxy-L-arabinose formyltransferase ArnA
296125 297027 + 4-deoxy-4-formamido-L-arabinose-phospho-UDP deformylase PmrJ
297024 298682 + Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase ArnT
298679 299017 + 4-amino-4-deoxy-L-arabinose-phospho-UDP flippase PmrL
299017 299397 + 4-amino-4-deoxy-L-arabinose-phospho-UDP flippase PmrM
373562 374329 + Transcriptional regulatory protein ompR
374326 375681 + osmolarity sensor protein envZ
408428 409060 - Crp/Fnr family transcriptional regulator
424107 425291 + Elongation factor Tu
457426 460536 - multidrug transporter AcrB
460549 461688 - acrE
462055 462717 + AcrAB operon repressor
532636 532923 - yhbH
536245 536811 - yrbI
540606 541172 + yrbD/mlad
541191 541826 + mlac
553941 554792 + dihydropteroate synthase
4632900 4634141 + multidrug transporter
4638808 4639326 - Transcriptional regulator, MarR family protein
4646942 4648030 - ABC-type_sugar_transport_system,_periplasmic_component
4682645 4683964 - xylose isomerase
4684337 4685830 + Xyloside transporter
4685889 4687568 + beta-xylosidase
4845809 4846771 + Phosphatidylserine_decarboxylase psd
4853100 4854890 + fumarate reductase frdA
4854835 4855617 + frdB
4855628 4856023 + fumarate reductase frdC
4856004 4856393 + frdD
4856507 4857040 + Bacterial_lipocalin
4857037 4857354 - Membrane_transporter_of_cations_and_cationic_drugs sugE
4874086 4875387 + C4-dicarboxylate ABC transporter DcuA
4901698 4904016 - Ferrienterobactin receptor precursor fepA
4996917 5000978 - rpoB
5005173 5006357 - elongation factor Tu
5149976 5150674 + cpxR
5150671 5152044 + Sensor protein cpxA
5160685 5161671 + ABC-type_sugar_transport_system,_periplasmic_component rhaS
5256865 5258115 - Chloramphenicol resistance protein
~1.3 Mb
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FIGURE S1
Clustering of core SNPs in the 319 Klebsiella pneumoniae genomes. The phylogenetic reconstruction is shown on the left, while the core SNP 
frequency is shown on the right, in shades of red representing number of core SNPs per 1000bp windows for each genome. Detected 
recombinations are indicated on the top of the ﬁgure, main clades detected in the phylogenetic analysis are indicated on the 
right side of the ﬁgure.
FIGURE S2
Recombination analysis obtained with BRATnextgen. A subdataset of 187 genomes was used as input for a 100 iteration 
analysis with 100 replicates with the BRATnextgen software. The recombination proposed by Chen and coworkers is detected 
in green while the recombination proposed in this work is detected in blue. Recombined regions as detected with the SNP-
based method are indicated with boxes, using the same colors as those chosen by the BRATnextgen software.
FIGURE S3
FIGURE S3. Phylogeny of the 319 Klebsiella pneumoniae genomes based on core SNPs in non-recombined
regions. Phylogeny was reconstructed starting from an alignment of 55,368 core SNPs, located outside of
the two main recombined regions of the genome, using the software RAxML, with the Generalised time-
reversible (GTR) model and 100 bootstrap replicates. Bootstrap is shown only for the three main nodes of
Clonal Complex 258.
FIGURE S4
phylogeny of  the 319  Klebsiella pneumoniae genomes based on core SNPs in the ~1.3Mb recombined
region. Phylogeny was reconstructed starting from an alignment of 24,537 core SNPs present only in the
recombined region located from 4,554,906 to 629,621, spanning the origin of replication, using coordinates
of  genome NJST258_1.  The  tree  was obtained  using  the software  RAxML,  with  the  Generalised  time-
reversible (GTR) model and 100 bootstrap replicates, bootstraps are shown only for nodes of interest. The
putative donor of the ~1.3Mb recombined region, 67BO, results as sister clade of the recipient CC258.
FIGURE S5.  phylogeny of the 319  Klebsiella pneumoniae genomes based on core SNPs in the ~1.1Mb
recombined region. Phylogeny was reconstructed starting from an alignment of 14,905 core SNPs present
only  in  the  recombined  region  located  from  1,675,550  to  2,740,033,  using  coordinates  of  genome
NJST258_1. The tree was obtained using the software RAxML, with the Generalised time-reversible (GTR)
model and 100 bootstrap replicates, bootstraps are shown only for nodes of interest. The putative donor of
the ~1.1Mb recombined region, Kp13, results as sister clade of the recipient CC258 clade, with the exclusion
of the ST11 clade.
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Supplementary Figure 1. Global phylogeny of the species Acinetobacter baumannii obtained using 
fasttree on a dataset of core SNPs. The genomes of the Sequence Type 78 are highlighted in red 
and indicated with an arrow; names of the strains are not reported for seek of better visualization. 
  
 
 
Supplementary Figure 2. Synteny analysis of the plasmids containing the gene blaOXA-58 among all 
strains of the Sequence Type 78. The analysis was run on the software Mauve. 
  
  
 
Supplementary Figure 3. Structure of the genomic locus encompassing the gene blaOXA-58 in the 
three newly described Acinetobacter baumannii plasmids and the previously described plasmids 
p3909 and p183Eco 
  
  
Isolate MIC (μg/ml) Biofilm formation 
capability (OD600) 
MER IPM 
2MG 0.75 0.38 0.4 0.4 0.4 
65SM01 0.75 0.75 0.4 0.4 0.3 
5MO >32 >32 0.6 0.7 0.5 
2RED09 >32 >32 0.4 0.4 0.6 
14336 >32 >32 0.4 0.4 0.5 
20C15 >32 >32 0.6 0.4 0.6 
25C30 >32 >32 0.5 0.5 0.5 
96SM 1 0.5 0.6 0.7 0.4 
103SM 1 0.38 0.6 0.7 0.5 
74SM01 0.75 0.5 0.4 0.4 0.3 
MGTN 1 0.5 0.4 0.4 0.4 
72SM01 0.5 0.38 0.6 0.7 0.8 
68SM01 >32 0.38 0.2 0.7 0.5 
MONUR >32 0.38 0.5 0.5 0.5 
3909 32 6 0.4 0.4 0.4 
61SM01 >32 0.38 0.5 0.5 0.3 
 
Supplementary Table 1. Phenotypic testing on the 16 Italian strains. A. Results of Minimum 
Inhibitory Concentration using the E-test method. B. Results of the biofilm formation capability assay 
  
Table 2-A 
Strain blaOXA-90 ISAba1 blaOXA-58 blaOXA-23 blaADC-52 
blaCARB-
PSE 
carO adeR adeS floR sul2 aadB aph(3')-Ic	
2MG x x   1SNP x x x x x x x x	
2RED09 x x x  1SNP  x x x x x x x	
5MO x x  x 1SNP  x x x x x x x	
20C15 x x x x 1SNP  x x x x x x x	
25C30 1SNP x   1SNP  x x x x x x x	
61SM01 x x   1SNP  x x x x x x x	
65SM01 x x   1SNP  x x x x x x x	
68SM01 x x   1SNP x x x x x x x x	
72SM01 x x   1SNP  x x x x x x x	
74SM01 x x   1SNP  x x x x x x x	
96SM x x   1SNP  x x x x x x x	
103SM x x   1SNP  x x x   x x	
14336 x x x  1SNP  x x x   x x	
MGTN x x   1SNP  x x x x x x x	
MONUR x x   1SNP  x x x x x x x	
3909 x x x  1SNP  x x INT x x x x	
TG22142 3SNP x   1SNP x x x INT x x x x	
TG22146 3SNP x   1SNP x x x INT x x x x	
TG22150 3SNP x   1SNP x x x INT    x	
UH5207 x    x  x x x     
1096934 x    x  x x x     
831240 x    x  x x x     
855125 x    x  x x INT     
UH1752 x x   x  x x x     
ABBL025 x    x  x x x     
ABBL026 x    x  x x x     
	
Supplementary Table 2-A. Results of the refined analysis of presence of genes of interest of the 
following categories: A. Resistance. B. Virulence. C. Competence. D. Biofilm formation
Table 2-B 
Strain pil genes*  ptk cap8J zur hcp pmt entE sc1 bfmR envZ ompF ostA pbpG ptk rstA epsA bap	
2MG x x x x x x x x x x x x x x x  x	
2RED09 x x x x x x x x x x x x x x x  x	
5MO x x x x x x x x x x x x x x x  x	
20C15 x x x x x x x x x x x x x x x  x	
25C30 x x x x x x x x x x x x x x x  x	
61SM01 x x x x x x x x x x x x x x x  x	
65SM01 x x x x x x x x x x x x x x x  x	
68SM01 x x x x x x x x x x x x x x x  x	
72SM01 x x x x x x x x x x x x x x x  x	
74SM01 x x x x x x x x x x x x x x x  x	
96SM x x x x x x x x x x x x x x x  x	
103SM x x x x x x x x x x x x x x x  x	
14336 x x x x x x x x x x x x x x x  x	
MGTN x x x x x x x x x x x x x x x  x	
MONUR x x x x x x x x x x x x x x x  x	
3909 x x x x x x x x x x INT x x x x  x	
TG22142 x x x x x x x x x x x x x x x  x	
TG22146 x x x x x x x x x x x x x x x  x	
TG22150 x x x x x x x x x x x x x x x  x	
UH5207 x x  x x x x x x x x x x x x x x	
1096934 x x  x x x x x x x x x x x x x x	
831240 x x  x x x x x x x x x x x x x x	
855125 x x  x x x x x x x x x x x x x x	
UH1752 x x  x x x x x x x x x x x x x x	
ABBL025 x x  x x x x x x x x x x x x x x	
ABBL026 x x  x x x x x x x x x x x x x x	
	
*. pil genes are A, B, C, F, M, O, Q, W, R, S, T, and U.	
	
Supplementary Table 2-B. Results of the refined analysis of presence of genes of interest of the 
following categories: A. Resistance. B. Virulence. C. Competence. D. Biofilm formation	
 
 
Table 2-C 
Strain comEC comB comC comD comE	
2MG INT x x x x	
2RED09 INT x x x x	
5MO INT x x x x	
20C15 INT x x x x	
25C30 INT x x x x	
61SM01 INT x x x x	
65SM01 INT x x x x	
68SM01 INT x x x x	
72SM01 INT x x x x	
74SM01 INT x x x x	
96SM INT x x x x	
103SM INT x x x x	
14336 INT x x x x	
MGTN INT x x x x	
MONUR INT x x x x	
3909 INT x x x x	
TG22142 x x x x x	
TG22146 x x x x x	
TG22150 x x x x x	
UH5207 x x x x x	
1096934 x x x x x	
831240 x x x x x	
855125 x x x x x	
UH1752 x x x x x	
ABBL025 x x x x x	
ABBL026 x x x x x	
	
Supplementary Table 2-C. Results of the refined analysis of presence of genes of interest of the 
following categories: A. Resistance. B. Virulence. C. Competence. D. Biofilm formation 
Table 2-D 
Strain csuA csuB csuC csuD csuE ompA pgaA pgaB pgaC pgaD bfmS bfmR	
103SM x x x x x x x x x x x x	
1096934 x x 1SNP x x x 1SNP x x x 1SNP x	
14336 x x 1SNP x x x x x x x 1SNP x	
20C15 x x 1SNP x x x x x x x 1SNP x	
25C30 x x 1SNP x x x x x x x 1SNP x	
2MG x x 1SNP x x x x x x x 1SNP x	
2RED09 x x 1SNP x x x x x x x 1SNP x	
3909 x x 1SNP x x x 1INS (Stop Codon)# x x ND* 1SNP x	
5MO x x 1SNP x x x x x x x 1SNP x	
61SM01 x x 1SNP x x x x x x x 1SNP x	
65SM01 x x 1SNP x x x x x x x 1SNP x	
68SM01 x x 1SNP x x x x x x x 1SNP x	
72SM01 x x 1SNP x x x x x x x 1SNP x	
74SM01 x x 1SNP x x x x x x x 1SNP x	
831240 x 1SNP 2SNP 1SNP x x 2SNP x x x 1SNP x	
855125 x x 1SNP x x x 1SNP 1INS (Stop Codon)## x x 1SNP x	
96SM x x x x x Triplet INS x x x x x x	
ABBL025 x x 1SNP x x x 1SNP x x x 2SNP x	
ABBL026 x x 1SNP x x x ND** x x x 1SNP x	
MGNT x x 1SNP x x x x x x x 1SNP x	
MONUR x x 1SNP x x x x x x x 1SNP x	
TG22142 x x 1SNP x x x x x x x 1SNP x	
TG22146 x x 1SNP x x x x x x x 1SNP x	
TG22150 x x 1SNP x x x x x x x 1SNP x	
UH1752 x x 1SNP x x x 1SNP x x x 1SNP x	
UH5207 x x 1SNP x x x 1SNP x x x 1SNP x	
	
* the first 239 bases are not assembled; i.e. the contig ends at base 239 in a +/+ alignment. No evidence of the presence 
of the other half 
** the gene is split in two different contigs, no sign of insertion sequences. Impossible to determine if it is an assembly error 
#  insertion of an adenine in position 805, Stop codon at base 840  
## insertion of a timine in position 1203, Stop codon at base 1227 
Please note: all SNPs indicated are mutations of the allele found in strain 103SM 
 
 
Supplementary Table 2-D. Results of the refined analysis of presence of genes of interest of the 
following categories: A. Resistance. B. Virulence. C. Competence. D. Biofilm formation 
 
 
 
 
Strain IS5 ssgr IS903 
IS3 ssgr 
IS51 
IS5 ssgr 
IS427 IS1 ISL3 IS6 
IS4 ssgr 
IS10 
IS3 ssgr 
IS150 IS256 
IS3 ssgr 
IS3 IS91 IS66 
IS5 ssgr 
ISL2 ISNCY 
74SM01 28 0 0 0 3 4 9 3 0 0 6 13 0 0 
65SM01 18 0 0 0 3 4 2 2 0 0 8 13 0 1 
20C15 62 12 0 3 1 26 9 3 0 0 5 6 0 0 
72SM01 6 0 0 0 3 25 2 6 0 0 2 5 0 1 
14336 20 3 0 2 3 18 10 1 0 0 0 8 0 0 
MONUR 5 0 0 0 2 20 11 4 0 0 7 32 0 1 
MGTN 20 0 0 0 3 18 10 5 0 0 7 12 0 1 
96SM 4 0 0 0 3 32 6 5 0 0 6 41 0 1 
103SM 31 0 0 0 3 9 7 2 0 0 0 48 0 1 
2MG 11 0 0 0 1 4 4 5 0 1 10 6 0 1 
5MO 12 0 0 0 3 5 7 2 0 0 10 10 2 1 
3909 2 1 0 2 3 2 2 2 0 0 4 1 0 0 
61SM01 17 0 0 0 3 3 5 5 0 0 6 6 0 1 
25C30 2 0 0 0 2 19 6 3 0 0 8 9 0 1 
68SM01 3 0 0 0 3 12 2 8 0 1 8 5 0 1 
2RED09 4 5 0 3 3 32 4 3 0 0 2 6 0 1 
TG22146 5 0 0 0 3 7 40 6 0 1 4 4 0 1 
TG22142 1 0 0 0 3 7 36 7 0 1 5 43 0 1 
TG22150 2 0 0 0 3 1 2 3 0 1 2 2 0 1 
831240 3 0 1 0 4 0 0 0 0 2 0 0 0 1 
UH5207 3 1 0 0 4 0 0 0 0 1 0 0 1 1 
1096934 3 1 0 0 3 0 0 0 0 1 0 0 1 1 
855125 1 0 0 0 3 0 0 0 0 4 0 0 1 1 
ABBL026 0 0 0 0 3 0 0 0 6 0 0 0 0 0 
UH1752 3 1 0 0 4 0 2 0 0 1 0 0 1 1 
ABBL025 4 0 0 0 4 1 2 0 0 0 0 0 1 1 
 
Supplementary Table 3. Number of insertion sequences of different classes detected by the platform ISSaga on each genome of the ST78. The 
number reported is the total number of putative sequence detected by the algorithm 
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